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Abstract 
 
Introduction: There is a nationwide shortage of sperm donors and over the last few 
years this has been evident at Newcastle Fertility Centre (NFC). As the most common 
cause for rejection of sperm donors is suboptimal semen quality, external factors that 
may influence semen quality (i.e. season and vitamin D) were studied to investigate 
their impact (if any) to improve donor recruitment. 
 
Methods: A retrospective review of donor sperm treatments at NFC between Jan 2000 
and Dec 2010 was performed to investigate sperm donor shortage. A retrospective 
review (Dec 2006 to Nov 2009) and a longitudinal study (32 sperm donors) of the 
semen analyses were conducted to investigate seasonal variation in semen parameters. 
We performed a retrospective review of donor insemination treatments over 6 years to 
investigate seasonal variation in donor conceptions. The correlation between semen 
parameters and serum vitamin D was investigated in a cross sectional study (125 
participants) and a cohort study, to examine the change in semen parameters with a rise 
in serum vitamin D level (with vitamin D supplementation and seasonal rise).  
 
Results: A significant reduction in the number of sperm donors recruited and a smaller 
pool of available donors was seen, which lead to fewer patients receiving treatment and 
a longer wait for treatment. Seasonal variation with improved semen parameters in 
winter / spring was noted, but was more prevalent in sperm donors than in patients 
attending NFC. However, there were no variation donor conceptions by the season of 
original sperm production. In the cross sectional association study there was no 
significant difference in the semen parameters between men with different serum 
vitamin D levels, however in the cohort study, semen parameters deteriorated 
significantly with increased serum vitamin D levels secondary to vitamin D 
supplementation and also seasonal rise. 
 
Conclusions: A significant local problem of sperm donor shortage is confirmed. 
Despite significant seasonal differences in donor semen parameters (but not donor 
conceptions), we do not recommend restricting recruitment of sperm donors to winter / 
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spring. A negative association between vitamin D and semen parameters is noted; 
therefore vitamin D supplementation should not be recommended to improve to semen 
parameters.
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Chapter 1 Introduction 
 
1.1 Is there a problem with the sperm donor recruitment currently at Newcastle 
Fertility Centre?  
Assisted conception treatment with donor sperm is a vital treatment option for couples 
with severe male factor infertility, same sex couples and single women. Between 1992 
and 2009, 26,638 children were born in the UK from 226,662 cycles of treatment with 
donor sperm (HFEA, 2011). The need for donor sperm treatment continues despite the 
wide availability of ICSI, which since 2000 has become a well-established treatment for 
male factor infertility (Hamilton et al., 2008a; Pacey, 2010). It is estimated that 
approximately 4000 patients need donor sperm treatment every year (Hamilton et al., 
2008a) in the UK.  
 
Over recent years, at the Newcastle Fertility Centre (NFC), a long waiting time for 
donor sperm treatments (about 18 months) has developed with the perception of an 
increase in the amount of sperm imported to the centre from overseas commercial sperm 
banks. These issues were non-existent in the early part of the 21st century, but 
significant national and local changes since then have influenced the sperm donor 
programme at the centre and various strategies have been introduced to cope with the 
changes. 
  
The significant national changes were: 
1. Removal of gamete donor anonymity in 2005. 
2. Changes to the sperm donor payment in 2006. 
3. Guidelines for the screening of sperm (egg and embryo) donors updated in 2008. 
 
The local changes are:  
1. Introduction of a comprehensive integrated Andrology service in 2009. 
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1.1.1 Removal of sperm donor anonymity 
Assisted conception treatment with donor sperm was legalized in the UK from 1992, 
(HMSO, 1990) although it had been practiced from the 1930s in secrecy (Frith, 2001). 
Mary Barton published on the use of donor sperm to treat what was described as 
incurable male infertility and for genetic reasons (Barton, 1945). This was condemned 
across the world and specifically by religious leaders. 
 
Over the following few decades, committees were set up to consider various aspects of 
artificial insemination with donor sperm. Namely the Feversham Committee (Earl of 
Feversham’s report 1960), which held the view that donor insemination should not be 
allowed and the Peel committee (Peel report 1973), which accepted that donor 
insemination treatment should be carried out in the NHS, available as a clinical service 
from 1968. During these years donor insemination treatments were carried out with 
anonymous sperm donation and without any regulation or maintenance of records.  
 
The UK government in 1982 appointed a Committee of Inquiry into Human 
Fertilisation and Embryology under the guidance of Mary Warnock to ensure that the 
new technology of IVF was not abused. The Warnock Report published in 1984, 
included recommendations on the issues of the creation of embryos in vitro, the storage 
of gametes / embryos and on research involving embryos. The Warnock Report,  
essentially supported the practice of treatment with donor sperm but suggested that it 
should remain anonymous to prevent any disturbance in the family dynamics (Spallone, 
1986). 
 
With anonymous sperm donation treatments, the woman’s husband was registered as 
the birth father to keep the birth origin a secret. In reality this was an offence against the 
law until the 1987 Family Law Reform Act, which gave the right to the women’s 
husband to register as the father legally (McWhinnie, 2001). 
 
The Human Fertilisation Embryology Act 1990 (which was implemented from August 
1991) legitimised donor sperm treatment. The act supported anonymous sperm donation 
and also gave protection to the sperm donor with no legal liability for any off spring. 
The act also led to the establishment of the Human Fertilisation Embryo Authority 
(HFEA) as an independent regulator of all treatments and research involving gametes 
and embryos, which is answerable to Parliament.  
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Only HFEA licensed centres can offer treatment with donor sperm and the HFEA 
maintains a central register for all donors and the information on donor-conceived 
children. The information about the donor was held only to allow tracking if the child 
was diagnosed with any heritable disorder. In exceptional circumstances a donor 
offspring upon reaching 18 years can sue the donor if born with a disability which the 
donor should have disclosed (Van den Akker, 2006). The Act also put in place a legal 
safeguard at the time that should the practice of anonymity be considered to be 
removed, it would need to be done by legislation (Frith, 2001). 
 
The first country to remove donor anonymity was Sweden in 1984 (Frith, 2001). Since 
then approximately 35 countries, mainly economically developed countries like Austria, 
Germany, Finland, Norway, Holland, Switzerland and also Australia and New Zealand 
have moved to non-anonymous sperm donation (Janssens et al., 2011), where the child 
born from donor sperm treatment has a right to know the identifying details of the 
genetic father when they reach majority, which varies from 16 to 18 years in different 
countries. 
 
Removal of donor anonymity has been an issue of public debate in the UK from about 
the 1990s (Cooke, 1993; Haimes, 1993; Snowden, 1993; HFEA, 1998). The debates on 
this topic were published in various journals such as articles published in the Journal of 
assisted Reproduction and Genetics in 1997 entitled ‘Controversies in assisted 
reproduction and genetics -Privacy versus disclosure’ and in 2001 in Human 
Reproduction titled ‘Gamete donation and anonymity’. Some of these and others’ 
arguments are presented in the following paragraphs. 
 
The fundamental issue raised in support of removing anonymity was that it is a child’s 
right to know their parents identity as per the 1989 United Nations Convention on the 
Rights of the Child (McWhinnie, 2001), although this was written for children in 
general and not taking children born by gamete donation specifically into account 
(Frith, 2001). It has been suggested that they have a right to know the truth (Daniels and 
Taylor, 1993) and the importance of genetic knowledge for health information was 
emphasized (Van den Akker, 2006).  
 
A frequent theme emerging from the life experiences of donor offspring is that the 
system in place deceived them and was not justified (McWhinnie, 2001). As the HFEA 
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Code of Practice emphasizes that women are offered treatment only after accounting for 
the  ‘welfare of the child’ to be born as a result of treatment, (Shenfield, 1994; Daniels, 
1997) secrecy may not be considered in their best interest (Van den Akker, 2006). The 
qualitative study by Turner and Coyle of 16 donor-conceived adults between the ages of 
26 and 55 has raised issues in donor conceived children such as a lack of trust in the 
family, a struggle to cope with their new identity and frustration because of opposition 
in the quest for their biological parent (Turner and Coyle, 2000).  
 
Although there were concerns about the psychological wellbeing of children due to the 
damaging effect of secrecy and deception, (Daniels and Taylor, 1993) generally it was 
shown that children conceived using donor sperm develop normally with good 
psychosocial and emotional wellbeing and good parent-child relationships between 
parents and donor offspring (Golombok, 1997; McWhinnie, 2001; Van den Akker, 
2006). However, it is also acknowledged that as the majority of children born by sperm 
donation treatments are unaware of the truth (Janssens et al., 2006; Van den Akker, 
2006), it is difficult to conduct large enough studies to know with certainty the impact 
of disclosure and anonymity (Frith, 2001; McWhinnie, 2001). 
 
The concerns about removing anonymity included the parental worries about the 
rejection of the child by relatives, also the possibility of the child having to face 
isolation and bullying by their peers. Moreover the practice of anonymity helped the 
couple keep the male infertility problem a secret (Daniels and Taylor, 1993; Frith, 
2001). Parents were worried that revealing the truth may cause psychological problems 
and rifts in the family, particularly between a father and his son (Frith, 2001). 
 
While most of the damaging effects on donor offspring by denying them the knowledge 
of their birth origins is inferred from the literature on adopted children (Golombok, 
1997), it was argued that the two groups are in fact different, as unlike adopted children, 
donor offspring are not disowned by their biological parents and also have direct genetic 
links with their mother (Frith, 2001).  Despite the fact that clinicians and regulators in 
Reproductive Medicine worried about a potential fall in donor numbers, associated with 
the removal of donor anonymity (Cooke, 1993; Daniels and Taylor, 1993; Snowden, 
1993; Hunt and Fleming, 2002; Dyer, 2004; Daniels et al., 2005; Van den Akker, 2006), 
it was maintained  that it did not  justify denying the donor offspring the truth of their 
birth origin (Gollancz, 2001). 
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Donor conceived children campaigned for a change in the law to remove donor 
anonymity (Gollancz, 2001; Hamilton, 2010; Pacey, 2010). A public consultation was 
held in 2001 by the Department of Health to consider the issue (Department of Health, 
2001). Although the British Fertility Society in general supported the move towards 
openness from anonymity, it felt that it was not the time for a radical change as both 
donors and recipients needed to be prepared for this with information, support and 
counselling. The concern of possible decline in the number of sperm donors coming 
forward was discussed. However, the idea of a twin track system with both anonymous 
and identifiable donors was not favoured to avoid discrimination and also to avoid 
potential conflicts in families where anonymous donors were used (Hunt and Fleming, 
2002). 
 
Following the feedback from public consultation alongside a background of  public 
debates and campaigns from donor conceived individuals, the HFEA Disclosure of 
donor information Regulations 2004 (HMSO, 2004) was approved in the UK 
Parliament, which meant that prospectively donor conceived children would be allowed  
to know identifying information about their donor when they reached the age of 18. 
Only donors who agreed to be identified to the children born of their donation could be 
registered with the HFEA after 1st April 2005, which means that donor conceived 
children from 2023 will be able to contact their genetic parent (if they were aware that 
they were conceived using a donor gamete and wished to make contact with their 
biological parent). The amended Act came into force from 1st April 2005 and was not 
applied retrospectively. Licensed centres were allowed a transition period of one year 
during which they could continue to offer the service using previously recruited 
anonymous donors whilst recruiting identifiable donors. Therefore the Act was 
implemented in full with identifiable donors only from April 2006. Thereafter 
anonymous sperm donations from prior to 2005 could only be used for siblings of 
children conceived with the same donors. 
 
After the removal of anonymity, a shortage of donor sperm was reported through 
workshops and surveys (Pike and Pacey, 2005; BBC survey, 2006).  The experience 
from other countries that moved from anonymous to open donations prior to the UK 
(Austria, Australia and The Netherlands) has shown that the change did not negatively 
affect donor recruitment although the evidence was limited at the time of regulatory 
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change in the UK (Hunt and Fleming, 2002; Van den Akker, 2006; Blyth and Frith, 
2008).  
 
Sweden appeared to recover from the shortage (Daniels and Lalos, 1995; Gollancz, 
2001; Dyer, 2004; Van den Akker, 2006), but recent reports  indicate a shortage of 
sperm donors, long waiting time for donor sperm treatments and more than 250 
Swedish sperm recipients  travelling abroad  every year  for treatment, suggesting that 
the donor supply does not meet their needs (Ernst et al., 2007; Ekerhovd and Faurskov, 
2008). 
 
 In the Netherlands where gamete donor anonymity was abolished in 2004, during the 
15 years of debate that preceded the legislative change, the number of donors decreased 
by more than 70% and the number of sperm banks by 50% (Janssens et al., 2006). A 
questionnaire study on Danish sperm donors’ views suggested that lifting anonymity 
may lead to shortage of sperm donors (Ernst et al., 2007). In Denmark anonymous 
sperm donation is legal and Denmark also has (for unknown reasons) a higher number 
of sperm donors than other European countries (Pennings, 2010).  
 
However a sperm donor shortage is seen globally and is not restricted to countries 
where donor anonymity has been removed. A decline in sperm donors has been reported 
in France, where donor anonymity is protected (Blyth and Frith, 2008). In the United 
States where there is no legislation regarding gamete donation (both identifiable and 
anonymous donors are accepted), an internet search of the 31 centres offering donor 
insemination which also recruit their own donors, showed that the number of open 
identity programmes were increasing and more importantly the longer a centre had 
offered an open identity donor recruitment programme, the higher the ratio of 
identifiable to anonymous donors (Scheib and Cushing, 2007) suggesting a shift 
towards being identifiable. 
 
1.1.2 Payment to the donors   
Prior to the HFEA, the payment to sperm donors for their donation was decided by local 
policies and these payments varied considerably from minimal to large amounts. When 
the HFEA was established it was decided that all clinics who were paying donors prior 
to 1991 could continue to do so with an upper limit set at £15 in addition to  ‘reasonable 
expenses’, whilst clinics paying less than £15 were not allowed to increase to £15 and  
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new clinics were not allowed to make any payments at all until the authority had 
considered the issue in greater depth in the future (HFEA, 1996; Johnson, 1997).  
 
The intention of the HFEA was to eventually phase out donor payment, and although it 
was unsure over what period the transition should take place research was 
commissioned to obtain information on the clinics’ views on semen donation and the 
attitudes and motivations of semen donors.  
 
A cross sectional survey of 144  sperm donors from 14 clinics revealed that 81% of 
donors were young, single students mainly motivated by payment and a survey of 81 
fertility centres  in the UK reported that the centres estimated to lose more than 80% of 
their donors, if the donors were not paid (Golombok and Cook, 1994; Cook and 
Golombok, 1995). The working group set up by HFEA reported in 1998, that gamete 
donation should be a gift voluntarily given with informed consent. The donation should 
be financially neutral; therefore the donors were to be reimbursed for the expenses 
incurred as a result of the donation but not for any loss of earnings. However 
recognizing that the removal of payments would further jeopardize the recruitment of 
donors, the HFEA decided to allow the centers to continue with payments of up to £15 
for each gamete donation. So overall the sperm donors received £15 and a 
reimbursement of the expenses for donation (HFEA, 1998).  
 
Sperm donors donate on an average 45 times to allow enough semen samples to create 
10 families (Paul et al., 2006). As the payment was for each donation, the sperm donors 
eventually received a higher total payment compared to egg donors because of the 
multiple ejaculates donated (Gazvani et al., 1997; Pacey, 2010). 
 
The discussion on payments to gamete donors has been ongoing since the 
commencement of HFEA in 1991. Some of the arguments are outlined below. 
 
1.1.2.1 Arguments in favor of nonpayment of donors 
The term ‘donation’ means an act of generosity whilst receiving payment alters the 
perception to one that views human gametes as a commodity. (Johnson, 1997; Pennings, 
1997). Offering payment for the donation will promote a market for buyers and sellers 
of human body parts; the social implications of this being that the donor-conceived 
child could be perceived as a commodity from a commercial transaction and the welfare 
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of the child might therefore be compromised (Johnson, 1997; Yee, 2009; Hamilton, 
2010). Furthermore payment may encourage both clinics and patients to relegate the 
role of a sperm donor in donor insemination treatment (Johnson, 1997). 
 
 Payment can financially induce donors by attracting vulnerable groups such as students 
or unemployed people. Financially motivated donors may not fully consider the 
implications of their donation. They may fail to recognize the potential emotional or 
psychological impact of their donation, the potential to generate problems in their own 
families in future and may even regret their decision years later (Johnson, 1997; 
Pennings, 1997).  
 
The applicants could equally falsify their medical history and conceal important medical 
information that would otherwise make them unsuitable to become a donor (Guerin, 
1998). However it is important to acknowledge that there is no evidence to suggest that 
paid donors were at higher risk for the transmission of any genetic or infectious diseases 
when compared to altruistic donors (Yee, 2009). On the contrary, altruistic donors with 
well-established careers may find payment demeaning which may in turn deter them 
from donation (Yee, 2009). 
 
1.1.2.2 Arguments in favor of payment of donors 
Studies have shown that removal of payments will further reduce the number of donors 
(Golombok and Cook, 1994; Gazvani et al., 1997). The arguments in favor of payment 
to the donors are that the process of donation involves time, effort and also expense to 
the donor. It is not acceptable and amounts to exploitation if donors lose financially by 
donating gametes. Donors should be allowed fair payment for their time, effort, 
inconvenience and loss of earnings during the course of the donation, although 
authorities have difficulty in calculating the appropriate compensation for 
inconvenience that does not involve risk (Johnson, 1997; HFEA, 2011f). 
 
The idea that sperm donation should be a gift without any background financial 
motivation, in circumstances where the patients are paying up to £8000, in a private 
setting for their fertility treatment and where private fertility specialists in the so called 
‘fertility industry’ make good money by treating infertility, is argued to be inconsistent 
and irrational (Blackburn-Starza, 2009; Hamilton, 2010). It was widely argued that UK 
sperm donors were not adequately compensated and yet clinics were using imported 
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sperm from overseas commercial sperm banks, where the donors may have been paid 
(Heng, 2007; Hamilton, 2010; Tomlinson et al., 2010).  
 
Removal of payment to donors has the potential to attract different groups of men who 
may consider donating for the wrong reasons such as to prove their own fertility; 
however it can be argued that they are likely to come even if paid. Paid donors are likely 
to be more emotionally and psychologically detached from the outcome of their 
donation and therefore may be preferred to altruistic donors (Pennings, 1997; Yee, 
2009). 
 
Previously the majority of sperm donors were young single students. Many studies 
showed that they were motivated by the payment unlike married men with children who 
were keen on altruistic donation.  Only studies with students showed that payment is the 
reason to donate and that they would stop donating if not paid (Cook and Golombok, 
1995; Daniels et al., 2006). The HFEA SEED review in 2004-5, revealed that the 
commonest age group for sperm donors was between 36 and 40. 69% of the donors 
were aged above 30 and 41.5% of the donors already had children. This is in contrast to 
1994-1995 when the commonest age for sperm donors was between 18- 24 and only 
21% of them had children of their own at the time of donation (SEED Report, 2005). 
This suggests a move towards more altruistic donors (Hamilton, 2010). Also a review of 
the 22 studies between 1980 and 2003 on sperm donors revealed that men who are 
willing to be identified shared their demographics (such as age and parental status) with 
men keen on altruistic donation (Daniels et al., 2006). 
 
The regulations on payment were further considered in the Sperm, Egg and Embryo 
Donation Review (SEED), which was published in January 2006 and implemented from 
1
st
 April 2006. The SEED Review steering group considered the evidence from a survey 
of UK clinics and reviewed the scientific evidence supporting HFEA policies followed 
by public consultation to produce the report. 
 
At the time, the UK also adopted the EU Tissues and Cells Directive which led to a 
requirement to comply with new standards of quality and safety. Article 12(1) of the EU 
Tissues and Cells Directive provides that ‘Donors may receive compensation which is 
strictly limited to making good the expenses and inconveniences related to the 
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donation’. (Directive 2004/23/EC, 2004).This essentially supported voluntary and 
unpaid donations. 
 
The SEED review concluded  
 ‘Donors may be reimbursed all demonstrable out-of-pocket expenses incurred 
within the UK in connection with gamete or embryo donation’. 
 In addition to reimbursement of out-of-pocket expenses, donors may be 
compensated for loss of earnings (but not for other costs or inconveniences) up 
to a daily maximum commensurate with jury service but with an overall limit of 
£250 (or the equivalent in local currency) for each ‘course’ of sperm donation 
or each cycle of egg donation. 
 Gamete donors may receive benefits in kind in return for supplying gametes for 
the treatment of others but these benefits should be limited to discounted 
treatment services (SEED Report 2005).  
 
However a “course” of donation was interpreted variously, even though the HFEA has 
defined it as the period commencing from the first consultation to the release of sample 
for treatment. It could be applied to a single sample or to all the samples donated by a 
single donor (Tomlinson et al., 2010). Sperm donors donate about 45 times on average 
(Paul et al., 2006) and an amount of 250 pounds for the entire course of donation is 
unlikely to cover all the costs incurred by the donor during the process of donation. In 
2004 in Canada, the implementation of the Assisted Human Reproduction Act, led to 
the replacement of donor payment with reimbursement limited to reasonable expenses. 
In a study by Del Valle et al. (2008), of the 246 donor applicants who responded to the 
survey, 37.5% were willing to participate without reimbursement, whilst 44.4% 
declined and 18.1% were unsure, revealing the difficulty in recruitment without 
financial incentive. However, the willingness to participate without reimbursement was 
similar in all age groups, irrespective of occupation, marital status or whether the 
potential donor had children or not, contrary to previous findings. 
 
It is noteworthy that in France, semen donation is entirely altruistic and has been offered 
for over 30 years (the donors are men living together with a woman, who have at least 
one child and are anonymous). Although a decline in donors has been reported, it 
reveals that donor recruitment is possible without payment (Guerin, 1998; Daniels et al., 
2006; Blyth and Frith, 2008). 
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In early 2011 the HFEA launched a 3 month public consultation to review some policies 
with a view to improve sperm and egg donation services in UK. The outcome of the 
consultation raised the possibility that donors might be losing money due to the expense 
incurred and inconvenience of donation. Compensation had to be decided at a level that 
would not deter men interested in donation, but at the same time would not financially 
induce donors.   Following the consultation the new policy allows a fixed sum of £35 
per visit including expenses for sperm donors. Gamete donors may continue to receive 
benefits in kind such as discounted treatment services or moving up the waiting list for 
treatment (HFEA, 2011a). The new policy is outside the period examined in this study 
and its impact will only be revealed over the next few years. 
 
1.1.3 Updated UK guidelines for the screening of sperm donors 
The guidelines in 2008 (Association of Biomedical Andrologists et al., 2008), 
formulated by a multi-disciplinary group including BFS (British Fertility Society), BAS 
(British Andrology Society) and RCOG (Royal college of Obstetrics and Gynaecology) 
updated the 1999 British Andrology Society (BAS) guidelines (British Andrology 
Society, 1999) for the screening of sperm donors. The major changes to the previous 
guidelines included screening for Human T cell Lymphotropic viruses (HTLV) 1 and 2 
and to exclude men with considerable risk of transmissible spongiform 
encephalopathies from donating sperm. The introduction of new guidelines did not lead 
to increased rejection of donors and therefore does not appear to have had any 
significant impact on the donor recruitment.  
 
1.1.4 A comprehensive Andrology service 
Locally, changes include the introduction of a comprehensive and integrated Andrology 
service in 2009 led by a Consultant Uro-Andrologist. Prior to 2009, the centre offered 
surgical sperm retrievals in the form of PESA (percutaneous epididymal sperm 
aspiration) and patients were referred elsewhere if they needed sperm retrievals for non-
obstructive azoospermia. Since 2009 the centre has offered advanced surgical sperm 
retrieval techniques including micro TESE (micro surgical testicular sperm extraction) 
which has made own gamete treatment accessible to many more couples. The 
treatments usually involve the female partner going through controlled ovarian hyper 
stimulation concurrently. If sperm retrieval is unsuccessful those couples who have 
already been counseled and accepted donor back up, continue with donor IVF (D-IVF) 
treatment.   
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1.1.5 Sperm donor shortage  
The British Fertility Society Working Party Report acknowledged a problem of donor 
sperm shortage which continued to affect the majority of UK fertility centres, leading to 
the cessation of donor sperm treatments in some centres. With the estimate that at least 
500 sperm donors are needed per year to meet the UK’s demand for treatment, 
(Hamilton et al., 2008a) and with what is generally a low recruitment rate of less than 
5% of applicants ultimately becoming sperm donors (Paul et al., 2006), a large numbers 
of applicants are needed to come forward to meet the demand for sperm donation. 
 
Many fertility centres have in the meantime introduced strategies to improve the 
efficiency of local donor recruitment. Despite the absence of published evidence, it is 
felt that centres have coped variably with the problem of sperm donor shortage. While 
the majority of UK fertility centres are struggling to recruit donors (Wardle, 2008), 
some centres are coping (Adams et al., 2006; Ahuja, 2008; Tomlinson et al., 2010). 
This problem of a national sperm donor shortage was recognised by the Department of 
Health and in consultation with the BFS in 2010, a project was funded to explore and 
improve national sperm donation although the findings have not yet been made public 
(Hamilton, 2010). Following a further public consultation in 2011 the HFEA introduced 
policies attempting to improve sperm donation services in the UK (HFEA, 2011f). 
 
Overall briefly, in view of the current long waiting time for donor sperm treatments of 
about 18 months and a perception of an increase in sperm imports to NFC over recent 
years, we have discussed the various changes nationally and locally in the early years of 
the 21
st
 century which may have had an influence on the centre’s sperm donor 
programme. The described study aims to analyse the changes or trends in various 
aspects of the sperm donor programme at the NFC over 11years from 2000 to 2010 to 
investigate if there is a problem with sperm donor recruitment. 
 
1.2 Factors effecting semen quality 
If a problem in donor recruitment is present then a more efficient use of existing 
resources may be of benefit. Previous work done at the centre revealed that only 3.63% 
of applicants were eventually released as sperm donors; 65% of applicants were rejected 
and the most common reason for this was suboptimal semen quality (Paul et al., 2006) 
which is similar to the  experience of several other UK fertility centres (Hamilton et al., 
2008a).  
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Suboptimal semen quality is a common problem and is poorly understood. Biological 
variation in semen quality is well known and is linked to accessory gland secretions, 
testicular size, sexual activity, length of abstinence and completeness of the sample 
collection at analysis. The intra-individual variations range widely and are associated 
with largely uncontrollable factors (World Health Organisation, 2010). Some external 
factors that may influence semen quality are reviewed here. Influences of season and 
vitamin D on semen parameters have been considered in the following sections as these 
two factors have been widely studied. A better understanding of their impact on semen 
parameters (if any) may be of value in improving the efficiency of a sperm donor 
programme and also donor recruitment. 
 
1.3 Season and semen parameters 
Seasonal variation in birth rate is reported in the majority of human populations, but the 
patterns have been variable (James, 1990; Rojansky et al., 1992; Bronson, 1995; 
Ombelet et al., 1996; Wellings et al., 1999). For instance there was a deficit of spring 
births in United States, but in Canada and Europe the births are at their highest in late 
winter and spring (Bronson, 1995; Levine, 1999). However, studies also reported on 
changing patterns over time and recently on decline or loss of seasonality in births in 
western countries (James, 1990; Russell et al., 1993; Cancho-Candela et al., 2007). 
 
 Seasonal variation in birth is mostly due to corresponding changes in conception which 
in turn could be due to variations in the frequency of intercourse, female factors, (such 
as egg quality / ovulation / endometrial receptivity), semen quality or the loss of 
embryos at an early stage (James, 1990; Rojansky et al., 1992; Bronson, 1995). Levine 
et al. (1990) suggested that the link may be stronger with a seasonal variation in semen 
parameters, as the female reproductive axis is protected from environmental changes by 
homeostatic mechanisms, as opposed to the restricted thermo regulatory capacity of the 
scrotum. Furthermore it was shown that the fluctuations in sperm parameters paralleled 
fluctuations in natural and IVF conceptions (Fisch et al., 1997; Ossenbühn, 1998). 
 
Seasonal variation in testicular function and spermatogenesis is seen in several animal 
species (Fraile et al., 1989; Gosch and Fischer, 1989; Chemineau et al., 2008). In 
humans also seasonal variation in semen parameters has been reported widely in the 
literature; however the findings are variable and inconsistent. Studies have been 
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conducted in various regions globally, but mostly in the Northern hemisphere (Levine et 
al., 1988; Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; Levine et al., 
1992; Gyllenborg et al., 1999; Andolz et al., 2001; Krause and Krause, 2002; Chen et 
al., 2004; Moskovtsev and Mullen, 2005; Detti et al., 2006; Calonge et al., 2009) than 
Southern (Sobreiro et al., 2005) and in places with temperate (Levine et al., 1988; 
Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; Levine et al., 1992; 
Gyllenborg et al., 1999; Detti et al., 2006; Calonge et al., 2009), rather than tropical 
climates (Chia et al., 2001; Sobreiro et al., 2005). Studies from the UK are sparse.  
 
As it is difficult to recruit men for longitudinal semen quality studies (Mortimer et al., 
1983) which may necessitate financial incentives to improve recruitment (Levine et al., 
1990; Levine et al., 1992; Malm et al., 2004). The majority of studies are retrospective 
observational studies, but some with large population size (Tjoa et al., 1982; Levine et 
al., 1988; Politoff et al., 1989; Saint Pol et al., 1989; Centola and Eberly, 1999; 
Gyllenborg et al., 1999; Andolz et al., 2001; Chia et al., 2001; Chen et al., 2003; 
Moskovtsev and Mullen, 2005; Detti et al., 2006; Calonge et al., 2009). Poster 
presentations in scientific conferences have also contributed to our knowledge 
(Moskovtsev and Mullen, 2005; Detti et al., 2006). Few studies are prospective (Levine 
et al., 1990; Levine et al., 1992; Jørgensen et al., 2001; Carlsen et al., 2004; Sobreiro et 
al., 2005).  
 
A retrospective study involving 1159 samples from 903 men in New Orleans by Levine 
et al. (1988) revealed a significant deterioration in all semen parameters (count, motility 
and morphology) except semen volume in summer. The findings were confirmed in a 
subset of 61 men with paired samples (i.e. one in summer and the other in a season 
other than summer). The authors established the findings again in a prospective 
longitudinal study on 131 outdoor workers in San Antonio (Texas). There was 
significant deterioration in sperm count, total count and motile concentration in summer 
compared to winter by 34%, 24% and 28% respectively, but there was no seasonal 
difference in the percentage of motile sperm, furthermore sperm morphology was not 
assessed (Levine et al., 1990).  
 
Similar findings were seen in the large retrospective study by Gyllenborg et al. (1999) 
involving 1927 donors over a period from 1977 to 1995 conducted in Copenhagen, 
where there was a significant deterioration in sperm count and total concentration in 
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summer / autumn compared to winter / spring with no seasonal variation in semen 
volume or percent motility. Convincingly, the pattern of seasonal variation described 
was seen every year from 1977 to 1995 with few exceptions. Furthermore, a subset 
analysis of 32 donors with paired samples (summer / autumn and winter / spring) also 
confirmed the seasonal trend as described above although this did not reach statistical 
significance.  
 
Sobreiro et al. (2005) study involving 500 men coming in for vasectomy from 1999 to 
2002 at Sao Paulo (Brazil) in southern hemisphere where seasons are opposite to 
northern hemisphere (i.e. June to August is summer in northern hemisphere whilst it is 
winter in southern hemisphere), revealed a significant decline in all the semen 
parameters in summer compared to winter similar to the seasonal trends seen in many 
regions in the northern hemisphere (Levine, 1999). 
 
Overall the majority of studies, (largely retrospective cross-sectional association 
studies) reported a significant seasonal variation in semen parameters whilst few studies 
disputed this (Mortimer et al., 1982; Mallidis et al., 1991; Ombelet et al., 1996; Chia et 
al., 2001; Carlsen et al., 2004). Of those studies that showed a seasonal variation in 
semen parameters, a majority of the studies reported a deterioration in summer and or 
autumn  or  an improvement  in winter and or spring (Tjoa et al., 1982; Levine et al., 
1988; Reinberg et al., 1988; Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 
1990; Levine et al., 1992; Gyllenborg et al., 1999; Andolz et al., 2001; Jørgensen et al., 
2001; Chen et al., 2003; Chen et al., 2004; Moskovtsev and Mullen, 2005; Calonge et 
al., 2009; Levitas et al.)  whilst other studies reported varied patterns, for instance that 
sperm counts were lower in winter but higher in spring and autumn (Menge and Beitner, 
1989); or the percent of abnormal sperm was higher in spring (Swatowski et al., 1994), 
or progressive sperm motility was  lower in summer and also spring (Centola and 
Eberly, 1999) and also that morphology was better in summer and winter (Detti et al., 
2006). 
 
As mentioned some studies revealed a lack of seasonal variation. Ombelet et al. (1996) 
in their study, that analysed 340 semen samples from 107 men, did not reveal any 
seasonal variation in semen parameters (count, motility or morphology). The authors 
suggested that the lack of seasonal variation could be explained by large intra-individual 
variation in semen parameters. The effect of intra-individual variation in semen 
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parameters was reduced by considering the difference of each result from the mean (of 
at least 3 samples) for that individual.  
 
It was pointed out that generally longitudinal studies, for no clear reason, revealed a 
lack of seasonal variation (Mallidis et al., 1991; Ombelet et al., 1996; Carlsen et al., 
2004) although this is not always seen (Levine et al., 1990; Levine et al., 1992). The 
longitudinal studies apart from allowing for intra-individual variation in semen 
parameters also avoid selection bias by seasonal recruitment (Carlsen et al., 2004).  
 
In the study by Krause et al, although a significant trend for sperm count was seen in 
sub groups of men arranged by birth cohorts, with the peak counts being in different 
months (i.e. November, October and August), when the total group was analysed there 
was no seasonal variation identified (Krause and Krause, 2002). 
 
The majority of studies investigated the seasonal variation in all semen parameters (i.e. 
volume, concentration, motility and morphology) whilst some parameters were omitted 
in a few studies particularly sperm morphology and sometimes motility (Tjoa et al., 
1982; Reinberg et al., 1988; Saint Pol et al., 1989; Levine et al., 1990; Gyllenborg et 
al., 1999; Chia et al., 2001). 
  
In studies showing seasonal variation, whilst some studies revealed a deterioration in all 
semen parameters (except volume) (Levine et al., 1988; Andolz et al., 2001; Sobreiro et 
al., 2005); other studies revealed significant variation only in some parameters, mostly 
in sperm count or concentration parameters (i.e. total concentration, motile 
concentration etc) (Saint Pol et al., 1989; Levine et al., 1990; Gyllenborg et al., 1999; 
Krause and Krause, 2002; Chen et al., 2004; Moskovtsev and Mullen, 2005).  
 
In the meta-analysis by Levine (1999) including 11 studies, although a pattern of low 
summer sperm counts was confirmed, there was no consistent seasonal variation in  the 
rest of the parameters i.e. semen volume, sperm motility or morphology. In the study by 
Chen et al. (2004), where the sperm counts were significantly higher in spring 
compared to other three seasons, sperm motility and morphology also showed a similar 
trend, but were not statistically significant. In the study by Saint Pol et al. (1989), 
although there was higher sperm count in winter / spring in 4196  semen donors, there 
was no seasonal change seen in sperm motility. 
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Seasonal changes in semen volume have not been reported in majority of studies 
(Levine et al., 1988; Saint Pol et al., 1989; Levine et al., 1990; Levine et al., 1992; 
Centola and Eberly, 1999; Gyllenborg et al., 1999; Andolz et al., 2001; Chen et al., 
2003; Moskovtsev and Mullen, 2005; Sobreiro et al., 2005),   however Reinberg et al. 
(1988) reported an increased semen volume in spring in men pre-vasectomy. 
 
A prospective study conducted in four European cities (Denmark, Paris, Edinburgh and 
Turku i.e. temperate climate) revealed that despite regional differences in semen 
parameters, likely to be related to lifestyle and environmental exposure, there was a 
general seasonal variation with higher sperm counts in winter compared to summer 
(Jørgensen et al., 2001).  
 
Seasonal variation appeared to be more noticeable in temperate climates or non-
equatorial countries than in equatorial / tropical climates, but this was not always the 
case.  Despite being conducted in temperate climates, a prospective study of 27 healthy 
men over 16 months in Copenhagen (Carlsen et al., 2004) and a large retrospective 
study with more than 1500 samples over 5 years in Edinburgh (Mortimer et al., 1983), 
did not show any significant seasonal variation in semen parameters. However, in both 
studies there was a tendency for improved sperm counts in winter and or spring with no 
differences in other semen parameters.  
 
In tropical climates, whilst a study by Chia et al conducted in Singapore revealed the 
absence of seasonal variation (Chia et al., 2001), another study from Sao Paulo (Brazil) 
showed seasonal variation in sperm count, motility and morphology but not semen 
volume with parameters being significantly better in winter compared to summer 
(Sobreiro et al., 2005). 
 
Interestingly some studies considered four seasons whilst others noted the variation 
between two seasons or compared between summer and seasons other than summer. 
The majority of the studies defined winter as December to February, spring as March to 
May, summer as June to August and autumn as September to November (Centola and 
Eberly, 1999; Chen et al., 2003; Carlsen et al., 2004; Chen et al., 2004; Levitas et al., 
2013), however the definitions of seasons varied (Moskovtsev and Mullen, 2005).  
Notably even in studies concurring with the seasonal variation, the semen parameters 
were at their peak in different months (Ossenbühn, 1998), for instance peak sperm 
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counts were seen in February / March in the Tjoa et al (1982) study  whilst in April / 
May in the Reinberg et al (1988) study.  
 
Almost all studies considered the season in which the semen sample was produced, 
however a recent study by Levitas et al. (2013), in addition, analysed the data by the 
season 70 days prior to the sample production i.e. season at spermatogenesis. The trend 
of seasonal variation by the season of sample production in semen parameters (better 
sperm concentration, rapid motility and sperm morphology in winter) persisted when 
the data was reanalysed by the season of spermatogenesis. 
 
Overall there appears to be some evidence for a seasonal variation in semen parameters, 
at least in temperate climates, although the exact cause is unknown. A strong inverse 
association between the rising global temperatures and declining birth rates has been 
reported (Fisch et al., 2003) and although the relationship between sperm count and 
male fertility is crude, a strong correlation between sperm counts and birth rates was 
shown in a population based study (Fisch et al., 1997).  
 
It was suggested that summer heat may suppress spermatogenesis and or testicular 
steroidogenesis or have a damaging effect on epididymal spermatozoa (Levine et al., 
1988; Bronson, 1995). In semen samples sperm viability and motility decrease at a 
significantly higher rate at 37 degrees Celsius compared to 20 degrees Celsius (Appell 
et al., 1977). A temperature of 2-3ºC lower than core temperature is needed for 
spermatogenesis (Snyder, 1990).  A study by Mieusset and Bujan (1994) to investigate 
the potential of mild testicular heating as a contraceptive method for men revealed that 
one to two degree Celsius increase in testicular temperature decreased the sperm count 
and motility significantly. Men exposed to excessive heat at work such as ‘plant and 
machine operators’ were at higher risk of oligospermia (Chia et al., 1994).  
 
However it was argued  (Snyder, 1990; Gyllenborg et al., 1999) that summer heat may 
not be a major reason, as studies conducted in cooler climates i.e. where summer 
temperatures are moderate such as Basel in Switzerland, Lille in France and Edinburgh 
in Scotland  also showed a considerable deterioration in sperm counts in summer 
compared to winter and spring (Mortimer et al., 1982; Politoff et al., 1989; Saint Pol et 
al., 1989).  
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Moreover, Levine et al. (1992) in their further study revealed that the deterioration in 
semen parameters in summer was not much different between outdoor workers and 
indoor workers (who worked in air conditioned environments), this did not support their 
former hypothesis of detrimental summer heat (Levine et al., 1988; Levine et al., 1990) 
and so the possible effect of photoperiod on endogenous circannual rhythm was 
suggested.  
 
There was no seasonal variation in semen parameters (semen volume and sperm count) 
noted in men from Singapore i.e. a tropical region where the temperatures and 
photoperiod are generally stable throughout the year (Chia et al., 2001). Similarly the 
lack of seasonal variation in Ombelet et al’s study conducted in Belgium was also 
suggested secondary to minimal changes in the temperatures / photoperiod in summer 
and winter. However the authors mainly attributed this to the large intra-individual 
variation of semen parameters (Ombelet et al., 1996).  
 
Photoperiod (ratio of hours of day length to hours of darkness) may influence 
gametogenesis and steroidogenesis by a neuroendocrine pathway. The main 
components include melatonin (N-acetyl-5-methoxytryptamine) a neurohormone 
secreted by pineal gland. In response to the stimuli received by the retinohypothalamic 
tract, the suprachiasmatic nucleus in the hypothalamus generates a signal of day length, 
which is passed on to the pineal gland via the paraventicular nucleus (Bronson, 2004). 
Increased melatonin secretion leads to suppression of gonadotropin releasing hormone 
(GnRH), thereby suppressing follicle stimulating hormone (FSH) and luteinising 
hormone (LH) concentrations that control the changes in the testis. In animal studies the 
mode of action of the photoperiod was inferred as a signal that may either start or stop a 
breeding season by triggering gonadal development or regression; or which can 
synchronize an endogenously generated circannual rhythm of reproduction with 
seasonal changes in energy conditions (Bronson, 1995). 
 
In humans, melatonin is secreted in a circadian pattern and mostly at night. As the 
secretion is dependent on the duration of darkness, a longer duration is expected in 
winter compared to summer, however studies on seasonal variation of human melatonin 
secretion have been conflicting and inconclusive (Bronson, 2004).  Photo responsive 
mammals sense the seasons by the circulating levels of melatonin and in many farm 
animal species (sheep, goats, horses) artificial photoperiodic treatments such as indoor 
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lighting during short days or melatonin during long days are widely used to alter the 
breeding season or overcome the seasonal variation in semen parameters in artificial 
insemination centres (Chemineau et al., 2008).  
 
The neuroendocrine literature however, refutes that there is any form of reproductive 
photo responsiveness in humans (Bronson, 1995). In humans it has been shown that 
there is no difference in the duration of nocturnal melatonin secretion in summer and 
winter secondary to modern artificial lighting (Wehr et al., 1995). Furthermore, some 
suggest that this phenomenon may be an evolutionary remnant in humans rather than a 
physiological functional mechanism in the current environmental conditions i.e. post 
industrial revolution (Gyllenborg et al., 1999; Wehr, 2001) whilst others believe that 
there is large individual variation in responsiveness to photoperiod which may be 
responsible for the inconsistencies in studies in the literature (Bronson, 2004). 
 
Malm et al. (2004) conducted a longitudinal semen quality study to investigate the 
effect of varying lengths of photoperiod involving 2 regions, north (69ºN) and south 
(60ºN) of the Arctic Circle (67ºN). There is two months of total darkness during winter 
and 24 hour daylight during summer at the Arctic Circle. Men produced 2 semen 
samples one in summer and the other in winter, however there was no seasonal 
difference in the semen parameters (volume, count, motility) despite the fact that during 
the 11 week period prior to semen sample production (i.e. period of spermatogenesis), 
there was large variation in the daylight period (at least 19 hours longer in summer 
compared to winter at 69ºN), suggesting that photoperiod does not affect semen 
parameters significantly. 
 
Publication bias regarding the seasonal variation in semen parameters was suggested 
(Malm et al., 2004) as studies investigating temporal trends, coming across significant 
seasonal variation as a chance finding, may have published although this was not the 
premise of the study originally.  
 
The United Kingdom lies at a latitude of 50 to 58 degrees north and has a temperate 
climate, i.e. the weather is mild with temperatures generally not too far below 0ºC in 
winter and not much higher than 32ºC in summer. NFC’s catchment area is most of the 
North East region in England. As the study undertaken nearest to our centre 
geographically, in Edinburgh, revealed a pattern of improved sperm counts in winter 
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and spring (though not statistically significant) (Mortimer et al., 1983), we wondered if 
a similar pattern in semen parameters would emerge in men attending our centre. 
Evaluation of seasonal variation in semen parameters can be of clinical importance, as it 
could potentially have an impact on donor recruitment. This could then be positively 
utilised by timing the assessment of potential sperm donors for semen quality during the 
months of improved quality, to decrease the rejection rates related to suboptimal semen 
samples and also aiming for collection of semen donations, thus improving the 
efficiency of the sperm donor recruitment and donor programme. 
 
1.4 Seasonal variation in donor conceptions 
If a seasonal variation is semen parameters is confirmed, it is also worthwhile 
investigating the influence of this on conception rates to not only further understand the 
impact of season but also to strengthen the proposal of seasonal recruitment of donors. 
Semen quality is a surrogate measure of male fertility. In a population based study by 
Fisch et al. (1997) a significant correlation between sperm counts and birthrates was 
shown. Significantly improved semen parameters in winter were associated with peak 
of deliveries in autumn (Levitas et al., 2013) similar to the poor parameters in summer 
associated with a deficit of spring births in USA (Levine, 1999). Furthermore in 
Ossenbuhn’s retrospective study, it was shown that in IVF patients, the fluctuations in 
the semen parameters were congruent with fluctuations in the IVF conception rates and 
this also coincided with fluctuations in natural conceptions in the normal population 
(Ossenbühn, 1998). Although there are several factors influencing the chance of 
conception, the studies mentioned reveal a possible role for variation in semen 
parameters to influence this. 
 
Bonde et al. (1998) have shown that an increase in sperm count (but only up to a count 
of 40 million/ml) improved the chances of conception. Higher sperm concentrations did 
not improve the likelihood of conception. The contradicting reports in the literature on 
the association between sperm parameters and natural or assisted conception may be 
because of the lack of adjustment for confounding factors (such as female factors). In a 
review by Tomlinson et al. (2013), progressive motile sperm concentration was the 
most predictive semen parameter in both natural and artificial insemination for 
likelihood of conception. However the association between sperm morphology and 
conception was unclear owing to the variety of assessment methodologies, criteria for 
classification used and changing reference values.  
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Despite the fact that only men with optimal semen quality are recruited as donors, 
fecundity of sperm donors is variable and not always apparent from traditional semen 
parameters (Paraskevaides et al., 1991; Thyer et al., 1999; Navarrete et al., 2000). 
Could this be related to the season of sperm production? 
 
To evaluate the effect of seasonality of sperm on conception, we selected women 
undergoing donor insemination. The primary reason for this is that both the season in 
which sperm used for treatment was produced and the season of conception as well as 
the outcome (conceived or not) is known with certainty in this scenario. As this group 
of women are ovulating and are at low risk for tubal disease, they constitute a 
reasonably uniform group and variables such as frequency of intercourse and regularity 
of ovulation which affect the chances of conception can be excluded in this setting. To 
reduce the bias of other factors which can influence the chance of conception, we chose 
only unstimulated (natural cycles without ovulation induction drugs) and the 
intracervical insemination of unprepared sperm. Intrauterine inseminations which 
involve sperm preparation were excluded. 
 
A study by Paraskevaides et al. (1988), showed that donor conceptions in the artificial 
insemination programme of their clinic were highest between  October and March. 
Similarly in another study by Ronnberg (1989) in Northern Finland, i.e. Sub-arctic 
region, increased conceptions by donor insemination from October to March were seen. 
In contrast, in a large French epidemiological survey of an artificial insemination 
programme over six years, where frozen sperm was used, there was no seasonal 
variation in the donor conceptions (Mayaux and Spira, 1989). 
 
As generally sperm used in donor insemination treatments is cryopreserved for 
quarantine purposes (to avoid transmission of sexually transmitted infections), it is 
usually considered as a constant factor unlikely to influence the seasonal variation in the 
donor conceptions. It is well known that freezing and thawing is generally associated 
with reduced motility, morphology, viability and sperm function (Mahadevan and 
Trounson, 1984; Yogev et al., 2004), however interestingly seasonal variations are also 
reported in post thaw donor semen parameters with  post thaw progressive motile 
density being considerably  higher in winter /spring (Yogev et al., 2004; Zhang and 
Yao, 2010).   
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Furthermore, post-thaw motility and morphology are positively correlated with 
pregnancy rates in donor insemination treatments (Mahadevan and Trounson, 1984; 
Johnston et al., 1994). There is also some evidence to support that a prolonged duration 
of freezing does not adversely affect progressive motile concentration (Yogev et al., 
2010) and that fertilizing capacity is still comparable to that of fresh sperm (Marcus-
Braun et al., 2004). Therefore we decided for a novel approach of investigating the 
outcome of donor insemination treatments by the season of sperm production. 
 
I aimed to analyse the distribution of conceptions achieved by donor insemination (DI) 
treatment, with a view to finding out if there was any variation in relation to the 
seasonal timing of the original sperm donation. I also aimed to investigate the seasonal 
variation in the semen parameters of donors used for the above insemination 
programme to get a comprehensive picture of the influence of season on semen 
parameters and pregnancy rates.  
 
1.5 Association of vitamin D and semen parameters 
1.5.1 Background  
Vitamin D has been mainly recognised for its role in calcium homeostasis and bone 
integrity. The association of lack of exposure to sunlight and rickets was first revealed 
by Sniadecki in 1822 and only 100 years later it was demonstrated by Huldshinsky 
(1919) and Chick et al. (1923) independently that exposure to sunlight or artificially 
produced ultraviolet radiation B (UVB) cured rickets (DeLuca, 2004; Holick and Chen, 
2008). However research in the past couple of decades has revealed the diverse role of 
vitamin D in human physiology. As vitamins are substances essential for health but not 
endogenously produced in required quantities, vitamin D is not a true vitamin owing to 
its significant cutaneous synthesis (Bosomworth, 2011). Furthermore vitamin D exhibits 
properties of hormones such as activation, release into the circulation and exertion of 
biological activity in various target tissues via receptors (DeLuca, 2004; Reichranth et 
al., 2007; Bosomworth, 2011) and has been  referred as a pluripotent steroid hormone 
(Verstuyf et al., 2010). 
 
The term vitamin D (VD) (calciferol) generally includes vitamin D2 (ergocalciferol) 
and vitamin D3 (colecalciferol) [Figure 1].Vitamin D3 is formed by photosynthesis in 
the skin while vitamin D2  is derived by irradiation of ergosterol present in some yeast 
and fungi (mushrooms) (DeLuca, 2004).  The A, B, C, and D ring structure is derived 
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from the cyclopentanoperhydrophenanthrene ring structure of steroids. As one of the 
rings is broken (the 9, 10 carbon-carbon bond of ring B for vitamin D3) they are 
classified as seco-steroids.  
 
 
 
 
 
 
 
Figure 1: Vitamin D3 (Colecalciferol) 
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1.5.2 Sources  
The sources of vitamin D include endogenous cutaneous photosynthesis and dietary 
sources. 
1.5.2.1 Cutaneous photosynthesis 
The main source of vitamin D3, (about 90% for most of the individuals) is synthesis in 
the skin upon exposure to ultraviolet solar irradiation (Webb et al., 1988; Holick and 
Chen, 2008; Yuen and Jablonski, 2010). The initial step in the production of vitamin D3 
is the conversion of 7-dehydrocholesterol present in the dermal fibroblasts and 
epidermal keratinocytes of the skin to previtamin D3 upon exposure to UV-B solar 
radiation at wave lengths between 290 -315nm. In vitro experiments have shown that 
there is absent cutaneous photosynthesis above this wave range (Webb et al., 1988). 
This wave band (290 -315nm) is at the shortest wave length range of the solar radiation 
that reaches the earth and changes in magnitude with changes at the zenith angle. Solar 
zenith angle is the angle between a point on the ground (local zenith) and the line of 
sight from that point to the sun (Figure 2). Solar zenith angle alters with earth’s 
revolution (season) and rotation (day and night). 
 
It is well known that season is the major determinant of vitamin D3 levels (Ashwell et 
al., 2010). Apart from season, latitude affects the quantity and quality of solar radiation, 
in particular UVB radiation reaching the earth. Therefore cutaneous photosynthesis of 
vitamin D3 is dependent on latitude, season of the year and time of the day. In winter 
months and in the early morning / late afternoon,  the solar zenith angle is increased and 
the solar radiation is at a more oblique angle and  whilst filtering through the ozone 
layer, leads to a decrease in the UVB radiation (290 -315nm) reaching the earth’s 
surface (Webb et al., 1988; Holick, 2007; Holick and Chen, 2008) and therefore 
reducing vitamin D3 synthesis. Furthermore, clouds and aerosols can also considerably 
decrease the vitamin D3 synthesis by affecting the UVB reaching the earth (Engelsen et 
al., 2005). 
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Figure 2: Schematic illustration of the Solar Zenith Angle (SZA) and Viewing 
Zenith Angle (VZA)  
 
(http://sacs.aeronomie.be/info/sza.php)  
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In Boston (42.2 ºN) there is very little UVB in the range (290 -315nm) detected between 
November to February and there is no cutaneous photosynthesis. Moving further in the 
northern direction to Edmonton (52 ºN), there is no cutaneous photosynthesis between 
October to March whilst it is seen even in January as we move south towards the 
equator to Puerto Rico (18 ºN) (Webb et al., 1988).  Unsurprisingly, as the United 
Kingdom lies at latitude of 50 to 58 ºN, there is hardly any cutaneous photosynthesis 
between October and April (Pearce and Cheetam, 2010).  
 
Importantly skin also contains a range of substances that absorb UVB, such as melanin, 
which affect cutaneous photosynthesis (Holick and Chen, 2008). It is estimated that two 
to three (sub-erythematous ) sunlight exposures of  thirty minutes duration per week, to 
the face and forearms at midday (when UVB intensity is at its peak)  between April to 
October are sufficient to achieve healthy vitamin D levels in fair skinned individuals of 
the majority of UK (Department of Health, 1998; Ashwell et al., 2010); while the 
frequency and duration needs to be increased two to ten fold in dark skinned individuals 
to achieve similar levels (Pearce and Cheetam, 2010).  
 
1.5.2.2 Dietary sources 
Dietary sources only play a minor role (Holick and Chen, 2008). The research by UK 
food standards agency (UKFSA) confirmed that the typical dietary intake of vitamin D 
(3.5-5.5µg) contributed less than exposure to sunlight to the average year round vitamin 
D levels, however it did acknowledge the major contribution from the dietary sources 
during the winter months (Ashwell et al., 2010).  
 
Dietary sources include: oily fish (salmon, trout, mackerel, herring, sardines, anchovies, 
pilchards and fresh tuna), egg yolk, cod liver oil, mushrooms and red meat. Margarine 
(7-8.8µg/ 100g), some breakfast cereals (17-33% of the RDA of vitamin D per serving) 
and infant formula milk (40-100IU per 100kcal) are the only foods fortified with 
vitamin D in the UK (Department of Health, 2000).  
 
In 1930s fortified milk (100IU vitamin D2 per 8 ounces of milk) helped eradicate 
rickets in the United States and Europe. An outbreak of hyper-calcaemia in the UK in 
1950s, despite an absence of good evidence was attributed to the vitamin D fortification 
of milk and lead to the abandonment of the fortification of dairy products in Europe 
(Holick and Chen, 2008). 
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Vitamin D supplements are available in multivitamin preparations or by themselves in 
various strengths such as 400IU and 1000IU. In Canada the pharmaceutical form is 
vitamin D3 whilst in United States and Australia it is vitamin D2 (Holick and Chen, 
2008; Roth et al., 2008). Some of the food sources with vitamin D content are shown in  
Table 1 and vitamin D preparations available in the UK are shown in Table 2. 
 
 
Source Type Source Vitamin D Content 
Natural 
Sources 
Salmon  
Fresh, wild (3.5 oz) / 
Canned (3.5 oz) 
About 600–1000IU of vitamin D3 
Fresh, farmed (3.5 oz) About 100–250 IU of vitamin D3or D2 
Canned (3.5 oz) About 300–600IU of vitamin D3 
Sardines, canned (3.5 oz) About 300IU of vitamin D3 
Mackerel, canned (3.5 oz) About 250IU of vitamin D3 
Tuna, canned (3.6 oz) About 230IU of vitamin D3 
Cod liver oil (1 tsp) About 400–1000IU of vitamin D3 
Shiitake mushrooms Fresh 
(3.5 oz) 
About 100IU of vitamin D2 
Egg yolk About 20IU of vitamin D3 or D2 
Fortified 
foods 
Fortified milk About 100IU/8 oz, usually vitamin D3 
Fortified orange juice About 100IU/8 oz vitamin D3 
Infant formulas About 100IU/8 oz vitamin D3 
Fortified yogurts About 100IU/8 oz, usually vitamin D3 
Fortified butter About 50IU/3.5 oz, usually vitamin D3 
Fortified margarine About 430IU/3.5 oz, usually vitamin D3 
Fortified cheeses About 100IU/3 oz, usually vitamin D3 
Fortified breakfast cereals About 100IU/serving, usually vitamin D3 
 
Table 1: Dietary, Supplemental, and Pharmaceutical Sources of Vitamins D2 and 
D3 
 
* IU denotes international unit, which equals 25 ng. To convert values from ounces (oz) 
to grams, multiply by 28.3. To convert values from ounces to millilitres, multiply by 
29.6. ‡ When the term used on the product label is vitamin D or calciferol, the product 
usually contains vitamin D2; colecalciferol or vitamin D3 indicates that the product 
contains vitamin D3. [Adapted from (Holick, 2007)] 
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Product Vitamin D content 
Colevit D3 (colecalciferol) solution  20,000IU/ml of vitamin D3 
ProD3 (colecalciferol) 10,000IU capsules of vitamin D3 
Dekristol 20,000IU capsules of vitamin D3 
Sterogyl liquid 20,000IU/Ml of vitamin D2 
Adcal D3 400IU of vitamin D3 +600mg calcium 
Calcichew D3 Forte 400IU of vitamin D3 +500mg calcium 
Over the counter  
Calciferol tablets 400IU, 500IU, 1000IU 
 
Table 2: Vitamin D supplements available in UK 
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1.5.3 Physiology 
The natural vitamin D3 is absorbed from the diet or more commonly produced in the 
skin upon ultraviolet irradiation of the cholesterol derivative, 7-dehydrocholesterol 
(provitamin D3). The reaction in the skin appears to be an enzyme independent 
photochemical process. Ultraviolet light causes the electro cyclic rupture of the 9, 10 
bond to produce previtamin D3. Previtamin D3 is biologically inert and isomerizes 
spontaneously to vitamin D3. This is a temperature dependent process and at body 
temperature takes about 2-3 days (Webb et al., 1988). The vitamin D2 and D3 from 
dietary sources are integrated in the chylomicrons and transported by the lymphatics to 
the circulation. 
 
Vitamin D (include D2 and D3 from here onwards unless specified) is transported to the 
liver by vitamin D binding protein (DBP), a serum glycoprotein produced by the liver. 
Several cytochrome P450 enzymes (CYP) located in endoplasmic reticulum or 
mitochondria are involved in vitamin D metabolism (Table 3). Vitamin D is converted 
by mitochondrial vitamin D-25-hydroxylase (CYP2R1 supported by CYP27A1) to 25-
hydroxyvitamin D [25(OH)D], which is the major circulating form of  vitamin D. This 
is further metabolised by 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) to 1,25-
dihydroxyvitamin D3 (calcitriol) [1,25(OH)2D], a biologically active form of vitamin D 
produced primarily in kidney but also in many tissues throughout the body (extra renal 
or local production) when sufficient substrate is available (Figure 3). 
 
CYP27B1 is regulated by parathyroid hormone (PTH), calcium, phosphate and vitamin 
D metabolites, in particular by 1,25(OH)2D  (Figure 4) via feedback mechanisms to 
maintain optimal concentrations of 1,25(OH)2D both in the circulation and also target 
cells (Prosser and Jones, 2004).  
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Gene name Vitamin D 
metabolism 
Protein function Chromosomal 
location in human 
CYP2R1 Activation 25-hydroxylase 11p15.2 
CYP27A1 Activation 25-hydroxylase 2q33-qter 
CYP27B1 Activation 1α- hydroxylase 12q13.1-q13.3 
VDR Mediator Receptor 12q13.11 
CYP24A1 Inactivation 24-hydroxylase 20q13 
 
Table 3: Chromosomal location of vitamin D receptor and metabolising enzymes 
Adapted from (Blomberg Jensen, 2012) 
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Figure 3: Metabolic pathway of vitamin D  
Adapted from (Zhu and Okamura, 1995)
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Figure 4: Regulation of vitamin D  
 
(a) Regulation of the 1α, 25-(OH)2D3 concentration in vitamin-D-dependent gene 
expression. (b) Regulation of the expression of vitamin D hydroxylases: (i) renal 25-
OH-D3-1α-hydroxylase (CYP27B1); (ii) extrarenal 25-OH-D3-1α-hydroxylase 
(CYP27B1); (iii) target cell 1α,25-(OH)2D3-24-hydroxylase (CYP24A1).  
Adapted from (Prosser and Jones, 2004) 
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25(OH)D has a half-life of 2-3 weeks whilst it is shorter for 1,25(OH)2D (4-6 hours). 
When optimal levels of 1,25(OH)2D are reached, 25-hydroxyvitamin D3-24-
hydroxylase (CYP24A1) catabolises 25(OH)D and 1,25(OH)2D in the kidney to 24,25- 
dihydroxyvitamin D [24,25(OH)2D], which is further catabolised to water soluble 
inactive calcitroic acid and excreted in bile (Zhu and Okamura, 1995; Prosser and Jones, 
2004; Lips, 2006). CYP24A1 is induced by 1,25(OH)2D (feedback mechanisms to 
avoid toxicity) and CYP24A1 remains silent in vitamin D deficiency. Therefore 
CYP24A1 plays an important role in the determining the levels of 1,25(OH)2D (Figure 
4). Approximately 33 vitamin D metabolites, intermediates in the degradation of this 
molecule, have been identified (DeLuca, 2004).  
 
Vitamin D and its metabolites including 25(OH)D, 1,25(OH)2D and 24,25(OH)2D are 
carried in the circulation bound to DBP (Zanatta et al., 2011). 
 
Cellular vitamin D responsiveness is complex and not as tightly regulated as systemic 
vitamin D metabolism. It is dependent on VDR expression, uptake of the substrate by 
the cells and metabolism of the circulating forms of vitamin D (Blomberg Jensen, 
2012).  
 
1.5.4 Mode of Action  
1,25(OH)2D is transported to the various target tissues by DBP where it binds to 
specific receptors leading to genomic and non-genomic responses.  
  
1.5.4.1 Vitamin D receptors (VDR) 
VDR is a DNA binding protein (427 amino acid peptide) with a molecular weight of 
about 50kDa and the gene encoding VDR is located on chromosome 12 (DeLuca, 
2004). 
 
The VDRs are not only localized in the classic target organs of 1,25(OH)2D i.e. 
intestine, bone and kidney where they facilitate calcium homeostasis (Lips 2006), but 
also in over 38 different tissues such as the immune system, the reproductive system, 
and the endocrine system (DeLuca, 2004; Aquila et al., 2008; Haussler et al., 2011; 
Zanatta et al., 2011).  
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A variety of tissues like bone (osteoblasts), colon, brain, breast, placenta, pancreas, 
prostate,  lymph nodes, macrophages, skin and testis can produce 1,25(OH)2D locally, 
by CYP27B1 under the influence of cytokines and this does not contribute to the 
circulatory 1,25(OH)2D (Somjen et al., 2007; Holick and Chen, 2008; Zanatta et al., 
2011). The presence of VDR and CYP27B1 in various tissues is suggestive of the 
autocrine / paracrine role of vitamin D. 
 
1.5.4.2 Genomic response  
The receptor for 1,25(OH)2D belongs to the nuclear receptor superfamily which 
includes receptors for estrogen, progesterone, testosterone and cortisone. When 
1,25(OH)2D binds to the VDR, the receptor dimerizes with retinoid receptor and 
thereafter binds to the specific nucleotide sequences, vitamin D responsive elements 
(VDRE) located in the promoter regions of the target genes, recruiting either co-
activators or co-repressors leading to either activation or suppression of the target genes  
(Figure 5). 
 
 This binding of 1,25(OH)2D to VDR induces phosphorylation, conformational changes 
in the VDR and the release of co-repressors to allow gene expression. Following 
transcription and translation, a protein is formed (eg: osteocalcin), which elicits a 
physiological response (Lips, 2006; Haussler et al., 2011; Zanatta et al., 2011). The 
genomic pathway takes hours to days to produce the changes in the gene transcription 
(Lerchbaum and Obermayer-Pietsch, 2012). Vitamin D has been shown to regulate the 
expression of more than 1000 genes, reflecting its widespread biological activities 
(Bouillon et al., 2008; Haussler et al., 2011; Zanatta et al., 2011) whereas the traditional 
genomic action of vitamin D included intestinal calcium and phosphate absorption, 
calcium reabsorption in the kidney and calcium mobilisation in the bone (DeLuca, 
2004; Haussler et al., 2011).
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Figure 5: Diagrammatic representation of the known molecular events in the 
regulation of gene expression by the vitamin D hormone, 1,25(OH)2D3 acting 
through its receptor, VDR.  
 
The result of regulation may be either suppression or activation. RXR, Retinoid X 
receptor; VDRE, Vitamin D response elements; TFIIB, transcription factor IIB; TFIID, 
transcription factor IID; RNAP, RNA polymerase. Adopted from (DeLuca, 2004).
37 
 
1.5.4.3 Non-genomic response 
The non-genomic actions of 1,25(OH)2D are rapid (taking seconds to minutes) and act 
through a putative plasma membrane associated receptor. The membrane VDR 
primarily acts as a regulator of cytosolic second messengers such as cyclic Adenosine 
monophosphate (cyclic AMP) which in turn modulates the activity of various kinases 
[such as Protein Kinase A (PKA), Protein Kinase (PKC), Mitogen Activated Protein 
Kinase (MAP kinase)] and phosphatases. These enzymes are involved in the opening of 
calcium and chloride ionic channels leading to a biological response (Zanatta et al., 
2011).  
 
This mode of action is seen in transcaltachia (the Rapid Hormonal Stimulation of 
Intestinal Calcium Transport), insulin secretion by pancreatic beta cells, in monocytes 
and vascular smooth muscle (Lips, 2006). In Sertoli cells in testis, 1,25(OH)2D can 
modulate the kinase activities and influx of ions (such as chloride and calcium) at the 
plasma membrane, thus regulating the secretory process in these cells (Zanatta et al., 
2011). 
 
Contrary to the description of receptors of vitamin D as above (nuclear and membrane), 
it has been argued that there is only one receptor for vitamin D mediating all its actions 
(DeLuca, 2004; Haussler et al., 2011; Zanatta et al., 2011). Structure function studies 
have revealed that VDR mediated rapid responses use a different ligand (6-s-cis) of the 
VDR, whilst the nuclear actions are generated when 6-s-trans ligand is occupied. In 
other words, VDR contains two ligand binding sites, a genomic pocket (VDR-GP) and 
an alternative pocket (VDR-AP), which when occupied by conformationally  flexible 
vitamin D metabolites, lead to genomic and non-genomic responses respectively 
(Haussler et al., 2011; Zanatta et al., 2011). There is also some evidence to suggest that 
some of the genomic actions of vitamin D are initially triggered by the non-genomic 
pathway (Zanatta et al., 2011).       
 
1.5.4.4 Vitamin D receptor gene polymorphism 
VDR gene polymorphism is the variation in the VDR gene DNA structure. VDR gene 
comprises 8 protein coding exons 2-9, 6 untranslated exons 1a-1f and several promoter 
regions (Nejentsev et al., 2004). There are more than 470 single nucleotide 
polymorphisms (SNP) identified in the VDR (Toner et al., 2010). Some of the 
commonly studied VDR polymorphisms are FokI, BsmI, TaqI, Cdx-2 and ApaI. The 
38 
 
polymorphisms are generally named after the restriction enzymes initially used for 
genotyping. The effects of these polymorphisms on VDR activity are still not clear. 
 
Although not seen in all studies, an increase in bone mineral density (BMD) with 
vitamin D supplementation that is dependent on the VDR genotype has been 
demonstrated (Graafmans et al., 1997). This was also dependent on environmental 
factors such as calcium and vitamin D intake, with low calcium intake showing a 
positive association between specific VDR genotype and BMD, whilst increasing 
calcium intake showed no association. This can be explained by the fact that VDR 
dependent calcium absorption only occurs in calcium restrictive environments as 
opposed to when calcium is replete and VDR is not essential for calcium absorption 
(Pols et al., 1998). VDR polymorphisms (BsmI, FokI and Cdx2) have been linked to 
low BMD and fracture risk but the results are inconsistent (Casado-Diaz et al., 2013).  
 
Furthermore in the recent past there are several studies in the literature to suggest an 
association of specific VDR polymorphisms with cancer (such as breast, colon and 
skin), atopic dermatitis, diabetes and immune mediated disorders (Toner et al., 2010; 
Engel et al., 2012; Gündüz et al., 2012; Monticielo et al., 2012; Sahin et al., 2012; 
Heine et al., 2013) but again the results are not always consistent. However the studies 
suggest that VDR gene polymorphism may alter the relationship between vitamin D 
status and various health conditions and increasing knowledge of these polymorphisms 
may explain some of the inconsistencies in the literature and also identify at risk groups 
for certain diseases. 
 
1.5.4.4.1 Vitamin D receptor gene polymorphism and reproduction 
VDR polymorphisms have been demonstrated in some gynaecological conditions such 
as endometriosis and PCOS. 
 
Endometriosis: In a Brazilian study that recruited 132 women with endometriosis-
related infertility, 62 women with unexplained infertility and 133 controls, similar VDR 
polymorphisms (ApaI, TaqI, FokI, and BmsI) were seen in the different groups. There 
was no difference in VDR polymorphisms in infertile women with and without 
endometriosis (Vilarino et al., 2011).  
 
39 
 
Polycystic ovarian syndrome (PCOS): In a study by Wehr et al. (2011), including 545 
PCOS women and 145 control women, genotyping of VDR (Cdx2, Bsm-I, Fok-I, Apa-I, 
and Taq-I),was performed. In PCOS women with the Cdx2 genotype, lower levels of 
fasting insulin, lower insulin resistance and higher insulin sensitivity was noted.  
 
1.5.5 Epidemiology  
Vitamin D deficiency is now identified as a worldwide problem because of its 
prevalence in the United States, Europe, the Middle East, Asia and Australia, affecting 
both adults and children (Holick and Chen, 2008; Bosomworth, 2011). Season mainly 
influences vitamin D levels in Northern latitudes by affecting cutaneous photosynthesis 
of vitamin D3 (Webb et al., 1988). From October to March, at latitudes north of  52º N, 
such as Scandinavia, the majority of Western Europe including 90% of the UK and 50% 
of North America, lack exposure to the UV-B necessary for cutaneous photosynthesis 
(Webb et al., 1988; Pearce and Cheetam, 2010).  
 
A nationwide survey of middle-aged British adults revealed that 16% had severe 
deficiency during winter and spring and the prevalence of hypovitaminosis D increased 
on moving northward in the UK, with the highest rates seen in Scotland, northern 
England and Northern Ireland (Hyppönen and Power, 2007). Similar findings were seen 
in other United Kingdom Food standards agency (UKFSA) funded studies (Ashwell et 
al., 2010).  
 
In the past vitamin D deficiency has been considered as a health problem predominantly 
affecting ethnic minority population in the UK, but the national survey revealed that it is 
a problem among the indigenous British population as well and is more common than 
previously thought. 
 
However more recently, it was argued that the “epidemic” of vitamin D deficiency in 
North America was based on overestimation of adequacy and therefore population 
screening was not recommended (Aloia, 2011). 
 
1.5.6 Risk Factors for vitamin D deficiency 
One of the main risk factor for vitamin D deficiency is a lack of exposure to the sun. 
Increased time spent indoors, traditional clothing in some cultures (where most of the 
skin is covered) and pigmented skin limits the absorption of UV-B leading to reduced 
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synthesis (Glerup et al., 2000; Lips, 2006; McKinney et al., 2008; Greene-Finestone et 
al., 2011). Furthermore melanin in the skin also reduces the synthesis of 7-
dehydrocholesterol, thereby decreasing the availability of the substrate for vitamin D3 
synthesis (Aloia, 2011), making dark skinned individuals a high risk group. The use of 
sunscreen with sun protection factor 15 or more can block 99% of cutaneous synthesis 
of vitamin D3 (Pearce and Cheetam, 2010). Advancing age is recognised as a risk factor 
as the skin synthesis of vitamin D3 is reduced due to a decrease in precursor (7-
dehydrocholesterol) concentrations in the skin as well as from a potential decrease in 
sun exposure (Lips, 2006; Holick and Chen, 2008). 
 
There is a decreased to absent cutaneous synthesis of vitamin D3 in winter months in 
northern latitudes (Webb et al., 1988). One study however revealed higher vitamin D 
levels in northern European countries compared to southern, contrary to expectation. 
This difference could possibly be explained by dietary habits (consumption of fatty fish, 
a rich source of vitamin D in Northern European countries) and lifestyle with decreased 
sun exposure in residents of southern European countries (Lips et al., 2001).  
 
Vegetarians or people consuming a diet free of oily fish, pregnant and breast feeding 
women, infants and young children under 5 years and immigrants (specifically people 
with pigmented skin moving towards polar areas) are also at an increased risk (Holvik 
et al., 2004; Andersen et al., 2007). Obesity (as vitamin D gets sequestrated in fat), 
chronic liver and renal disease, mal-absorption syndromes, use of some medications like 
anticonvulsants and glucocorticoids are other risk factors  (Holvik et al., 2004; Lips, 
2006; McKinney et al., 2008; Gagnon et al., 2010; Aloia, 2011; Bosomworth, 2011; 
Greene-Finestone et al., 2011). 
 
A  recent genome wide association study involving 33,996 participants of European 
origin from 15 cohorts (5 discovery cohorts, 5 replication cohorts and 5 de-novo 
replication cohorts), revealed that in individuals with genetic variation at the loci 
involved in cholesterol synthesis (DHCR7), vitamin D hydroxylation (CYP2R1) and 
vitamin D transport (GC) were at significantly increased risk of vitamin D insufficiency 
(Wang et al., 2010). 
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1.5.7 Effects of vitamin D  
The effects of vitamin D can be classified into skeletal and non-skeletal effects. 
 
1.5.7.1 Skeletal effects 
Vitamin D plays a vital role in calcium and phosphorous homeostasis. The classic effect 
of 1,25(OH)2D is enabling active calcium absorption in the intestine by synthesizing 
calcium binding protein by its genomic action (Lips, 2006) and also promoting 
reabsorption of calcium in kidneys (DeLuca, 2004). Vitamin D promotes mineralization 
of the skeleton and the typical manifestation of vitamin D deficiency is rickets in 
children and osteomalacia in adults where mineralization of osteoid is affected. 
 
Vitamin D  deficiency leads to rise in serum parathyroid hormone levels (secondary 
hyperparathyroidism) causing bone resorption and osteoporosis (reduction in bone 
mineral density) thus increasing the risk of fractures (Lips, 2006). There is some 
evidence to suggest that vitamin D supplementation reduces the risk of falls and 
fractures (Yuen and Jablonski, 2010; Bosomworth, 2011). However it was pointed out 
that most of the studies included calcium supplements which makes it difficult to 
interpret the results (Aloia, 2011). In contrast a recent randomised controlled trial (RCT)  
where 500,000IU of vitamin D was given once yearly for 3 years revealed a 25% higher 
risk of fracture and a higher incidence of falls (Sanders et al., 2010). 
 
1.5.7.2 Non-skeletal effects 
The presence of VDR in  the majority of the tissues in the human body along with 
increasing observational data showing a link between vitamin D and various non-
skeletal conditions such as autoimmune diseases, infections, cardiovascular diseases and 
cancers has triggered a plethora of studies to investigate this further. Studies also 
investigated the therapeutic role of vitamin D in these non-skeletal conditions. Reviews 
on the non-skeletal effects of vitamin D have been published (Toner et al., 2010; Aloia, 
2011; Rosen et al., 2012). Here we briefly describe the biological plausibility of the 
association and a summary of the evidence. 
 
1.5.7.2.1 Vitamin D and infections 
Observational studies have shown increased an incidence of infections (such as 
influenza A, common cold and Respiratory Syncytial Virus infections) in winter 
months, which led to the hypothesis that low vitamin D may have a role in causation. 
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Further studies revealed an association between low serum vitamin D levels and an 
increased risk of viral and bacterial infections including tuberculosis and there is also 
some evidence to suggest  vitamin D supplementation decreased this risk (Yuen and 
Jablonski, 2010; Bosomworth, 2011). Historically it was noted that increased exposure 
to sunlight was beneficial in the treatment of tuberculosis.  
 
There is data to suggest that macrophages infected with mycobacterium tuberculosis 
increased the production of 1,25(OH)2D locally (paracrine pathway) and increased the 
expression of VDR. This combination then leads to up-regulation of the gene expressing 
the bactericidal protein cathelicidin, which attacks Mycobacterium tuberculosis or other 
infective agents and also triggers cells’ autophagy pathways (Holick and Chen, 2008; 
Rosen et al., 2012). However, the data is still inadequate to suggest vitamin D 
supplementation for treatment or prevention of infections. 
 
1.5.7.2.2 Vitamin D and cancer 
The potential role of vitamin D in cancer can be explained by in vitro studies, which 
apart from revealing VDR expression in most tissues including tumors also suggest the 
possibility of local production of 1,25(OH)2D in a variety of tissues. Furthermore in 
vitro studies suggest 1,25(OH)2D  promotes cell differentiation, inhibits cell growth (by 
regulating genes responsible for cell proliferation) in a variety of cell types and also 
exhibits pro-apoptotic and anti-angiogenic properties (Lips, 2006; Fleet, 2008; Toner et 
al., 2010; Verstuyf et al., 2010; Bremmer et al., 2012; Rosen et al., 2012).  
 
Several observational studies have shown the link between living at high altitude or low 
exposure to sunlight or low serum 25(OH)D levels, to an increased risk of  breast, 
colon, prostate and other cancers (Holick and Chen, 2008; Verstuyf et al., 2010; Yuen 
and Jablonski, 2010).  As higher levels of vitamin D were associated with lower  
estradiol and progesterone levels in healthy young women, it was hypothesized that this 
may be a potential mechanism in the reduction of breast cancer risk (Knight et al., 
2010). However there are studies in post-menopausal women which did not show an 
inverse relationship between vitamin D and breast cancer (Freedman et al., 2008). 
Furthermore the studies investigating the association of vitamin D and risk of prostate 
cancer revealed inconsistent results (Toner et al., 2010). Studies including a meta-
analysis suggested that increasing intake of vitamin D was associated with a decreased 
risk of colon, breast and other cancers. Whilst the evidence is promising for colorectal 
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cancer it is inconsistent for breast cancer (Toner et al., 2010). In the WHI (Women’s 
Health initiative) trial involving 36,000 women, the 7 year intervention of vitamin D3 
400IU and 1000mg of calcium per day did not reduce the incidence of total cancer or 
cancer mortality (Wactawski-Wende et al., 2006; Chlebowski et al., 2008). A large 
scale study found no evidence of a protective association between higher serum 
25(0H)D and cancer outcome in 7 less common cancers including endometrial and 
gastric cancers. Conversely an increased risk of pancreatic cancer was noted with serum 
25(OH)D levels above 100nmol/l (Helzlsouer and Vdpp Steering Committee, 2010). 
Furthermore there is some evidence of increased risk of esophageal and prostate cancers 
with higher levels of vitamin D levels in subgroups of the general population (Toner et 
al., 2010). 
 
1.5.7.2.3 Vitamin D and cardiovascular disease 
Epidemiological studies revealed higher rates of hypertension and cardiovascular 
diseases with increasing distance from the equator, raising the possibility for a role of 
vitamin D. The potential for a role in cardiovascular diseases is explained by the 
expression of VDR in cardiac muscles and vascular smooth muscle. Vitamin D deficient 
mice or VDR knockout mice develop hypertension and cardiac hypertrophy (Verstuyf et 
al., 2010). Pilz et al. (2008) revealed that low levels of  vitamin D were associated with 
an increased risk of heart failure and sudden cardiac death. However there are only a 
few observational studies investigating the association between serum 25(OH)D and 
cardiovascular disease and hypertension and the results are inconsistent (Rosen et al., 
2012) although a ‘U’ shaped association as described later has also been suggested 
(Ross et al., 2011). 
 
1.5.7.2.4 Vitamin D and autoimmune disease 
The role of vitamin D as an immune modulator can be explained by the presence of 
VDR in most cells of the immune system (monocytes, macrophages and lymphocytes) 
and many cells can synthesize the active form of vitamin D locally. It is involved in cell 
mediated immunity by down regulating inflammatory markers such as interleukins and 
tumour necrosis factor (IL1, IL2, IL-6 and TNFα) (Lips, 2006; Verstuyf et al., 2010; 
Grundmann and von Versen-Hoynck, 2011). The localization of VDRE in the human 
insulin receptor gene promoter (Maestro et al., 2003) makes it biologically plausible to 
hypothesize a role for vitamin D in the pathogenesis of diabetes. Furthermore in 
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diabetic rats, vitamin D supplementation improved the insulin response to glucose 
transport in adipocytes (Calle et al., 2008). 
 
Epidemiological studies have shown the association between low vitamin D levels and 
auto immune diseases such as Type I diabetes, multiple sclerosis and inflammatory 
bowel disease (DeLuca, 2004). The data is inadequate however, to support vitamin D 
supplementation for the treatment or prevention of autoimmune disorders. 
 
Overall, following a comprehensive review of the available evidence regarding vitamin 
D and extra skeletal outcomes, it was concluded that the associations are inconsistent 
and the evidence regarding causation was insufficient and inconclusive (Ross et al., 
2011; Rosen et al., 2012). Furthermore there is some evidence suggestive of a reverse 
‘J’ or ‘U’ shaped association i.e. increased risk at  high vitamin D levels of some non-
skeletal conditions including cardiovascular disease, pancreatic cancer, oesophageal 
cancer and overall mortality (Ross et al., 2011; Rosen et al., 2012). Clinicians are 
warned of the potential adverse effects of levels above 125nmol/l (50ng/ml) (Aloia, 
2011). It has to be acknowledged however, that the data on the extra-skeletal benefits of 
vitamin D are convincing enough to have initiated large scale randomised controlled 
studies. 
 
1.5.8 Assessment of vitamin D status 
Serum 25(OH)D is considered as the best measure of estimating vitamin D status, (Roth 
et al., 2008; Pearce and Cheetam, 2010; Aloia, 2011), as it has a long circulating half-
life of 2 to 3 weeks (Lips, 2001). This also enables the achievement of consistent results 
(Bosomworth, 2011). 
 
Methods  
There are several methods of measuring serum 25(OH)D and the variability in 
measurements due to utilized assay technology is well known (Carter et al., 2004; Roth 
et al., 2008; Thienpont et al., 2012).  The two common methods used are 
immunological (antibody-type) methods and liquid chromatography based methods. 
The assay methods essentially involve the process of releasing the 25(OH)D from its 
binding protein followed by quantification of the molecule. The gold standard is liquid 
chromatography tandem mass spectrometry (LC-MS/MS) (Holick and Chen, 2008; 
Roth et al., 2008; Aloia, 2011). This involves chemical release of hydroxyvitamin D, 
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followed by a protein precipitation (sample purification) and then separation of the 
25(OH)D by chromatography and finally quantification by mass spectrometry. 
 
Some of the other routinely available methods are high-performance liquid 
chromatography (HPLC), the Immunodiagnostic System’s radioimmunoassay (IDS-
RIA) and enzyme immunoassay (IDS-EIA) and DiaSorin’s automated immunoassays 
(Liaison 1 and Liaison 2) and automated immunoassay (Elecsys). With increasing 
demand for vitamin D assays many laboratories have moved onto automated immune 
assays from the traditional manual techniques. As there are method-related differences 
in 25(OH)D results, standardization of methods against a reference method would help 
to reduce the inter-method variability (Roth et al., 2008).  
 
The assays also differ in 25-hydroxyvitamin D3 and D2 metabolite recognition. Assays 
estimating 25-hydroxyvitamin D3 and D2 incorporate cutaneous synthesis and dietary 
intake (such as foods, fortified products and supplements), although it is noteworthy 
that 25-hydroxyvitamin D2 levels are low to undetectable in those who have not 
received vitamin D supplementation. Moreover in the majority of countries vitamin D 
supplementation is by Colecalciferol, however in United States and Australia it is by 
Ergocalciferol (Roth et al., 2008). 
 
The majority of the concerns about imprecise serum 25(OH)D assays are overcome by 
advances in methodology, calibration of equipment and regular participation in quality 
control assessments (Ross et al., 2011). The Vitamin D external Quality Assessment 
scheme (DEQAS) is an international on-going multicentre trial of measuring various 
vitamin D assays for their specificity and accuracy apart from offering an opportunity 
for the participating centres to maintain their standards (Carter et al., 2004). DEQAS is 
discussed in further detail in Chapter 6 (Section 6.5.8.1.1). 
 
1.5.9 Classification of vitamin D status 
The classification of vitamin D status including the optimal levels of vitamin D is 
ongoing  and debated extensively (Grundmann and von Versen-Hoynck, 2011) although 
many appear to accept serum concentrations of 50nmol/l or ≥ 75nmol/l as optimal. The 
higher levels were suggested based on the evidence of suppression of parathyroid 
hormone and some evidence on maximal intestinal calcium absorption above this level 
whilst levels of 50nmol/l were recommended based on the evidence on optimal skeletal 
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health (Dawson-Hughes et al., 2005; Lips, 2006; Hyppönen and Power, 2007; Holick 
and Chen, 2008; Aloia, 2011). Serum concentrations of vitamin D < 25nmol/l are 
considered as deficiency as this can cause softening of bone and present as rickets in 
children and osteomalacia in adults (Ashwell et al., 2010; Bosomworth, 2011), therefore 
levels above this (i.e. >25nmol/l) are internationally recognised as the most conservative 
threshold of adequacy.  
 
A widely used classification of vitamin D status in relation to serum concentration is 
presented here (Pearce and Cheetam, 2010; Blomberg Jensen et al., 2011) whilst 
recognising the modified classifications published in literature (Aloia, 2011; 
Bosomworth, 2011)  
• < 25nmol/l - Deficiency 
• 25-50nmol/l –Insufficiency 
• 50-75nmol/l – Adequate 
• >75nmol/l – Optimal 
 
The Institute of Medicine (IOM) has further added: 
 >125nmol/l – Risk of excess (Aloia, 2011) 
The common variations noted are:  
 < 40nmol/l –insufficiency or inadequacy. 
 
The concentrations of vitamin D are given in molar units (nmol/l); to convert to mass 
units ng/ml divide the molar units by 2.496; to convert to mass units µg/l, multiply the 
molar units by 0.4. 
 
1.5.10 Recommended daily intake of vitamin D  
In the UK, the recommended daily intake of vitamin D for an adult is 400IU 
(Department of Health, 1998), however it has been argued that this intake would 
provide adequate vitamin D levels to only prevent osteomalacia (Pearce and Cheetam, 
2010). The institute of medicine (IOM) recommends a daily intake of 600IU of vitamin 
D for ages 1-70 years and 800IU for above 70 years old, with optimal bone health being 
the target. This advised intake is also based on the assumption of a lack of adequate sun 
exposure and aims for 50nmol/l of serum vitamin D. The recommendations by 
Endocrine Society of North America however, for patients at risk for vitamin D 
deficiency  (acknowledging the fact that vitamin D deficiency is very common) 
47 
 
suggested a higher intake and aim for sufficiency of serum vitamin D i.e. 75nmol/l. 
(Holick et al., 2011). 
 
Despite a high therapeutic index of vitamin D and toxicity seen at levels of 500nmol/l, 
the upper limits for intake in adults suggested are 4000IU / day (corresponding to serum 
vitamin D level of 125nmol/l) as the risk of harm such as hypercalcemia, hypercalciuria, 
soft tissue calcification, and nephrolithiasis increases above this level (Aloia, 2011; 
Ross et al., 2011). Pharmaceutical preparations with vitamin D2 are as effective as 
vitamin D3 in maintaining serum 25(OH)D levels (Holick and Chen, 2008). 
 
1.5.11 Management of vitamin D deficiency 
Although there are several treatment regimens, the principle of treatment remains to 
replenish the stores with high dose vitamin D for a short period of 8-12 weeks, followed 
by low dose maintenance therapy. It has been demonstrated that serum vitamin D 
increases by approximately 2.5 nmol/l (1 ng/ml) for every 100IU of oral vitamin D 
taken each day (Heaney, 2008). The oral route is better tolerated and is more effective 
because of  improved absorption than parenteral forms (Grundmann and von Versen-
Hoynck, 2011).   
 
As vitamin D is stored in fat and gradually released, it does not matter whether vitamin 
D is  given weekly, monthly, 6 monthly or annually (Lips, 2001; Bosomworth, 2011).  
Hydroxylated and potent forms like Calcidiol and Calcitriol are not recommended as 
they are not only ineffective but can cause hypercalcemia, which can be dangerous. Life 
style changes such as maximal use of sunlight and dietary modification also improve 
vitamin D. Some suggested medical regimes are shown in Table 4 and Table 5. 
48 
 
 
 
 
 
 
 
  
Calciferol dose Frequency Route Length of course 
10,000 IU (0.25mg) daily Oral (capsules) 8-12 weeks 
60,000 IU (1.5mg) Once Weekly Oral 8-12 weeks 
300,000 IU (7.5mg) 
Ergocalciferol 
Twice  Oral / IM Two stat doses, 
one month apart 
 
Table 4: Deficiency [25(OH)D <25 nmol/1) –  Treatment for Adults 
 
 
 
 
 
 
 
 
 
 
 
 
 Frequency Route Length of course 
Colecalciferol or 
Ergocalciferol tablets 
1000-2000 IU 
Daily Oral Indefinite 
Colecalciferol 
capsules 10,000 IU. 
 Weekly or twice 
monthly 
Oral Indefinite 
 
Table 5: Maintenance treatment for adults following treatment of Deficiency 
[25(OH)D <25 nmol/1) 
Tables adapted from (Pearce and Cheetam, 2010)
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1.5.12 Vitamin D and Reproduction 
The diverse roles of vitamin D in human physiology also include a potential role in 
reproductive physiology. The role of vitamin D in reproduction both in males and 
females has been shown in animal experiments for decades, however there is increasing 
evidence in the recent literature to suggest a potential role of vitamin D in human 
reproduction also. 
 
1.5.12.1 Vitamin D and Female Fertility 
The expression of VDR in female reproductive tract followed by studies investigating 
the role of vitamin D in female reproduction and pregnancy are described in this 
section. 
 
1.5.12.1.1 Expression of VDR and vitamin D metabolising enzymes in female 
reproductive system 
In female rats, immunohistochemistry studies using polyclonal antibodies against VDR 
have localized VDR in ovary (granulosa cells, theca cells, stroma, corpus luteum and 
germinal epithelium), Fallopian tubes and uterus (Johnson et al., 1996). In humans 
VDR and the metabolising enzymes are expressed in the endometrium and ovaries 
(Agic et al., 2007; Parikh et al., 2010; Grundmann and von Versen-Hoynck, 2011). 
Furthermore VDR expression in the human pituitary gland has been shown suggesting a 
role of vitamin D in hormone secretion (Pérez-Fernandez et al., 1996). 
 
1.5.12.1.2 Studies on female reproductive function 
Animal studies have shown that vitamin D deficiency affects female reproductive 
function, reducing overall fertility by 75% and litter sizes by 30% (Halloran and 
DeLuca 1980). VDR null mutant mice showed impaired folliculogenesis, infrequent 
conception, uterine hypoplasia, decreased aromatase expression, hypergonadotrophic 
hypogonadism, fewer viable fetuses in utero and also more offspring with low birth 
weight (Yoshizawa et al., 1997; Kinuta et al., 2000; Kovacs et al., 2005) than wild type 
controls.  
 
Similarly the transgenic 25-hydroxyvitamin D-1α-hydroxylase female mice, were 
infertile and showed decreased estrogen and progesterone levels, elevated FSH and LH, 
adverse effects on folliculogenesis, uterine hypoplasia and decreased ovarian expression 
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of angiogenic factors such as VEGF and angiopoetin (Panda et al., 2001; Sun et al., 
2010).  
 
Vitamin D deficient female rats maintained on diets varying in calcium concentrations 
including normal calcium levels, when mated with vitamin D replete males, showed 
reduced litter sizes and fertility compared to vitamin D replete female rats. Furthermore 
the effect was reversed on supplementing vitamin D to deficient female rats suggesting 
that vitamin D has a direct effect on female reproductive function (Kwiecinksi et al., 
1989b). Similarly Kinuta et al also showed supplementation of calcium only partially 
corrected the hypogonadism in VDR null mice and vitamin D directly regulated 
aromatase gene expression (necessary for estrogen synthesis) and was essential for full 
gonadal function.  
 
However there have been studies undertaken on VDR null mice or transgenic 25-
hydroxyvitamin D-1α-hydroxylase mice where impaired reproductive function was 
restored by calcium, or calcium and phosphorous supplementation, suggesting an 
indirect action of vitamin D (Johnson and DeLuca, 2001; Sun et al., 2010). 
 
A possible mechanism of action of vitamin D in female fertility is through its role in 
steroidogenesis. In a study on cultured human ovarian cells, vitamin D stimulated 
steroidogenesis (progesterone production by 13%, estradiol production by 9% and 
estrone production by 21%) and insulin- like growth factor binding protein-1 (IGFBP-1) 
production in the ovary (Parikh et al., 2010). In female rats injection of 1,25(OH)2D 
induced a decidual reaction and increased uterine weight (Halhali et al., 1991). In mice, 
peripubertal vitamin D deficiency delayed puberty and disturbed the estrous cycle 
suggesting vitamin D has a role as a regulator of the hypothalamo-pituitary axis, as an 
adequate vitamin D level appears to play an important role in the pubertal transition 
(Dicken et al., 2012). 
 
Malloy et al. (2009) identified a sequence in the anti-mullerian hormone (AMH) 
promoter gene that is almost identical to VDRE. In a HeLa (cervical cancer cell line) 
transfected with VDR, calcitriol stimulated the AMH promoter activity. As AMH is 
produced by the granulosa cells of the ovarian follicles and regulates follicular 
recruitment and selection, it was hypothesized that vitamin D may play a role in ovarian 
physiology by its regulatory role on AMH expression (Luk et al., 2012)   
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Conversely in the study by Horii et al. (1992), vitamin D  (with associated 
hypercalcemia) caused disturbances of the estrous cycle, adverse functional changes in 
the corpus luteum, uterus, endometrium and decreased progesterone but these changes 
were reversible on discontinuing vitamin D. Also in 101 healthy young women aged 
between 18 and 22 years, it was shown that higher levels of vitamin D are associated 
with decreased estradiol and progesterone levels (Knight et al., 2010). 
 
Studies have been undertaken to investigate the association of vitamin D and 
gynaecological conditions causing infertility (such as endometriosis and PCOS) and 
also in the IVF setting. 
 
1.5.12.1.2.1 Endometriosis 
An increased expression of the VDR and metabolising enzymes is shown in 
endometriosis, whilst the serum concentrations of 25(OH)D were comparable in women 
with and without endometriosis, suggesting vitamin D by its potential autocrine / 
paracrine role may influence local immune cells and cytokines involved in the 
pathogenesis of endometriosis (Agic et al., 2007). In a prospective cohort study 
however, involving 87 women with endometriosis and 53 controls, higher serum levels 
of vitamin D were associated with increased risk of endometriosis. Moreover a positive 
gradient was recorded between serum vitamin D and the severity of the endometriosis 
(Somigliana et al., 2007). Serum and peritoneal concentrations DBP are comparable in 
women with and without endometriosis (Borkowski et al., 2008), however in a study by 
Faserl et al. (2011), DBP polymorphism (GC-2) was more prevalent in women with 
endometriosis compared to controls.   
 
1.5.12.1.2.2 PCOS (Polycystic ovarian syndrome) 
As both vitamin D deficiency and PCOS are associated with features of the metabolic 
syndrome, (particularly insulin resistance) several studies have investigated the role of 
vitamin D in the pathogenesis of PCOS (Luk et al., 2012). Women with PCOS are at a 
higher risk of vitamin D insufficiency and deficiency compared to women without 
PCOS (Wehr et al., 2009; Selimoglu et al., 2010; Li et al., 2011). In PCOS women, 
vitamin D levels show a significant inverse relation with BMI, free androgen index and  
insulin resistance (generally measured by the Homeostasis model assessment of insulin 
resistance –HOMA IR) and a positive correlation with insulin sensitivity (generally 
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measured by quantitative insulin sensitivity check index QUICKI)  (Wehr et al., 2009; 
Li et al., 2011; Wehr et al., 2011).  
 
PCOS women with metabolic syndrome have lower levels of serum vitamin D levels 
compared to PCOS without metabolic syndrome (Wehr et al., 2009). Similarly in the 
study by Yildizhan et al. (2009) serum vitamin D levels were lower in obese PCOS 
participants compared to non-obese PCOS and an association of low vitamin D with 
increased insulin resistance, BMI, testosterone and DHEAS was noted in obese PCOS 
participants.   
 
It has been argued that a major limitation in most of the studies investigating the 
association of low vitamin D levels and PCOS is the confounding factor obesity and 
therefore whether vitamin D deficiency independently contributes to pathogenesis of 
PCOS  is still debatable (Grundmann and von Versen-Hoynck, 2011; Lerchbaum and 
Obermayer-Pietsch, 2012; Luk et al., 2012). Also it  has to be acknowledged that the 
relationship between hypovitaminosis D and obesity is complex and interestingly there 
are studies to suggest low vitamin D to be an independent risk factor for obesity 
(Kamycheva et al., 2003; Foss, 2009).  
 
Studies on vitamin D supplementation in PCOS women show inconsistent results. In a 
study by Selimoglu, eleven obese insulin-resistant women with PCOS were 
supplemented with vitamin D (single dose of 300,000 units of vitamin D3 orally) and 
the HOMA-IR decreased significantly, suggesting a potential beneficial role of vitamin 
D replacement therapy in obese PCOS women (Selimoglu et al., 2010). However a 
more recent randomized, placebo-controlled, double-blinded trial with 50 PCOS women 
failed to demonstrate a beneficial effect of vitamin D supplementation on insulin 
sensitivity and insulin resistance (Ardabili et al., 2012). 
  
1.5.12.1.2.3 IVF 
There are few studies of vitamin D and IVF and they provide conflicting results. Whilst 
a study by Ozkan et al revealed that a higher vitamin D level in the serum and follicular 
fluid in IVF was significantly more likely to achieve pregnancy (Ozkan et al., 2010), 
Anifandis et al found excess serum and follicular fluid vitamin D levels to be  
detrimental to  the IVF outcome (Anifandis et al., 2010). 
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1.5.12.2 Vitamin D and Pregnancy  
CYP27B1 is localized in human placenta (Barrera et al., 2008) and the placenta 
synthesizes 1,25(OH)2D (Stephanou et al., 1994). Furthermore the localization of  VDR 
in the placenta (Tanamura et al., 1995) suggests a possible role for vitamin D in 
placental function. 
 
1,25(OH)2D regulates the  secretion of human chorionic gonadotrophin (HCG) through 
VDR and a cAMP / PKA pathway (Barrera et al., 2008), stimulates estradiol and 
progesterone production in  trophoblasts (Barrera et al., 2007), stimulates synthesis and 
release of human placental lactogen (genomic pathway) (Stephanou et al., 1994) and up 
regulates the HOXA10 expression necessary for embryo implantation in endometrial 
cells (genomic pathway) (Du et al., 2005). 
 
The phases in life of rapid growth like foetal life, infancy, early childhood, puberty, 
pregnancy and lactation, where demand can exceed supply, are the vulnerable times for 
vitamin D deficiency (Bosomworth, 2011). The National Institute of Clinical 
Excellence (NICE) ‘Antenatal care’ guideline was updated in 2008 (NICE, 2008) and 
now includes a statement that; ‘All women should be informed at the booking 
appointment about the importance for their own and their baby’s health of maintaining 
adequate vitamin D stores during pregnancy and whilst breastfeeding. In order to 
achieve this, women may choose to take 10 micrograms of vitamin D per day’. 
 
At the present time the advice is focussed on women with deficiency or those in at-risk 
groups only. Although the safety aspects of vitamin D supplementation in pregnancy 
have been proven in many studies, (Hollis et al., 2011) further research is warranted to 
investigate the effectiveness of routine vitamin D supplementation to improve 
pregnancy outcomes for healthy pregnant women at low risk of vitamin D deficiency 
(NICE, 2008). More recently however, UK health departments are recommending that 
all pregnant and breastfeeding women take a vitamin D supplement (10µg/ day) to meet 
maternal requirements and build adequate fetal stores (Department of Health, 2012).   
 
 There are observational studies linking vitamin D deficiency to an increased risk of pre-
eclampsia, gestational diabetes, preterm delivery, bacterial vaginosis and an increased 
risk of caesarean section, but so far the evidence is equivocal and large scale clinical 
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trials confirming these associations are lacking (Barrett and McElduff, 2010; 
Grundmann and von Versen-Hoynck, 2011). 
 
The vitamin D status of the new-born is dependent on the vitamin D status of the 
mother (Thomas et al., 2011). Studies have shown that children of mothers with 
inadequate vitamin D levels are at risk of osteoporotic fractures (Javaid et al., 2006) and 
are more susceptible to rickets. A study by Camargo et al showed a strong inverse 
association between maternal vitamin D supplementation during pregnancy and the risk 
of recurrent wheeze in children at three years of age (Camargo et al., 2007). It is well 
known that exclusively breastfed babies have lower levels of vitamin D compared to 
formula milk fed babies as breast milk is a poor source of vitamin D and the latter is 
fortified with vitamin D. Therefore breastfed babies are more prone to rickets (Jain et 
al., 2011). 
 
1.5.12.3 Vitamin D and Male fertility 
The expression of VDR in the male reproductive tract followed by studies (animal / 
human lab based / clinical) investigating the role of vitamin D in male reproduction are 
described in this section. 
 
1.5.12.3.1 Expression of VDR and Vitamin D metabolising enzymes 
In animal studies, the VDR has been identified in the testis (seminiferous tubules, 
epididymis, Sertoli cells), elsewhere in the male reproductive tract (seminal vesicles and 
prostate) and throughout various stages of spermatogenesis (spermatogonia, 
spermatocytes but only sparsely in sperm) (Merke et al., 1985; Johnson et al., 1996). 
 
Similarly in humans, the VDR is expressed widely in testis (Sertoli, Leydig cells, 
epididymis), the male reproductive tract (seminal vesicles and prostate) and various 
stages of spermatogenesis (spermatogonia, spermatid and sperm) (Nangia et al., 2007; 
Hirai et al., 2009; Blomberg Jensen et al., 2010; Zanatta et al., 2011) . A variation in the 
expression of VDR in human sperm is noted. Studies have revealed that VDRs are  
localized mostly in the sperm nucleus and neck (Corbett et al., 2006; Aquila et al., 
2008), whilst more recently it was revealed that other predominant areas of VDR 
expression in sperm were the post-acrosomal region of the head and mid-piece 
(Blomberg Jensen et al., 2010). The sperm nucleus is comprised of transcriptionally 
silent and highly condensed chromatin (Aquila et al., 2008), but the VDR expressed in 
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the post-acrosomal region of the head, neck and mid-piece evoke responses via non-
genomic pathways (Blomberg Jensen and Dissing, 2012) . 
 
Moreover, vitamin D metabolising enzymes are expressed in the male genital tract 
(Leydig cells, epididymis, seminal vesicles, prostate, sperm) suggesting that 1,25 
(OH)2D is locally produced, increasing the possibility for a role for vitamin D in human 
male reproduction (Aquila et al., 2009; Blomberg Jensen et al., 2010; Foresta et al., 
2011). 
In sperm, vitamin D metabolising enzymes are expressed (Blomberg Jensen et al., 
2012) as detailed below: 
• CYP2R1, CYP27A1 – neck, tail 
• CYP27B1 - neck, post acrosomal region of the head 
• CYP24A1 - neck, annulus  
 Interestingly, infertile men have lower expression of VDR and vitamin D metabolising 
enzymes in testis and sperm compared to normal men (Aquila et al., 2009; Foresta et 
al., 2011; Blomberg Jensen et al., 2012). 
 
1.5.12.3.2 Animal studies 
Several animal studies have been conducted to investigate the effect of vitamin D 
deficiency on male fertility. The proportion of vitamin D deficient male rats 
inseminating female rats (as determined by sperm positive vaginal smears) was 
significantly lower (73%) when compared to vitamin D replete rats (90%). Furthermore 
there was a significant reduction in the size of  litters from vitamin D deficient male rat 
inseminations compared to inseminations by vitamin D replete rats (Kwiecinski et al., 
1989a). Vitamin D deficient rats revealed adverse histological changes in the testis such 
as reduced tubule diameter in the seminiferous tubules and marked disruption of 
spermatogenesis (Osmundsen et al., 1989). 
 
Mechanism(s) of action suggested from animal studies 
Various studies have suggested the possible mechanism(s) by which vitamin D affects  
male reproductive function. 
 
The impaired fertility of vitamin D deficient rats was restored by treating with either 
vitamin D or calcium suggesting that the probable mode of action of vitamin D is by 
regulating calcium levels in reproductive tissues (Uhland et al., 1992). This fits in with 
56 
 
the classic role of vitamin D i.e. calcium homeostasis, particularly with the role of 
calcium having been demonstrated during spermatogenesis, sperm motility, sperm 
capacitation and the acrosome reaction (Benoff et al., 1994; Breitbart, 2002; Yoshida et 
al., 2008; Mendoza et al., 2012). Furthermore as calcium increases VDR expression, it 
is speculated that calcium may be an important co-factor in VDR expression (Nangia et 
al., 2007).  
 
It has also been shown however that calcium supplementation only partially corrects  
hypogonadism in VDR null mutant mice (Kinuta et al., 2000) as described later and 
also a direct positive effect of vitamin D action on semen quality has been shown 
(Blomberg Jensen et al., 2011; Blomberg Jensen, 2012). 
 
In vitamin D deficient rats, there is a significant reduction in testicular and epididymal 
sperm count, testicular glutamyl transpeptidase activity (an index of Sertoli cell function 
as glutamyl transpeptidase is involved in the synthesis of specific proteins secreted by 
sertoli cells) and Leydig cell count along with degenerative changes in germinal 
epithelium, but there is no difference in testicular lactate dehydrogenase activity (an 
index of germ cell function) compared to rats with vitamin D replete diets (Sood et al., 
1992). These results suggested that vitamin D deficiency retards spermatogenesis by 
interfering with the function of Sertoli and Leydig cells. 
 
In another study by the same authors, Sood et al. (1995) showed that the above changes 
in testicular function were reversed by supplementation with an optimal dose of vitamin 
D. However they also showed that high dose of vitamin D caused deterioration in 
testicular function.  
 
As  1,25(OH)2D via its non-genomic pathway leads to chloride channel activation and 
exocytosis in a mouse sertoli cell line, it has been suggested that vitamin D may be 
involved in the secretory activity of the Sertoli cells, essential for spermatogenesis 
(Menegaz et al., 2010).   
 
Some studies suggest that vitamin D affects fertility by the regulation of certain genes. 
VDR null mutant mice show reduced gene expression of aromatase (essential for 
estrogen synthesis), decreased aromatase activity and hypergonadotropic  
hypogonadism; and also demonstrate histological abnormalities in testes (dilated 
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seminiferous tubules, thinner layer of epithelial cells and decreased spermatogenesis). 
Calcium supplementation only partially corrects the hypogonadism (increased 
aromatase gene expression and activity without a change in FSH and LH levels), 
suggesting a direct vitamin D action. Supplementation of estradiol normalizes the 
histological abnormalities in the testes suggesting that vitamin D is an important factor 
in estrogen biosynthesis in male gonads by maintaining calcium homeostasis and also 
by regulation of aromatase gene expression (Kinuta et al., 2000), thus explaining a 
possible regulatory role for vitamin D in gonadal function. 
 
 Furthermore as estrogen receptor alpha and aromatase null mice had a similar 
reproductive and gonadal phenotype to VDR knockout mice, it was hypothesized that 
the impaired spermatogenesis in the VDR knockout mice may be mediated via 
deficiencies in estrogen signalling (Mahato et al., 2000; Couse et al., 2001; Luk et al., 
2012). 
 
A study by Hirai et al. (2009) noted that 19 out of 2483 testis-specific genes showed up-
regulation by vitamin D treatment. Of these genes, the regulator of cellular cholesterol 
homeostasis, ABCA1 (ATP- binding cassette transporter) was expressed mainly in 
Sertoli cells and the study concluded that vitamin D contributes to spermatogenesis by 
up regulating certain specific genes in Sertoli cells. 
  
ABCA1 causes the outflow of cellular cholesterol and phospholipid, which is the rate-
limiting step in the synthesis of high-density lipoprotein, the main source of cholesterol 
in steroidogenic tissues (such as for testosterone synthesis by Leydig cells). It has been 
shown that ABCA1 knockout mice had an accumulation of lipids in Sertoli cells and 
significant reduction in intratesticular testosterone levels and sperm counts (Selva et al., 
2004). 
 
Calbindin, (vitamin D dependent calcium binding protein) was localized in developing 
and growing chick testes. A comparison of the time course of the appearance and 
increase in the calbindin content in spermatogonia and spermatocytes in chickens 
suggests that calbindin may be involved in the mitotic process in spermatogenesis 
(Inpanbutr and Taylor, 1992).  
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1,25(OH)2D stimulated amino acid accumulation in 11 day old rat testis which was 
blocked by cycloheximide and verapamil /apamine, providing evidence for a dual action 
of vitamin D, by both genomic (triggered by PKA)  and rapid  non genomic pathways 
(involving Ca
+2
 dependent K
+
 channels on the plasma membrane) (Menegaz et al., 
2009). 
 
1.5.12.3.3 Human lab based Studies 
The lab studies investigating the association between vitamin D and sperm and also 
vitamin D and androgens are described in this section. 
 
1.5.12.3.3.1  Vitamin D and sperm 
In vitro human studies have shown that vitamin D enables sperm capacitation by 
contributing to involved processes such as increasing cholesterol efflux, protein 
phosphorylation and also by improving sperm survival (Aquila et al., 2008). 
   
1,25(OH)2D increases intracellular calcium levels in sperm by 5-10 fold from baseline 
via a non-genomic pathway. Furthermore vitamin D in in vitro studies at levels 
corresponding closely to the physiologic levels in serum improved sperm motility and 
also increased the acrosome reacted sperm numbers significantly (Aquila et al., 2009; 
Blomberg Jensen et al., 2011). As the association between vitamin D and sperm 
motility was not affected by an adjustment for calcium levels, it was suggested that the 
improvement in sperm motility may be due to a direct action of vitamin D, rather than 
being secondary to increasing calcium levels.  
 
It was shown in sperm that 1,25(OH)2D  (via VDR) decreased triglyceride content with 
concurrent increase in lipase activity. The authors suggested that the energy demands of 
the capacitation process may be met by this vitamin D triggered energy expenditure 
(Aquila et al., 2009).  
 
This association between vitamin D and sperm function (acrosin activity or sperm 
motility) in the in vitro studies  appears to be dose dependent with higher concentrations 
either being ineffective or inhibitory (Aquila et al., 2008; Blomberg Jensen et al., 2011), 
suggesting the  possibility of receptor down-regulation with higher levels of hormones 
(Aquila et al., 2009). 
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Interestingly further in vitro experiments by Blomberg Jensen et al. (2012) on 22 young 
and  18 sub-fertile men revealed 1,25(OH)2D increased sperm motility in young men, 
but not in sub-fertile men. 
 
1.5.12.3.3.2 Vitamin D and androgens 
Concomitant expression of receptors and metabolising enzymes in Leydig cells 
suggested the possible role of vitamin D in hormone production (Blomberg Jensen et 
al., 2010).The interaction between vitamin D and androgens appears to involve complex 
pathways (Lerchbaum and Obermayer-Pietsch, 2012). Testosterone down regulated 
VDR expression in the testis, whilst increasing concentrations of vitamin D increased 
VDR expression (Nangia et al., 2007). However in cultured human osteoblasts, 
dihydrotestosterone  increased CYP27B1 activity and 1,25(OH)2D levels (Somjen et al., 
2007). 
  
In the LPB-Tag [large probasin promoter (LPB) linked to the large T antigen (Tag)]  
transgenic mouse model of prostate cancer, tumour progression was significantly more 
rapid in VDR knockout mice compared to wild type mice. However following 
testosterone supplementation, the differences in the tumour progression were abolished, 
suggesting considerable cross interaction between androgens and vitamin D (Mordan-
McCombs et al., 2010).   
 
1.5.12.3.4  Clinical studies 
Several clinical studies have investigated the role of vitamin D in human male 
reproduction. To ease classification, I have divided the studies into those investigating 
the association between: 
 Vitamin D and androgens 
 Vitamin D and semen parameters 
 Vitamin D and testicular function 
 
1.5.12.3.4.1 Vitamin D and androgens 
A positive association including a concordant seasonal variation has been shown 
between serum vitamin D levels and androgens (testosterone and free androgen index) 
(Wehr et al., 2010b). Nimptsch et al. (2012) confirmed this positive association in their 
association study but denied any seasonal variation in serum testosterone levels. 
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However, other studies showed either no link between serum vitamin D levels and 
androgens or indicators of spermatogenesis (Blomberg Jensen et al., 2011; Hammoud et 
al., 2012; Yang et al., 2012) or a negative association as men with high serum vitamin 
D had a lower free androgen index (Ramlau-Hansen et al., 2011). 
 
To explain these study findings in further detail, Blomberg Jensen et al. (2011) revealed 
that there is no association between serum vitamin D levels and FSH / inhibin B. In a 
study by Hammoud et al. (2012) there was no significant difference between the mean 
levels of total testosterone, sex hormone-binding globulin (SHBG), FSH and LH in the 
various vitamin D groups. In a cross sectional association study by Ramlau-Hansen et 
al. (2011), men with higher vitamin D levels (94- 227nmol/l) had 16% higher levels of 
SHBG and 11% lower levels of free androgen index compared to men with vitamin D 
levels between 8and 62nmol/l. There was no association between serum vitamin D 
levels and estradiol, testosterone, FSH, LH and inhibin B levels.Yang et al. (2012) 
showed there was no correlation between serum testosterone and serum vitamin D 
levels in either fertile or infertile men. 
 
In a large cross sectional population study (European male ageing study-EMAS) 
involving 3369 participants from 8 European centres, there was no association between 
serum vitamin D levels and hormones of the hypothalamo-pitiuitary (HPT) axis. Unlike 
Wehr et al. (2010a) study, there was no seasonal variation noted in reproductive 
hormones. Vitamin D deficiency defined in their study as less than 50nmol/l was 
associated with compensated (normal testosterone 10.5nmol/l and high LH >9.4IU/l), 
and secondary (low testosterone <10.5nmol/l and normal LH 9.4IU/l) hypogonadism, 
which are strongly linked to obesity and limited mobility respectively. Based on this 
significant association with hypogonadism and serum vitamin D levels, the authors 
speculated that low vitamin D could potentially adversely affect the HPT axis at 
multiple levels (Lee et al., 2012). However the clinical significance of this association is 
not understood and needs further investigation. 
 
Interestingly, a placebo controlled trial involving 54 men participating in a weight 
reduction programme revealed that men who were supplemented with vitamin D 
(3332IU daily for 1 year) had higher levels of total and free testosterone compared to 
the placebo group (Pilz et al., 2011). 
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Following a review of 13 studies investigating the association between vitamin D levels 
and androgens, Blomberg Jensen (2012) reported that a positive association is generally 
seen in men above 40 years and with co–morbidities whilst in young healthy men either 
there was a negative association or no association noted. Caution was advised in 
interpreting these studies as the interaction between bone metabolism, gonadal and 
pituitary function and calcium homeostasis is complex, particularly as various 
compensatory mechanisms can affect the association between vitamin D and serum 
testosterone.  
 
1.5.12.3.4.2 Vitamin D and semen parameters 
 Increased serum vitamin D has been associated with improved sperm motility but not 
sperm counts or morphology (Blomberg Jensen et al., 2011). Conversely a study by 
Ramlau Hansen et al showed no correlation between serum vitamin D and semen 
parameters (Ramlau-Hansen et al., 2011). Interestingly in an association study 
conducted in Salt Lake, Utah, sperm motility and morphology were lower in men with 
low (<50nmol/l) as well as high (above 125nmol/l) concentrations of vitamin D 
(Hammoud et al., 2012). All the above association studies were conducted in men from 
the general population. 
 
Studies recruiting sub-fertile men include a further small cross sectional association 
study by Blomberg Jensen et al. (2012) of 70 men [25 men (partners of infertile 
couples) and 45 young unselected men], which revealed progressive sperm motility was 
significantly better in the vitamin D non-deficient group (>25nmol/l) compared to the 
vitamin D deficiency group. There was no statistical difference in other semen 
parameters (i.e. sperm concentration, total motility and morphology) between the 
groups.  
 
In a large recent cross sectional association study by Yang et al. (2012) (314 infertile 
and 195 fertile men), a significant positive association between serum vitamin D and 
sperm motility and sperm morphology but not sperm concentration was seen in the 
infertile male group. The positive association between vitamin D and sperm motility 
and morphology was only of borderline significance in fertile men and there was no 
association between sperm concentration and vitamin D in the fertile male group. 
However in another small study recruiting 90 men attending an infertility clinic, there 
was no correlation between vitamin D and semen parameters (poster presentation at 
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American Urological Association) (Knopf et al., 2011). Recently CYP24A1 expression 
in sperm has been suggested as a marker of semen quality owing to its positive 
association with semen parameters and ability to distinguish infertile and fertile men 
with high positive predictive value (Blomberg Jensen et al., 2012). 
 
Overall, despite some studies showing no link between serum vitamin D and semen 
parameters, a significant positive association (mainly on sperm motility and 
morphology, but not on semen volume or sperm count) has been reported in fertile and 
infertile men with some evidence of a negative association at higher vitamin D levels.  
 
1.5.12.3.4.3 Vitamin D and testicular function 
In a study by Foresta et al. (2011), 57 infertile men (azoospermia secondary to sertoli 
cell only syndrome and oligoazoospermia) were compared with 41 men with normal 
testicular function. Men with normal testicular function had significant higher 
expression of CYP2R1 gene expression compared to men with testicular pathology. 
Men in the testicular pathology group had significantly lower levels of serum vitamin 
D, higher levels of PTH and higher levels of bone specific alkaline phosphatase. 
Moreover these men were more likely to have osteopenia and osteoporosis despite 
normal testosterone and estrogen levels compared to men with normal testicular 
function, suggesting that testis was involved in systemic activation of vitamin D. 
 
The presence of VDR and metabolising enzyme expression in the male genital tract 
increases the possibility of a role for vitamin D in human male reproduction, however 
the importance of these receptors and the role of vitamin D in spermatogenesis and the 
male reproductive tract is still not completely understood and therefore the biological 
mechanisms are speculative. 
 
Further studies are needed to elucidate the precise role of vitamin D in human 
spermatogenesis and reproduction. In this study I aimed to investigate the hypothesis 
that vitamin D has an important role in male fertility by investigating if there was a 
correlation between serum levels of vitamin D and semen parameters.  
 
1.6  Summary of introduction 
To summarize, over recent years at NFC the waiting time for donor sperm treatments, 
was not only over a year but also perceived to be increasing. There have been some 
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significant changes nationally and locally during the first decade of the millennium, 
including the regulations regarding the removal of donor anonymity, which may have 
influenced the sperm donor programme at the centre. The Disclosure of Donor 
Information Regulations introduced by the Human Fertilisation and Embryology 
Authority (HFEA) were approved in the UK Parliament in 2004 (HMSO, 2004). From 
1st April 2005, only donors who have agreed to reveal their identity to the children born 
by their donation are allowed to donate.   
 
The British Fertility Society (BFS) Working Party report in 2008 recognised the 
problem of donor sperm shortage to affect most of fertility centres in UK (Hamilton et 
al., 2008a). Despite the absence of published evidence, it appears that centres have 
coped variably with the majority of the UK fertility centres struggling to recruit donors 
(Wardle, 2008), whilst some centres are successful (Adams et al., 2006; Ahuja, 2008; 
Tomlinson et al., 2010).  We aimed to analyse the changes or trends in various aspects 
of the sperm donor programme at the NFC over 11years from 2000 to 2010 to 
investigate if there is a problem with sperm donor recruitment. 
 
The most common reason for rejection of potential sperm donors is suboptimal semen 
quality (Paul et al., 2006; Hamilton et al., 2008a) . Suboptimal semen quality is a 
common problem but is poorly understood. I have reviewed a couple of external factors, 
widely studied in literature (i.e. season and vitamin D) that may influence semen 
parameters. A better understanding of their impact on semen quality (if any) may be of 
value in improving the efficiency of a sperm donor programme and also donor 
recruitment. 
 
The findings on seasonal variation in semen parameters, although extensively described 
in literature, have been variable and inconsistent. The majority of studies reveal a 
significant seasonal variation with improved parameters in Winter / Spring (or 
worsening parameters in Summer / Autumn) (Tjoa et al., 1982; Levine et al., 1988; 
Reinberg et al., 1988; Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; 
Levine et al., 1992; Gyllenborg et al., 1999; Andolz et al., 2001; Jørgensen et al., 2001; 
Chen et al., 2003; Chen et al., 2004; Moskovtsev and Mullen, 2005; Calonge et al., 
2009) whilst some have revealed an absence of seasonal variation (Mortimer et al., 
1982; Mallidis et al., 1991; Ombelet et al., 1996; Chia et al., 2001; Carlsen et al., 2004).   
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Most of the data is accrued from retrospective cross sectional observation studies as 
there are few longitudinal studies. Although not always, seasonal variation is more 
commonly seen in temperate than tropical climates (Chia et al., 2001). Seasonal 
variation has been consistently reported in sperm concentration but the data on semen 
volume, sperm motility and morphology is inconsistent (Levine, 1999). 
 
Men in the UK, being exposed to temperate climate may be subjected to seasonal 
variation in semen parameters; however studies from UK are sparse. As the study 
undertaken nearest to our centre geographically, in Edinburgh  revealed a pattern of 
improved sperm counts in Winter and Spring, though not statistically significant 
(Mortimer et al., 1983), we wondered if a similar pattern in semen parameters would 
emerge in men attending our centre.   
 
If a seasonal variation is semen parameters are confirmed, it is also worthwhile 
investigating the influence of this on the conception rates to not only further understand 
the impact of season but also strengthen the proposal of seasonal recruitment of donors. 
Studies have shown concurrence of variation in sperm parameters with variation in 
natural births and also IVF conceptions (Fisch et al., 1997; Ossenbühn, 1998; Levitas et 
al., 2013). It is well known that despite the fact that only men with optimal semen 
quality are recruited as donors, the fecundity of sperm donors is variable (Thyer et al., 
1999; Navarrete et al., 2000). Can this be related to the season of sperm donation?  
  
Studies have revealed that conceptions by donor insemination were highest between  
October and March (Paraskevaides et al., 1988; Ronnberg, 1989). In contrast, in a large 
French epidemiological survey of an artificial insemination programme over six years, 
where frozen sperm was used, there was no seasonal variation in donor conceptions 
(Mayaux and Spira, 1989). Studies investigating the effect of seasonality of sperm on 
conception are scant in the literature. I have taken the novel approach of investigating 
the distribution of conceptions achieved by donor insemination (DI) treatment, with 
regards to season of original sperm donation to find out if there was any variation.  
 
The role of vitamin D in male reproduction has been known for decades in animal 
studies. vitamin D deficient rats and /or VDR knockout  mice show low sperm count, 
decreased sperm motility,  impaired fertility, decreased testicular function and adverse 
histological changes in the testis (Kwiecinski et al., 1989a; Sood et al., 1992; Kinuta et 
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al., 2000). Repletion of vitamin D in these animals restored fertility and improved 
testicular function (Uhland et al., 1992; Sood et al., 1995).  
 
In humans wide expression of VDR and vitamin D metabolising enzymes in the male 
reproductive tract suggest local production of 1,25 (OH)2D and also supports the 
potential for autocrine –paracrine responses (Aquila et al., 2009; Blomberg Jensen et 
al., 2010; Foresta et al., 2011).  
 
In vitro human studies have shown that vitamin D enables sperm capacitation by 
contributing to involved processes such as increasing cholesterol efflux, protein 
phosphorylation and also by improving sperm survival (Aquila et al., 2008). It has also 
been revealed that vitamin D increases intracellular calcium levels in sperm, improves 
sperm motility and induces the acrosome reaction (Aquila et al., 2009; Blomberg Jensen 
et al., 2011). 
 
Interest in vitamin D has increased as its deficiency has now been identified as a 
worldwide problem, in particular a nationwide survey of middle-aged British adults 
revealed a high prevalence of hypovitaminosis D in the UK (Hyppönen and Power, 
2007; Holick and Chen, 2008). With this background, we aimed to investigate the 
potential role of vitamin D in human male fertility. In addition if vitamin D is found to 
have a strong link with semen quality, applicants for sperm donation could either be 
invited for initial screening of semen quality when their vitamin D levels are high or 
potentially to consider vitamin D supplementation to improve parameters, thereby 
improving sperm donor recruitment. 
 
I will consolidate our aims and objectives in the next section.
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Chapter 2 Aims of the project 
 
The central aim of the project is to optimise the use of human sperm in subfertility. 
Over recent years at the Newcastle Fertility Centre (NFC) a long waiting time for donor 
sperm treatments has developed. Various changes both nationally and locally may have 
had an influence on the sperm donor programme. 
 
Our first aim was  
To analyse the changes or trends in various aspects of the sperm donor programme at 
the NFC over 11years from 2000 to 2010, to investigate the issue of sperm donor 
recruitment. 
If a problem in donor recruitment is present, then a more efficient use of existing 
resources may be of benefit. The most common reason for rejection of a potential sperm 
donor is suboptimal semen quality. We will review some external factors that may 
influence semen quality. 
 
Our second aim was therefore 
To investigate if there was a seasonal variation in the semen parameters of men 
attending NFC. 
In order to understand further the influence of season, we investigated the impact of 
season on conception.  
 
Our third aim was  
To investigate the distribution of conceptions achieved by donor insemination 
treatment, with a view to finding out if there was any variation in relation to the 
seasonal timing of the original sperm donation. 
In view of clinical and preclinical data suggesting that vitamin D has a role in male 
reproduction as well as linking this to possible seasonal effects,  
 
Our fourth aim was 
To investigate if there is association between serum vitamin D level and semen 
parameters. 
We further wished to evaluate the impact of serum vitamin D on male fertility. 
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Our fifth aim therefore was 
To investigate if there is correlation between serum vitamin D and  
1. semen quality 
2.  IVF treatment outcomes. 
This study will contribute to potentially increasing the efficiency of the treatment 
programme with donor sperm and also the understanding of male infertility 
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Chapter 3 Is there a problem with sperm donor recruitment currently 
at NFC? 
3.1 Introduction 
In this chapter, I have examined the sperm donor programme at NFC over a period of 
11 years from 2000 to 2010 inclusive.  
 
At NFC over recent years a gradually increasing waiting time for donor sperm 
treatments has been noted. In addition, there was a perception of an increase in sperm 
import to the centre. Significant national and local changes to the sperm donor 
programme in the 2000 decade may have influenced this. One of the major changes 
included the removal of sperm donor anonymity which allowed only donors agreeing to 
reveal their identity to children born by their donation (when children reached 18years 
of age) to donate from 1st April 2005 (HMSO, 2004).  
 
Following on from the adoption of EU Tissues and Cells Directive in the UK, (Directive 
2004/23/EC, 2004), the SEED (Sperm Egg and Embryo Donation) review in 2005 
concluded that sperm donors may be reimbursed to cover demonstrable out of pocket 
expenses and loss of earnings, but not for inconvenience related to donation and 
reimbursement was capped at £250 pounds for each course of sperm donation (SEED 
Report, 2005). However the recent review of HFEA policies allows a fixed sum of £35 
per visit for sperm donors (HFEA, 2011a).  
 
Local changes affecting the donor recruitment and treatment programmes include the 
introduction of a comprehensive and integrated andrology service in 2009 offering 
advanced surgical sperm retrieval techniques such as microsurgical testicular sperm 
extraction (Micro – TESE) which has made own gamete treatment accessible to many 
more couples than previously. However, a proportion of these will opt for donor sperm 
to be available as a back-up when they are aware of a significant risk that no sperm will 
be retrieved. 
 
The problem of donor sperm shortage was recognised as a national problem by the BFS 
working party report in 2008 affecting most of the UK fertility centres (Hamilton et al., 
2008a). However, despite the absence of published evidence, it appears that centres 
have coped variably with the problem of sperm donor shortage. Some of the UK fertility 
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centres are struggling to recruit donors (Wardle, 2008),  whilst other centres are 
successful (Adams et al., 2006; Ahuja, 2008; Tomlinson et al., 2010). 
 
3.2  Aim  
To analyse the changes or trends in the various aspects of the sperm donor programme 
between 2000 and 2010 at our tertiary care referral centre, NFC. 
 
3.3 Objectives 
To identify any changes in: 
1. Sperm donor recruitment per year. 
2. The number of patients treated, the number of treatment cycles performed and 
the indications for treatment. 
3. The amount of sperm imported and exported. 
4. The waiting times for treatment. 
 
3.4 Outcome Measures 
To investigate if there is a problem of sperm donor shortage and if confirmed, to devise 
appropriate strategies to manage the shortage. 
 
3.5 Subjects and Methods 
3.5.1 Subjects 
All the patients who had treatment with donor sperm between 2000 and 2010 were 
included in the study i.e. heterosexual couples, same sex couples and single women. 
There is NHS funding available for all those childless couples where the woman is 
under 40, although not for same sex couples where there is no other fertility issue or 
single women in our region at the time of the study. However since the new NICE 
guidance same sex couples are eligible for treatment under NHS (NICE, 2013). 
 
3.5.2 Recruitment of sperm donors at the Centre 
All sperm donors undergo a standard screening process. Prior to 2008 this was 
undertaken  in accordance with the British Andrology Society (BAS) guidelines for the 
screening of semen donors  (British Andrology Society, 1999) and since 2008 in 
accordance with the updated UK Guidelines for the medical and laboratory screening of 
sperm donors 2008 (Association of Biomedical Andrologists et al., 2008). This involves 
taking a detailed medical history (including a family and genetic history), performing a 
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physical examination and carrying out various screening tests (including cytogenetic 
tests and tests to exclude blood borne viral and sexually transmitted infections).  
 
The assessment of semen parameters includes a freeze-thaw analysis. The acceptable 
standards for fresh semen parameters have changed over the years in an attempt to 
increase the efficiency of donor recruitment, whilst not compromising the success of 
donor sperm treatments. By taking a more critical view of the post-thaw parameters, 
more variation in pre-freeze samples has been accommodated, though still within 
normal limits. The current criteria include: volume ≥ 1ml, initial motile concentration ≥ 
40 million/ml, post thaw motile concentration ≥ 10million/ml, morphology ≥ 10%, and 
mixed antiglobulin reaction (MAR) test negative.  
 
Semen samples are frozen and quarantined for 6 months. At the end of the quarantine 
period the screening tests for sexually transmitted infections are repeated and confirmed 
negative, prior to releasing the samples for use. Once the donor samples are released, 
patients are allocated to a donor. A maximum of 10 patients are allocated at a time to 
each sperm donor (HFEA, 2011b). Once 10 families have been achieved, the semen 
samples are not used for further treatment unless for a sibling, up to the 10 year storage 
limit. 
 
3.5.3 Donor programme 
The donor programme offered at our centre begins with ultrasound monitored natural 
cycle  insemination, commonly referred to as unstimulated donor insemination 
(unstimulated DI or DI) as the first line of treatment. This involves inseminating the 
thawed semen samples into the cervix, timed to the ovulation of a mature follicle. 
Despite the National Institute of Clinical Excellence (NICE) guidance on Fertility 
suggested IUI over intracervical insemination (NICE, 2013), as unstimulated DI 
treatment success rates were consistent with the national average (and at times higher) 
(Paul et al., 2006) and particularly as the majority of women treated had no female 
infertility factor, this remained the first line treatment  (Flierman et al., 1997; Harris, 
2000) during the study period and until recently.  
 
If unsuccessful, then the more interventional techniques of ovarian stimulation with 
intra-uterine insemination (stimulated IUI) (Goldberg et al., 1999; Carroll and Palmer, 
2001; Besselink et al., 2008) and in-vitro fertilization (D-IVF) are offered sequentially. 
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Stimulated IUI involves stimulating the ovaries with gonadotrophins aiming for no 
more than two mature follicles and inseminating the prepared sperm directly into the 
uterus, timed to the stimulated ovulation of mature follicle(s) with HCG. IVF is more 
complex and encompasses ovarian stimulation, egg collection, fertilization in vitro and 
the transfer of embryos into the womb.  
 
Generally patients are offered 3 cycles of each method of treatment sequentially (a 
maximum of 9 donor sperm treatment cycles) until pregnancy is achieved, although the 
programme may be modified depending on other prognostic factors such as age and 
ovarian reserve or the presence of female subfertility factors. Our programme is slightly 
different to the recently issued NICE guidance in 2013 which suggests a minimum of 6 
cycles of unstimulated IUI but up to 12 cycles are recommended prior to considering 
IVF (NICE, 2013). 
 
3.5.4 Methodology 
 
We performed a retrospective review of NFC’s registers and databases of assisted 
conception treatments using donor sperm, between January 2000 and December 2010. 
These sources of information were used to collate the information needed for this study. 
 
1. Laboratory database of donor sperm use for treatment.  
The laboratory data base records the patient’s details with date and type of donor sperm 
treatment carried out. The number of patients treated and the number and type of 
treatment cycle performed per year were calculated from this database.  
 
2.  Database and records maintained for sperm donor programme outcomes. 
The treatment database holds patient details including the indication for treatment, 
patient status (eg. heterosexual couple, same sex couple or single women) with date, 
type of treatment and treatment and pregnancy outcomes. The indications for donor 
sperm treatment per year and the success rates of the treatments were calculated using 
this information.  
 
3. Donor files. 
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All the donor files were studied for the year of HFEA registration, from which the 
number of donors recruited per year was calculated. Known donors have been excluded 
from the analysis. 
 
4. Weekly donor sperm straw consumption sheets: These sheets are completed with the 
patient details and donor code of the sperm used and date of treatment just prior to 
carrying out treatment. The number of donors used per year could be calculated from 
these sheets. 
 
5. Sperm transfer Log 
The sperm transfer log records the donor code, date and number of straws of sperm 
transferred from NFC to other fertility centres. The sperm export per year was derived 
from this database. 
 
6.  Sperm import records 
 A separate register of sperm import is maintained with patient details, year of import, 
sperm bank and donor details and amount of sperm imported.  From these records the 
number of patients importing sperm per year was calculated. 
 
7.  Waiting list for donor sperm treatment registers 
This register records the date of placement on the waiting list, the date when treatment 
was offered and the response to this invitation.  Of the patients placed on the waiting list 
up to 2010, the response to the invitation was studied till May 2012. This enabled the 
calculation of the numbers of patients placed on the waiting list per year, their waiting 
time and the outcome. 
 
3.6 Statistical analysis 
Statistical analysis was performed using the Minitab software (version 15). Linear 
Regression analysis was done to examine the trends over the years. A p value of <0.05 
was considered significant. 
 
3.7 Results 
A total of 1889 cycles of treatment were undertaken during this time period for 420 
patients. 
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3.7.1 Recruitment of donors 
In the early years of the decade the recruitment rate for sperm donors on average was 4 
donors per year Table 6. Around the years of change in donor anonymity (2003 to 2006), 
variations in the apparent number of donors recruited per year (between 1 and 6) were 
seen. This was in part a strategic effort to pre-empt the effects of the anonymity changes 
by “stockpiling” identifiable donors recruited earlier for use after the transition date (i.e. 
they were not released for treatment until the anonymity change was mandatory).  
 
Although the numbers are small, Table 6 shows the decline in the number of donors 
recruited since 2006, with none recruited in 2009 and 2010. This decline generally 
reflects a reduced number of enquiries from potential sperm donors from 123 in year 
2000 to 18 in 2010 (Table 6) although there was a slight rise in 2010 compared with the 
previous two years.  
 
 Before the removal of sperm donor anonymity the average size of the donor pool was 
44 donors (data not shown in the table 6; calculated from weekly donor sperm straw 
consumption sheets), with no sperm donor shortage.  This donor bank, adequate for 
demand and allowing for a choice of donor characteristics, was effectively shelved with 
the removal of sperm donor anonymity as the donors were not consented for later 
identification or for later contact, which precluded direct invitation for re-registration as 
identifiable donors.  Despite publicity at the time none volunteered to make this change. 
This left a stock of donors for sibling use only at the end of the transition period and a 
drastic fall in the number of sperm donors available. The pool in 2010 of identifiable 
donors comprised 14 donors only (data not shown in table 6). The centre’s advertising 
strategy, which was through student magazines, local magazines and newspapers 
remained consistent throughout the study period.  
 
Unsurprisingly, given the donor shortage there has been an increase in the requests for 
consideration of single use donations for family members (known donors) although as 
yet only a very small number of such donors have proved suitable for a number of 
reasons including poor quality sperm and not pursuing the treatment option further 
following counselling of the involved parties. 
 
 
.
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Year Sperm donor 
enquiries 
No: sperm 
donors 
registered per 
year 
No: Straws of 
sperm 
transferred  
No: patients per 
year importing 
sperm  
Waiting times 
(months) for 
donor sperm 
treatment 
2000 123 3 44 0 0 
2001 60 4 85 0 0 
2002 58 5 58 0 0 
2003 22 1 142 1 0 
2004 * 6 129 0 0 
2005 * 1 24 0 0 
2006 13 5 20 1 0 
2007 17 2 2 2 6 
2008 5 1 6 3 8 
2009 4 0 0 0 10 
2010 18 0 0 12 18 
 
Table 6: Sperm donor enquiries, recruitment, sperm export / import, and waiting times 
for donor sperm treatment at the Newcastle Fertility Centre from 2000 to 2010. 
 
*unable to retrieve data 
The number of straws of sperm transferred per year to other centres is shown in the 
fourth column.  
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3.7.2 Donor sperm treatments  
The number of patients treated, treatment cycles carried out, indications for treatment 
and success of treatments during the study period are discussed in this section. 
3.7.2.1 Patients treated 
 Figure 6 shows a declining trend in the number of patients treated. Approximately 50% 
fewer patients received treatment in 2010 compared to 2000 (26 versus 46). A 
considerable drop in 2007 was noted when the demand for donor sperm started to 
outstrip the supply. However a marked increase was apparent in 2008 following the 
release of four sperm donors at once enabling forty patient slots to be made available.  
These were promptly taken up by patients commencing treatment. 
 
 
 
Figure 6: Number of patients starting treatment with donor sperm per year 
The graph shows the regression line of the number of patients starting treatment from 
2000 to 2010.  Regression p=0.06; R
2
 (adjusted) =25.3%.
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3.7.2.2 Treatment cycles carried out 
Figure 7 reveals a non-significant declining trend in the number of donor insemination 
cycles (unstimulated and stimulated) (p=0.4), even though only 84 cycles were 
performed in 2010, compared to 157 cycles in 2000. An increase in the treatment cycles 
in 2008 and 2009 reflected the extra patients starting treatment in 2008. Whether the 
marked drop in 2010 is one off or a persistent phenomenon will be revealed in future 
studies. 
  
 There was a significant increase in D-IVF cycles (p= 0.002) (Figure 7) performed over 
this period. The proportion of D-IVF cycles performed in relation to the total donor 
sperm treatment cycles also increased gradually from 5.9% in 2000 to 16.6% in 2009 
(Table 7). There was a sharp increase in that proportion to 33% in 2010, most likely due 
to the lower total numbers of patients starting treatment in 2010 and therefore caution is 
advised in interpreting this rise.   
 
 
Figure 7: Number of treatment cycles with donor sperm per year 
 
The graph shows the regression line of the number of Donor Insemination (DI) cycles 
(Unstimulated and Stimulated) and Donor IVF cycles per year from 2000 to 2010.  For 
DI, Regression p= 0.4; R
2
 (adjusted) =0.0%; For IVF, Regression p= 0.002; R
2 
(adjusted) = 65.1%. 
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Year Donor IVF cycles Total donor sperm 
treatments 
Proportion of 
Donor IVF (%) 
2000 10 167 5.9 
2001 6 130 4.6 
2002 13 162 8 
2003 10 207 4.8 
2004 13 216 6 
2005 14 172 8.1 
2006 7 153 4.5 
2007 18 150 12 
2008 24 203 11.8 
2009 34 204 16.6 
2010 41 125 32.8 
 
           Table 7:  Rising proportion of Donor IVF in donor sperm treatment cycles.
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3.7.2.3 Indications for treatment with donor sperm 
Figure 8 shows as expected that, male factor remained the commonest indication for 
treatment with donor sperm and was the indication in an average of 83% of cases over 
the study period, although a significant decline in that proportion was noted over the 
years (p= 0.01). There was a significant rising trend in the proportion of same sex 
couples attending for treatment from 4% of the total in 2000 to 11.5% in 2010 (p= 0.01) 
and a rising trend (although non-significant) in the number of single women treated (2% 
of the total  in 2000 to 8% in 2010 (p=0.2).  
 
 
 
 
 
Figure 8: Indications for use of donor sperm 
 
The graph shows the trend of the patients with Male factor infertility, same sex couples 
and single women starting donor treatment per year from 2000 to 2010. Patients 
starting treatment are expressed in percentages. For Male factor infertility, Regression 
p= 0.01; R
2
 (adjusted) = 45.9%; For same sex couples, Regression p= 0.01; R
2
 
(adjusted) = 47.9%; For single women, Regression p= 0.2; R
2
 (adjusted) = 4.7%. 
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3.7.2.4 Success Rates 
The live birth rate per cycle with unstimulated DI, Stimulated DI and IVF were 10.8%, 
16.8% and 20% respectively over the study period. More importantly the overall 
cumulative live birth rate with the donor programme during this time period was 55%. 
 
3.7.3 Sperm export and imports 
Table 6 shows a decline in the number of straws of sperm transferred outside the centre 
(44 straws in 2000 to 0 straws in 2010). Sperm was transferred at nominal cost to 
secondary care centres in our region that did not have a facility to recruit donors to 
enable them offer DI treatments locally. This has all but disappeared  with the shortage 
of sperm such that since 2005,  sperm is only passed to other Centres for  the sole 
purpose of  treating couples who had undergone prior successful treatment with our 
centre’s sperm donor (i.e. for the purpose of siblings only).  
 
Conversely during the same time period there was an increase in the number of patients 
(none in 2000 to 12 in 2010, Table 6) importing sperm from commercial sperm banks to 
fast track their treatment instead of waiting for the availability of sperm on the NHS. 
When there was no shortage of sperm donors, sperm was imported only occasionally 
when the centre could not provide a suitable match eg: a specific racial match to for 
non-Caucasian couples requesting donor sperm treatment.  Whilst solving waiting 
issues for some patients this comes with a burden of cost to couples selecting this option 
and is therefore not accessible to all. 
  
3.7.4 Waiting list issues 
The waiting times and outcomes of the patients on the waiting list are described in the 
following section. 
 
3.7.4.1 Waiting times 
 It is evident from Table 6 that the waiting list appeared in 2007, and that by 2010 the 
waiting time had increased to 18 months.  
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3.7.4.2 Patients on the waiting list 
From 2007 to 2010, 186 patients were added to the waiting list. Male factor was the 
indication in 75.8%. 3.7% were single women and 20.4% were same sex couples 
amongst these patients (Table 8), similar to the trend illustrated previously in Figure 8. 
The waiting list is not attributable to primary care trust (PCT) funding which supports 
the programme appropriately.   By May 2012, 166 of the 186 had been called for 
treatment, however treatment was commenced only in 65.6% of those patients called. 
Reasons for not commencing treatment in the remaining patients are shown in  
Table 9.  
 
 
 
 
Year Number of 
patients added 
to the waiting 
list 
Same sex 
couple 
Single women Male factor 
infertility 
2007 56 7 2 47 
2008 57 11 2 44 
2009 30 8 3 19 
2010 43 12 0 31 
Total 186 (100%) 38 (20.4%) 7 (3.7%) 141 (75.8%) 
 
Table 8: Patients added to the waiting list for donor sperm treatment – with their 
indications
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Patients who reached the top of the waiting list (by May 2012) 166 (100%) 
Treatment commenced 109 (65.6%) 
Did not attend (no obvious reason) 34 (20.4%) 
Decided not to pursue further treatment 8 (4.8%) 
Sought treatment in other centres including abroad 5 (3.0%) 
Couple separated 3 (1.8%) 
Patients turned 40 (lost NHS funding / declined self-funded 
treatment) 
2(1.2%) 
BMI over 30 (treatment could not be commenced) 5 (3.0%) 
 
Table 9: Patients on the waiting list- Outcome 
 
At the time of writing (May 2012) 166 patients of the 186 who were placed on the 
waiting list by 2010 had been called for treatment.
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3.8 Discussion 
In this chapter we have examined the donor programme at our tertiary centre over a 
period of 11 years between 2000 and 2010. There has been a significant change in the 
sperm donor programme at NFC over this time with fewer donors recruited, a smaller 
pool of donors,  fewer patients receiving treatment, a decline in the number of  donor 
insemination cycles undertaken accompanied by rising D-IVF cycle numbers, 
increasing sperm imports and a longer waiting time for treatments. 
 
3.8.1 Recruitment of donors 
There is an obvious decline in the number of donors registered with the HFEA at our 
centre  since the removal of anonymity, which is similar to the experience of other 
fertility centres across the country (Wardle, 2008).  Previous work done at our centre 
(between 1994 and 2003) showed a significant decline in the number of enquiries to be 
sperm donors.  As the number predominantly declined after 2000, it was possibly 
related to the growing awareness of the removal of donor anonymity at the time (Paul et 
al., 2006). However the HFEA data (HFEA, 2011d) shows a decline in the number of 
donors from 426 in 1993 to 239 in 2004, much before the removal of anonymity.  
 
 In a Department of Health survey of UK gamete donor’s views on the removal of 
anonymity prior to the Regulations in 2004, only 50% of the participating 43 sperm 
donors expressed their willingness to continue to donate following the removal of 
anonymity (Frith et al., 2007). In my study, there were variations seen in the numbers of 
donors registered around the years of introducing the disclosure of donor information 
regulations 2004. Apart from the centre’s effort to recruit identifiable donors prior to the 
regulations in preparation for the potential shortage after anonymity changes, there were 
other factors influencing this variation. There was increased media interest heightening 
awareness at the time and also prospective donors’ apprehensions about the potential 
legal and financial responsibilities and concerns about the consequences of contact with 
the donor offspring and their (sperm donor) rights regarding the access to information 
about the offspring (Frith et al., 2007).  Whilst some were unfounded, these concerns 
reveal the difficulty in decision making for potential sperm donors at the time.  
 
In the British Fertility Society Donor Survey 2005/06 which included responses from 35 
treatment and storage centres, 37% agreed that it was harder to recruit donors and in 9% 
of centres the service of donor sperm treatment ceased (British Fertility Society survey, 
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2006). In a BBC survey in 2006, it  was revealed that 75% of donors were recruited 
from just 9 clinics and 50 out of the 74 clinics contacted either had no sperm or 
insufficient supplies of donor sperm (BBC survey, 2006).  
 
In a recent study where responses from 324 UK men registering as sperm donors on 
Sperm Donors Worldwide website (which “facilitates free donation of sperm in private 
arrangements”) were included, there was decreased willingness by donors to be 
identified and 47% desired no involvement with children born by their donation (Riggs 
and Russell, 2011).  
 
There has been conjecture about the significant rise in the cost to purchase sperm 
following the removal of anonymity owing to the shortage and the smaller centres 
which  purchased sperm  previously have struggled to maintain their services  (Wardle, 
2008). The BFS Donor survey showed that 94% of the 35 centres found it harder to 
purchase sperm from commercial banks and 89% reported associated increased costs 
involved with donor sperm treatments.  
 
The other debated contributing factor to the low sperm donor numbers is donor 
payment. It was widely argued that UK sperm donors were not adequately compensated 
and yet clinics were using imported sperm from overseas commercial sperm banks, 
where the donors may have been well compensated (Heng, 2007; Hamilton, 2010; 
Tomlinson et al., 2010).  In the recent HFEA review  following a 3 month public 
consultation including all relevant stakeholders, the policy regarding gamete donor 
payment was revised to compensate UK sperm donors a fixed sum of £35  per visit 
(which reflects their expenses) to avoid exploiting altruistic sperm donors and yet 
prevent financially motivated donations (HFEA, 2011a). Restrictions were also made 
regarding acceptable compensation to men donating in foreign centres where the sperm 
is later imported to the UK. This policy was introduced outside our study period and the 
outcomes will be investigated in a future review. 
 
As suboptimal semen parameters is the commonest cause of rejection of sperm donors  
(Paul et al., 2006; Hamilton et al., 2008a) a general decline in the semen parameters in 
men over years although debatable because of the conflicting results and geographical 
limitations (Carlsen et al., 1992; Adamopoulos et al., 1996; Irvine et al., 1996; 
Gyllenborg et al., 1999; Dindyal, 2004; Sripada et al., 2007; Calonge et al., 2009; 
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Hiltrud et al., 2010; Axelsson et al., 2011; Olsen et al., 2011; Prisant et al., 2011; 
Priskorn et al., 2012; Splingart et al., 2012) may be considered as it could possibly lead 
to a greater rejection of potential sperm donors. The minimum standards of fresh semen 
parameters for acceptance have been cautiously adjusted to the current criteria (detailed 
in methods) from those previously published (Paul et al., 2006). By taking a more 
critical view of the post thaw parameters, more variation in pre freeze samples has been 
accommodated (still with in normal limits) whilst maintaining satisfactory treatment 
outcomes on par with national averages. 
 
The decline in donor recruitment compounded with losing a large pool of sperm donors 
(anonymous donors) led to increasing waiting times for treatment, increasing sperm 
import and an increase in the request for known sperm donations at our centre. 
Interestingly the number of sperm donors registered with the  HFEA has risen  from 272 
in 2005 to 480 in 2010 (HFEA, 2011d) despite the fact that the number of patients 
treated  and the total number of donor  treatment cycles performed were still lower in 
2010 than in 2004 (HFEA, 2011c). Even though the number of sperm donors in 2010  
(480) is so close to the estimated need of sperm donors in the UK per year i.e. 500 
(Hamilton and Pacey, 2008b), there is  evidence of unmet demand for donor sperm. 
 
 It is unclear why the  rise in donors  has not translated  into a  proportionate increase in 
the  number of patients receiving treatment, which is also reflected in an apparent  
increase in  patient waiting times, the amount of sperm imported  and the numbers of 
patients travelling abroad for treatment (Hamilton, 2010; Culley et al., 2011). It has 
been suggested that the recent rise in sperm donor numbers is contributed to by the 
increase in numbers of overseas  sperm donors used (who need to be screened as per the 
UK guidelines for sperm donors and also registered with HFEA)  i.e. sperm import, and 
the increasing  use of known donations  by friends and family of the recipients of donor 
sperm treatments (Tomlinson et al., 2010). Such imports and donations are unlikely to 
lead to treatment of more than one couple but are registered individually hence there are 
fewer patients per donor overall than if each was used to the 10 family capacity 
available with altruistic donors who consent to it.  
 
HFEA data  shows  that 11 % of donors were from  overseas in 2005 and this had 
increased to about 24%  by  2010 (HFEA, 2011e). Moreover, 16% of newly registered 
sperm donors in 2008 limited their donation to one family i.e. were likely to be ‘known 
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donors’ donating to family or friends (HFEA, 2011b). Janssens et al. (2006) reported an 
increase in  known donors during  the years of debate and following the  removal of 
anonymity in the Netherlands. 
 
 It is worth noting that less than 1% of donors registered with the HFEA between 2006 -
2008 actually created 10 families (upper limit) (HFEA, 2011b). The average number of 
families created was only one or two with one or two children in each family. This was 
explained by the non-use of 19% of donors probably due to the withdrawal of consent 
or of not being chosen by the patients, clinic protocols involving under-utilisation of a 
donor (i.e. create only 6 families) and approximately about 20% of the donors being 
overseas usually being imported for only one patient. 
 
3.8.2 Donor sperm treatments 
3.8.2.1 Fewer patients receiving treatment 
There has been a noticeable decline in the number of patients receiving treatment with 
donor sperm over the study period. The fewer number of treatment cycles undertaken 
and therefore patients receiving treatment is primarily the result of the sperm donor 
shortage which has also led to the waiting list for treatment. Furthermore it is notable 
and regrettable that about 30% of the patients on the waiting list never return for 
treatment.   
 
Contributing to the change in treatment patterns is the fact that more couples are able to 
be treated with the man’s own sperm owing to the success of advanced surgical sperm 
retrieval techniques since 2009 (At NFC eight men underwent surgical sperm retrieval 
in 2002 compared to 57 men in 2010 alone with successful sperm recovery in 40%, data 
not shown in the results).  
 
The decline in the numbers of patients treated is unlikely to be due to reduced referrals 
to the Centre, even though there is no formal recording of the referrals specifically for 
donor sperm treatment, since the waiting list (although stabilising) has not declined to 
any extent. 
 
Nationally the HFEA published figures show a decline in the number of patients 
receiving donor sperm treatments since 1993. This was initially thought to be due to the 
acceptance of ICSI which was a well-established method of treatment by the year 2000. 
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However the expected stabilization of this decline has not materialized (Pacey, 2010).  
The numbers of patients treated with DI and D-IVF only started to gradually rise again 
from 2007 to 2010 (from 2389 patients in 2007 to 2960 patients in 2010). Despite this 
encouraging trend, the number of patients treated and the total number of donor 
treatment cycles performed are still lower in 2010 than in 2004 (3712 patients in 2004) 
(HFEA, 2011c) 
 
3.8.2.2 Treatment cycles carried out 
There is a declining trend in the number of DI cycles (unstimulated and stimulated) 
performed at our Centre reflecting the decline in the total number of patients treated 
with donor sperm. Nationally, the decline in DI cycles stabilized between 2007 and 
2010 (3871 cycles in 2007 to 3878 cycles in 2010) (HFEA, 2011c) as the number of 
patients receiving treatment rose.  
 
Our data shows that an increasing proportion of donor treatments involve D-IVF (i.e. 
the ratio of D-IVF cycles to the total donor sperm treatment cycles increased) although 
this has been generally lower than the comparable HFEA data which remained stable 
between 15 to 18% of total treatments (Hamilton et al., 2008a). However the recent 
HFEA data of 2009 and 2010 does show that the proportion of IVF treatments are on 
the rise at 22% (HFEA, 2011c).  
 
It has been suggested that  fertility centres may be resorting  to increasing  use of IVF 
with donor sperm,  to improve the efficiency of limited sperm stores (Pike and Pacey, 
2005; British Fertility Society survey, 2006). Our data show a similar increase in the 
proportion of donor treatments involving IVF. The likely reasons for the increase in our 
centre are not only because of the strategies to improve the efficiency of the treatment 
(particularly for women in their late thirties and forties to start IVF instead of 
insemination) but also an increase in NHS funding for IVF treatment from two to three 
cycles in the majority of primary care trusts in the North East region. Furthermore, the 
use of back up donor for our men undergoing surgical sperm retrieval who aren’t 
successful also contributed to this rise.  
 
3.8.2.3 Indications for treatment with donor sperm 
In our study there was a rising trend in the proportion of same sex couples and single 
women treated, particularly as there was no restriction on the utilisation of sperm 
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services, unlike in some European countries such as France (Shenfield et al., 2010). The 
Human Fertilisation and Embryology Act of 2008 (HFEAct, 2008), apart from 
recognising same sex couples as legal parents of children, also  replaced the reference  
‘need for a father’ with ‘need for supportive parenting’, recognising  the role of all 
parents. This recognition in the Act is  likely to further increase  the numbers of single 
women (Jadva et al., 2009) and same sex couples coming forward for treatment.  
 
The rising trend  was  also seen nationally and it was reported that in 2010 40%  of DI 
services were used  by same sex couples and single women, as opposed to 20% in the 
year 2000 (Hamilton, 2010). It was pointed out by the author however that absolute 
numbers of same sex couple and single women are not significantly higher. Our data 
concurs that these increasing proportions of same sex couple or single women 
treatments are secondary to a fall in the numbers of heterosexual couples receiving 
treatment.  
 
3.8.3 Sperm export and imports 
The transfer of sperm to the peripheral centres within the North East region and rest of 
UK  has essentially stopped after the removal of anonymity to try and unify the waiting 
lists within the catchment area, which is  likely to have led to  difficulties for some  
patients in  accessing  treatment,  similar to the experiences of other fertility centres 
(Hamilton, 2010). The amount of sperm imported to NFC has increased in recent few 
years and this is comparable to the rising number of overseas sperm donors nationally, 
as per the HFEA data detailed above. 
 
3.8.4 Waiting list issues 
We have developed a waiting list for treatment similar to many other centres (Hamilton, 
2010; Culley et al., 2011). In the BFS Donor survey 05/06, 74% of centres reported an 
increase in waiting times and also commented that waiting could essentially impose 
infertility upon older women (British Fertility Society survey, 2006). The BBC survey 
also reported that many of the 74 fertility clinics surveyed had a waiting time of at least 
6 months for treatment (BBC survey, 2006).  
 
Due to the current limited pool of donors at NFC, large numbers of patients wait for 
treatment and there is little or no choice of donors for selection. As a maximum of only 
10 patients can be allocated to a sperm donor at any time, the donors are fully saturated, 
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leaving the patients with no choice, in contrast to before the removal of anonymity.   In 
the BBC survey 86% of the centres reported less choice of donor for the recipients and 
as Wardle reported, the majority of centres provide only a ‘racial match’ (Wardle, 
2008). Even if NFC succeeds in reverting to donor recruitment similar to earlier in the 
decade (40 in 10 years i.e. about four per year) (Paul et al., 2006), it will take at least ten 
years to build a donor bank up to a similar in size to before the removal of anonymity, 
to allow improved choice and immediate treatment for patients.   
 
Significant proportions (31.3%) of patients called for treatment failed to return to the 
centre because of the waiting times. Whilst only 3% of the patients admitted to seeking 
treatment elsewhere (i.e. abroad), there is a possibility that this could be much higher 
(20.4% did not respond when called for treatment) and also that patients could be 
accessing unlicensed sperm services that are easily available over the internet and could 
be associated with significant risks. 
 
Cross border reproductive care appears to be increasing globally although the empirical 
evidence on the incidence is scant (Hudson et al., 2011).  Professor Culley’s group 
interviewed 41 couples from the UK seeking treatment abroad and found that 12% 
travelled for donor sperm and a further 10% for both donor sperm and egg treatments. 
Among the couples travelling for donor gametes which included for donor oocytes, the 
commonest reason mentioned was donor shortage. The factors taken into account by the 
couples in choosing a destination for treatment included shorter waiting times and a 
greater availability of donors (Culley et al., 2011).   
 
A 2008 the European Society of Human Reproduction and Embryology (ESHRE) task 
force study on cross border reproductive care showed that 17% of the 53 forms received 
from UK couples seeking treatment abroad was for donor sperm treatment; and a 
quarter of the patients seeking treatment with donor gametes (including eggs and 
embryos) wished for anonymous donors although it was unclear if this was the main 
reason for travelling abroad (Pennings, 2010; Shenfield et al., 2010). 
 
Single women  and same sex couples are the biggest groups accessing internet based 
sperm services (Hamilton and Pacey, 2008b),  which first appeared  to be available from 
2004 (Pacey, 2010). Following the conviction of the owners of Fertility First which 
couriered sperm to women trying to conceive, the HFEA has investigated such websites  
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(Dyer, 2010). Whilst it is illegal to obtain, test, process or issue gametes including 
sperm without a HFEA license, the HFEA is aware of ‘grey market’ sites and urges 
couples to be cautious in dealing with these unlicensed providers.   
 
3.9 Strategies to cope with the sperm donor shortage 
Previous authors have suggested that there are two areas which may help to improve 
sperm donor recruitment, which includes advertising strategies and aspects of customer 
care relations. 
 
Having no specific budget for advertising for gamete donors, the sperm donor 
programme at NFC is primarily dependent on opportunistic publicity and word of 
mouth (Paul et al., 2006). The previous study done at NFC on sperm donor recruitment 
showed that the popular sources of information for potential sperm donors were certain 
media, student sources and word of mouth or friends (Paul et al., 2006). Amongst the 
various media sources, the magazines and local newspapers were found to be popular 
sources of information whilst television, radio and tabloids were not. As student sources 
contributed considerably as an information source to non-students as well, since this 
group appear to be the biggest group of potential sperm donors in the current non-
anonymous environment identified by the HFEA database (SEED Report, 2005), it 
emphasises the need to continue advertising through student sources such as student 
magazines.  
 
Tomlinson et al. (2010) showed an increase in the enquiry rate from potential sperm 
donors when higher-cost advertising was used.  The fact that 14 donors were released in 
a 4 year period from 151 enquiries at a cost of 5,500 pounds each gives an estimation of 
the resources needed for successful recruitment. However, novel advertising ideas have 
also been used, such as advertising for donors on the pay slips of NHS employees 
(Sinclair, 2009).   
 
Raising the awareness of the sperm donor shortage using appropriate advertising 
strategies, nationally rather than locally, utilises the resources efficiently (Hamilton et 
al., 2008a). The National Gamete Donation Trust (NGDT) is a national government-
funded charity set up in 1998 to try to alleviate the national shortage of donors. One of 
their main goals is to raise public awareness of the donor need and it has launched 
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several large scale public awareness campaigns with some increase in the enquiry rate 
about becoming a donor (ww.ngdt.co.uk). 
 
Despite fertility centres struggling to recruit sperm donors (Wardle, 2008; Hamilton et 
al., 2008a; Culley et al., 2011), it is certainly not in the entire UK, as some centres 
continue to be successful in the current framework (Adams et al., 2006; Ahuja, 2008; 
Tomlinson et al., 2010). Focused advertising, a dedicated recruitment team trained to 
improve customer care relations and better facilities for donors including out of hours 
services are some of the strategies used by these centres and which are both attitude and 
resource dependent. The underlying principle of this training should be to acknowledge 
the value of sperm donors and their contribution, making the entire process more donor 
friendly and hence to reduce the dropout rate (Blackburn-Starza, 2009). It is known that 
providing written information leaflets, counselling and support to sperm donors aids the 
recruitment process (Frith et al., 2007). 
 
At NFC changes have been made to improve donor recruitment, efficiency of the donor 
programme and to support patients as detailed below.  
 
The donor selection and recruitment criteria have been addressed to improve sperm 
donor recruitment. We have maintained an upper age limit for donors of 45 years, 
[although UK guidelines for sperm donors recommend 40 years] (Association of 
Biomedical Andrologists et al., 2008)  and broadened our donor selection criteria as we 
no longer  routinely exclude  men with a past history of treated sexually transmitted 
infections.  In particular, prospective donors at the centre are not currently rejected 
unless at least two (rather than one) of their semen samples fail to meet the required 
standard.  Our previous study revealed that 95% of the applicants rejected because of 
suboptimal semen parameters had only 1 semen analysis (Paul et al., 2006).  
 
The strategies to improve the efficiency of the service have included the cessation of 
sperm transfer to other centres in order to unify regional waiting times for treatment. 
Also the laboratory processing of semen samples has been modified i.e. the samples are 
prepared for IUI prior to cryopreservation as opposed to the previous practice of 
cryopreserving neat semen samples, thus enabling more straws per ejaculate to be 
stored.  
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Historically intracervical insemination was done for unstimulated cycles at the centre 
which were high in straw consumption particularly when multiple inseminations were 
needed. Instead single IUI is undertaken to reduce the utilization of straws.  This is also 
donor friendly as it decreases the number of ejaculates needed to create 10 families 
where consented.  
 
NFC, with its small knowledgeable recruitment team continued to support patients by 
assisting in their efforts for donor sperm treatment. The centre does not discourage 
known donations and known donors once referred by their General Practitioner (GP) to 
the centre are offered a consultation, written information, preliminary semen analysis, 
support and counselling to enable their decision making.  
 
The centre also provides support (albeit limited) to couples planning to travel abroad for 
treatment. Even though associated with a significant administrative burden for the 
centre, support is also given to patients who are keen to import sperm from other UK or 
foreign sperm banks for treatment. Overseas donors have to be identifiable and 
registered with the HFEA, apart from undergoing screening as per UK guidelines before 
being used for treatment. Registering imported donors only for single use (12 in 2010) 
takes considerable staff time and resources to streamline the process and prevent errors; 
hence financial viability has to be kept in mind.    
 
Nationally the proposed solutions are:  
 A hub and spoke model: A BFS working party in 2008 proposed a national 
sperm donation service programme to improve the sperm donor recruitment. 
This service frame work would have the regional centres as hub centres (14) 
coordinating donor recruitment by facilitating sperm donation at local centres to 
make it donor friendly (with regards to facilities, distances to travel, and/or 
convenient opening hours). The resources are to be focussed at the hub centres 
(14 hub centres have been proposed based on the proportion of UK patients 
treated including 3 centres in London and 2 in Scotland (Glasgow, Dundee), 
which will also co-ordinate distribution of the donor samples to the peripheral 
fertility centres to enable patients to access treatment locally (Hamilton et al., 
2008a) . This proposal from the BFS was piloted by Department of Health in 
Manchester, however the results have not yet been made public.  
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 A 2011 HFEA review of gamete donation policies to improve sperm and egg 
donation services in UK confirmed that the current family limit of 10 is to 
remain (HFEA, 2011b). The family limit of 10 was initially intended to avoid 
inadvertent consanguinity, however it was not evidence based. There is a wide 
safety margin with this family limit considering the geographical distribution 
and population density in UK (Janssens, 2003). However, taking into 
consideration the donors’ perspective (particularly with the open identity 
system) and the psychosocial interests of all involved in donor insemination 
treatment, it was decided to maintain the same family limit (Hamilton and 
Pacey, 2008b; Janssens et al., 2011).  
 Sperm sharing schemes are also proposed whereby the fertile male partner of the 
couple needing IVF could donate sperm for other treatment benefits, such as the 
funding of treatment or movement up the waiting list (Hamilton and Pacey, 
2008b). 
 
Sperm donor shortage at a national level is a complex issue with limited empirical 
evidence. The possibility that the loss of anonymity in 2005 contributed to  the current 
shortage of donors has been extensively argued with contradicting views,  but  is 
confounded by the fact that the decline in donor recruitment was reported even before  
that came into effect  (Pike and Pacey, 2005; BBC survey, 2006; British Fertility 
Society survey, 2006; Witjens, 2007; Blyth and Frith, 2008; Wardle, 2008; Tomlinson 
et al., 2010). Furthermore donor shortage is a global issue also affecting countries 
where donor anonymity is protected (Blyth and Frith, 2008).  
 
A review in 2008 of the regulations, to consider revoking donor anonymity did not 
receive much support for change (Hamilton, 2010). Whilst some bodies like the NGDT 
strongly believe that removal of anonymity is not responsible for the decline in the 
numbers of sperm donors in the UK, others acknowledge its contributory role (Witjens, 
2007; Tomlinson et al., 2010). Most likely the removal of anonymity, along with the 
issue of payment to donors, (Tomlinson et al., 2010) combined with the lack of 
awareness of the problem (Witjens, 2007) have contributed to the current shortage. 
Although there is no clear ‘cause and effect’ relationship, the removal of anonymity 
appears to have had a significant impact particularly due to the abrupt loss of large pool 
of anonymous sperm donors and the fragility of low donor recruitment since (Blyth and 
Frith, 2008).  
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3.10 Limitations of the study 
Apart from the inherent limitations of a retrospective analysis, the study findings are 
from a single centre in the UK and cannot be generalised, but importantly the 
authoritative HFEA data does not seem to reflect the practice at the centre. In the 
absence of published empirical evidence apart from the national HFEA data, we used 
media surveys (BBC survey) and web news (Bionews) to understand the impact of 
removal of donor anonymity on various fertility centres in the UK. 
 
3.11 Conclusion 
Overall the sperm donor programme at our centre has been significantly altered in the 
past decade with fewer donors recruited, a smaller pool of donors, fewer patients 
receiving treatment, increased sperm import and increased waiting times for the 
patients. 
 
The majority of the solutions proposed to manage the problem are reliant on funding, 
which can be difficult to obtain in the current economic climate. Use of existing 
resources to improve the efficiency of use of donor sperm may be helpful. Sub optimal 
semen parameters were the commonest reason to reject a potential sperm donor. We 
will next therefore consider the influence of external factors on semen parameters with a 
view to investigate if it can be positively used to improve the use of donor sperm. The 
next section will examine the impact of ‘Season’ on semen parameters. 
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Chapter 4 Seasonal variation in semen parameters 
 
4.1 Introduction 
Seasonal variation in semen parameters has been extensively described in literature, 
although the findings have been variable and inconsistent. Seasonal variation does not 
appear to be universal, however the majority of studies revealed a significant seasonal 
variation with improved parameters in Winter/Spring (or worsening parameters in 
Summer/Autumn) (Tjoa et al., 1982; Levine et al., 1988; Reinberg et al., 1988; Politoff 
et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; Levine et al., 1992; Gyllenborg 
et al., 1999; Andolz et al., 2001; Jørgensen et al., 2001; Chen et al., 2003; Chen et al., 
2004; Moskovtsev and Mullen, 2005; Calonge et al., 2009) whilst some revealed an 
absence of seasonal variation (Mortimer et al., 1982; Mallidis et al., 1991; Ombelet et 
al., 1996; Chia et al., 2001; Carlsen et al., 2004). Furthermore varied patterns such as 
progressive sperm motility being lower in Summer and also Spring (Centola and Eberly, 
1999) or that morphology was better in Summer and Winter (Detti et al., 2006) have 
also been reported. 
 
There are few longitudinal studies and therefore most of the data is gained from 
retrospective cross sectional observational studies. Although the majority of the studies 
were conducted in the Northern hemisphere (Levine, 1999), a study done in the 
Southern hemisphere (Sobreiro et al., 2005) revealed a similar seasonal variation of 
significant decline in all semen parameters in Summer. Seasonal variation is more 
commonly seen in temperate than tropical climates (Chia et al., 2001), though not 
always. Seasonal variation in sperm concentration has been consistently reported whilst 
the data on semen volume, sperm motility and morphology is contradictory (Levine, 
1999). 
 
Although men in the UK, being in the Northern hemisphere and exposed to a temperate 
climate could be subjected to seasonal variation in semen parameters; this has not been 
confirmed because of limited number of studies from the UK. A study undertaken 
nearest to our centre geographically, in Edinburgh, revealed a non-significant 
improvement in sperm counts in Winter and Spring (Mortimer et al., 1983).  
  
In this chapter we studied all the semen analyses performed at the centre over 3 years. 
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4.2 Aim  
We aimed to investigate the seasonal variation in semen parameters. 
 
4.3 Objectives 
The objectives were to investigate if there was any variation in semen parameters 
(semen volume, sperm concentration, total concentration, motile concentration, 
progressive motile concentration, progressive motility, total motility and morphology) 
between different seasons. 
 
4.4 Outcome measures  
To determine if the semen parameters were significantly better or poor in any particular 
season. 
 
4.5 Subjects and Methods 
4.5.1 Subjects  
Men who had their semen analysis performed at NFC as part of their preliminary 
fertility investigations were included in the study. Some men attended the centre for 
more than one semen analysis. 
 
4.5.2 Methods 
A retrospective review of all the semen analyses done at NFC between December 2006 
and November 2009 was performed. Semen analysis reports were routinely saved in 
Microsoft access. All the relevant data was transferred to an EXCEL spread sheet. 
Semen analyses were divided into 4 groups by season. 
 
4.5.3 Study size  
There were 4081 semen analyses undertaken during the study period after excluding 
samples showing azoospermia (absence of sperm in the ejaculate). Eleven further semen 
analyses were not included as the reports had more than one missing value. Three 
semen analyses were not included as the sample volumes were very high (36ml, 47ml, 
68ml) with poor counts indicating that whilst not specifically recorded, they were likely 
to have been retrograde samples. A single missing semen volume was entered as 2ml as 
the rest of the parameters were available and normal. Two of the semen volumes were 
corrected to 10.8 and 4.9 from 108ml and 49ml respectively, as the rest of the semen 
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parameters were normal. After excluding or amending the above, a total of 4067 semen 
analysis results were included in the study.  
 
4.5.4  Semen Analysis 
4.5.4.1 Sample collection 
Men attending for semen analysis were generally given written instructions regarding 
abstinence (2-7 days) and the method of collection. Men produced samples by 
masturbation into a clean wide mouthed container. Men producing the sample at home 
or outside the centre were advised to bring the sample to the centre within 90 minutes of 
production, keeping the sample warm during transit. 
 
4.5.4.2 Liquefaction  
Semen samples were left to liquefy for a maximum of 30 minutes at ambient 
temperature. The samples were analysed soon after liquefaction or at 30 minutes. 
 
4.5.4.3 Volume 
The volume of the ejaculate was measured using an appropriate sized, graduated, 
disposable serological pipette with 0.1ml accuracy. 
 
4.5.4.4  Sperm concentration and motility  
The sperm concentration and motility were routinely performed via computer-assisted 
semen analysis (CASA) using the Hobson Sperm Tracker (Hobson Tracking Systems 
Ltd, Sheffield, United Kingdom). An IBM (International Business Machines 
Corporation, Armonk, New York) compatible computer equipped with Hobson sperm 
tracker image analysis software (version 7.08) and hardware connected to a phase 
contrast microscope (Nikon Labophot -2) via a video camera (Sony CCD-IRIS) was 
used. 10µl of the semen sample was loaded into one of the two chambers of a Leja 20 
micron glass counting chamber (Nieuw Vennep, The Netherlands) using a Gilson P20 
pipette. The chamber was filled and placed on a warm microscope stage whilst the 
microscope was focussed on the heads of the sperm. The sample was allowed to settle 
and the analysis commenced. The computer analysed the images acquired by the video 
monitor, 200 sperm were tracked averaging 100 sperm tracks per minute for total of 2 
minutes. The minimum track time was at least 3 seconds for each sperm and 30 frames 
were analysed per field. Sperm were quantified and the results printed out. The Hobson 
Sperm Tracker was pre-set by the manufacturer to grade motility parameters based on 
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average path velocity (VAP) as follows - Grade A (VAP>25 µm/s), Grade B ( VAP 10-
25 µm/s), Grade C ( VAP <10µm/s) and Grade D (VAP = 0 µm/s). When the motile 
sperm concentration was less than 5 million/ml manual assessment was done. Semen 
samples were diluted when the counts were over 80 million/ml. 
 
4.5.4.5 Sperm morphology 
Morphology assessment was done manually on unstained preparations. 10µl of the 
semen sample was pipetted onto a microscope slide and a coverslip applied. At a 
magnification of ×400 (×40 objective), using a phase contrast microscope, 100 different 
motile sperm were recorded for normality using the Celltrac counting chamber. The 
classification of sperm morphology was based on the 1999 World Health Organisation 
criteria (World Health Organisation, 1999).  
 
4.5.4.5.1 Classification of sperm morphology (WHO criteria – 4th edition) 
 
4.5.4.5.1.1 Normal morphology 
A Sperm consists of a head, neck, mid piece and tail. 
 
Head – The head should be oval in shape. The length of the head should be 4 -5 µm and 
the width 2.5 – 3.5µm.There should be well defined acrosome region comprising 40 – 
70% of the head area. 
 
Mid piece –The mid piece should be slender, less than 1µm in width, about one and 
half times the length of the head and attached axially to the head. Cytoplasmic droplets 
should be less than half the size of the normal head. 
 
Tail – The tail should be straight, uniform, thinner than the mid piece, uncoiled and 
approximately 45µm long.  
 
4.5.4.5.1.2 Abnormal morphology 
This classification categorised all the ‘borderline’ forms as abnormal. It was considered 
unnecessary to routinely distinguish between all the variations in head, midpiece or tail 
defects. Apart from the head, neck and mid piece and tail defects, the abnormalities 
included cytoplasmic droplets (located in the midpiece) larger than half of the sperm 
head size. 
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4.5.5  Quality assurance 
NFC labs routinely participated in regular 3 monthly National External Quality 
Assurance assessments (NEQAS) in addition to internal quality assessments to ensure 
that standards in semen analyses were maintained. The quality assurance methods are 
detailed in Chapter 6 (Section 6.5.8.2.4). 
 
4.5.6   Semen Parameters   
The variables noted were semen volume (ml), sperm concentration (millions/ml), the 
percentage of motile sperm and percentage of normal morphology. Grade A and B were 
added together to obtain the percentage of progressively motile sperms as per the World 
Health Organisation (2010) criteria and the percentage of total motile sperm was 
calculated by adding grades A, B and C together. The total sperm concentration was 
calculated by multiplying semen volume and sperm concentration. The motile sperm 
concentration was obtained by multiplying sperm concentration and the percentage of 
total motile sperm, divided by 100. Similarly progressive motile sperm concentration 
was obtained by multiplying sperm concentration and the percentage of progressively 
motile sperm, divided by 100.  
 
4.5.7 Seasons   
The seasons during which the semen samples were obtained were classified as Winter 
(December –February), Spring (March-May), Summer (June-August) and Autumn 
(September-November).  
 
4.5.8 Subsets 
It is believed that men with persistent severe oligospermia are likely to have a pathology 
contributing to the semen quality although this is not always proven. It is likely that the 
semen quality in these men may be unaffected by seasonal changes (Centola and Eberly, 
1999; Levitas et al., 2013). Analysing the entire study group, which included normal 
semen analyses and all grades of severity in oligospermia, could potentially fail to 
identify subtle seasonal variation in semen parameters (if there was any). Therefore to 
minimise selection bias and improve the efficiency of the evaluation of the effect of 
season on the semen parameters, we analysed the study group in the following subsets. 
1. Total study group (samples with azoospermia excluded) - 4067 samples  
2. Samples with sperm concentration ≥ 1 million / ml - 3905 samples 
3. Samples with sperm concentration ≥ 5 million / ml - 3748 samples 
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4. Samples with sperm concentration ≥ 10 million / ml - 3600 samples 
 
4.6 Statistical Analysis 
Statistical analysis was performed using IBM SPSS (Version19). All the semen 
parameters are expressed as median + centiles. As the study size was large, the 
Kolmogorov – Smirnov test of normality was applied which showed that the data was 
not normally distributed (p=0.00). Variables were not transformed to normalise the data. 
The non-parametric Kruskal Wallis test with a post hoc multiple comparisons test 
(Siegal and John jr, 1988) was applied to find any significant difference in semen 
parameters between the seasons.  
 
4.7 Results 
The age and semen parameters in each group were expressed as median + centiles. The 
median male age was 34 years (ranging from 15 to 67 years) and comparable in the four 
groups. The median (inter-quartile range) for semen volume (ml), sperm concentration 
(million/ ml), total motility (%) and normal morphology (%) for the entire study size 
(4067 samples) were 3 (2.1-4.1), 56 (26-99), 62 (46-74) and 6 (2-10) respectively.  As 
shown in Table 10, there was no significant difference in semen volume, sperm 
concentration, total concentration, total motile concentration, progressive motile 
concentration, total motility and progressive motility detected between the seasons (p 
>0.05). Sperm morphology was significantly better in Winter and Spring compared to 
Summer and Autumn, although the actual improvement was low. Furthermore all the 
subsets i.e. sperm concentration ≥ 1 million/ml, ≥ 5 million/ml and ≥ 10 million/ml 
showed similar results with sperm morphology being the only semen parameter with a 
significant seasonal variation (Table 11, Table 12 and Table 13). 
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     Table 10: Characteristics of the semen samples by seasons in the total study group (N= 4067 samples)
Semen parameters  
N=4067 samples; Median (25
th
 -75th centile)  
Winter (N=1015) 
 
 
Spring (N=966) Summer (N=1006) Autumn (N=1080) Kruskal 
Wallis test 
Age (years) 34 (30-38) 34 (30-38) 34 (30-38) 34 (30-38) 0.5 
Semen volume ( ml) 3.0 (2.1-4.1) 3.0 (2.0-4.1) 3.0 (2.1-4.2) 3.0 (2.2-4.1) 0.4 
Sperm concentration (millions/ml) 54 (26-98) 59 (26-99) 56 (29-103) 54 (23-95) 0.2 
Total sperm count (millions/ml) 166 (68-308) 165 (66-320) 173 (77-306)  157 (64-297) 0.3 
Total motile concentration (millions/ml)   34 (13-70) 37 (10-68) 35 (13-72) 34 (10-67) 0.3 
Progressive motile concentration (millions/ml)   26 (9-54) 29 (8-55) 27 (9-57)  26 (7-53) 0.3 
Total motility (%) 64 (50-74) 61 (45-74) 63 (46-74) 62 (44-74) 0.2 
Progressive motility (%) 49 (36-59) 48 (33-60) 48 (35-59) 48 (32-59) 0.3 
Morphology (%) 7 (2-12) 6 (2-11) 5 (2-10) 6 (1-10) <0.005 
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Semen parameters  
 
N= 3905 samples; Median (25th -75th centile) 
 
Winter (N=978)  Spring  (N=920)  Summer  (N=966) Autumn  (N=1041) Kruskal 
Wallis 
test Age (years) 34 (30-38) 34 (30-38) 34 (30-38) 34 (30-38) 0.5 
Semen volume ( ml) 3.0 (2.1-4.1) 3.0 (2.0-4.1) 3.0 (2.1-4.2) 3.0 (2.2-4.1) 0.5 
Sperm concentration (millions/ml) 57 (30-100) 53 (29-102) 59 (32-105) 57 (26-97) 0.09 
Total sperm count (millions/ml) 174 (77-314) 176 (83-330) 181 (90-314) 164 (70-302) 0.17 
Total motile concentration (millions/ml) 36 (15-71) 40 (15-71) 38 (15-75) 35 (12-68) 0.1 
Progressive motile concentration 
(millions/ml)  
  
28 (11-56) 31 (11-56) 28 (11-59) 27 (9-54) 0.1 
Total motility (%) 64 (50-74) 62 (48-75) 64 (50-75) 63 (46-74) 0.4 
Progressive motility (%) 49 (37-59) 49 (35-60) 48 (36-60) 48 (33-69) 0.4 
Morphology (%) 7 (4-12) 6 (2-12) 6 (2-10) 6 (2-10) <0.005 
             
        Table 11: Characteristics of the semen samples by seasons in samples with sperm concentration ≥ 1 million / ml (N= 3905 samples)
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Semen parameters 
 
N=3748 samples; Median (25th -75th centile) 
 
Winter (N= 942) 
 
Spring  (N= 
881) 
 
Summer (N=934) 
  
Autumn (N= 
991) 
  
Kruskal 
Wallis test 
Age (years) 34 (30-38) 34 (30-38) 34 (30-38) 34 (30-38) 0.6 
Semen volume ( ml) 3.0 (2.1-4.1) 3.0 (2-4.1) 3.0 (2.1-4.2) 3.0 (2.2-4.1) 0.5 
Sperm concentration (millions/ml) 60 (33-103) 65 (34-104) 60 (35-108) 59 (31-100) 0.1 
Total sperm count (millions/ml) 180 (86-324) 186 (90-336) 188 (98-319) 172 (83-308) 0.3 
Total motile concentration (millions/ml)  39 (17-73) 42 (17-73) 38 (18-77) 38.1 (15-71) 0.3 
Progressive motile  concentration (millions/ml)   29 (13-57) 33 (13-58) 30 (13-60) 29 (11-55) 0.2 
Total motility (%)  65 (50-75) 63 (50-75) 64 (50-75) 64 (50-75) 0.7 
Progressive motility (%) 50 (39-59) 49 (37-61) 49 (37-60) 49 (36-60) 0.6 
Morphology (%) 8 (4-12) 7 (4-12) 6 (2-10) 6 (2-10) <0.005 
 
            Table 12: Characteristics of the semen samples by seasons in samples with sperm concentration ≥ 5 million / ml (N=3748 samples)
 103 
Semen parameters  
 
N= 3600 Median (25th -75th centile) 
 
Winter (N=902) 
 
Spring (N=846) 
 
Summer (N= 900) 
 
Autumn 
(N=951) 
 
Kruskal 
Wallis test 
Age  (years) 34 (30-38) 34 (30-38) 34 (30-38) 34 (30-38) 0.5 
Semen volume  ( ml) 3.0 (2.1-4.1) 3.0 (2.0-4.1) 3.0 (2.1-4.2) 3.0 (2.2-4.1) 0.5 
Sperm concentration (millions/ml) 64 (37-106) 68 (38-107) 62 (37-110) 62 (34-103) 0.1 
Total sperm count (millions / ml) 190 (98-333) 193 (100-344) 194 (104-329) 183 (92-319) 0.3 
Total motile concentration (millions/ml) 41 (20-75) 44 (19-76) 40 (19-78) 40 (18-72) 0.3 
Progressive motile  concentration (millions/ml)   31 (15-59) 34 (14-60) 32 (14-62) 30 (13-58) 0.2 
Total motility (%) 65 (50-75) 64 (50-75) 65 (50-75) 65 (50-75) 0.8 
Progressive motility (%) 51 (40-60) 50 (38-61) 50 (38- 60.5) 50 (37-60) 0.7 
Morphology (%) 8 (4-12) 8 (4-12) 6 (2-11) 6 (2-11) <0.005  
 
      Table 13: Characteristics of the semen samples by seasons in samples with sperm concentration ≥ 10 million / ml (N= 3600 samples) 
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4.8  Discussion 
We conducted a retrospective database review of all the semen analyses performed at 
NFC between December 2006 and November 2009 which revealed sperm morphology 
to be significantly better in Winter and Spring compared to Summer and Autumn, but 
there was no significant seasonal variation in other semen parameters.  
 
Although the criteria for classification of sperm morphology used in our study was in 
accordance with WHO 1999 criteria, the methodology to assess this was not. 
Morphology was assessed on unstained motile sperm samples while the 
recommendation was to assess on stained samples which are inevitably immotile.  
 
Several surveys have been done to check the compliance with the WHO 
recommendations of laboratories regularly performing semen analyses. In a global 
questionnaire survey regarding sperm morphology assessment by Ombelet et al. (1997) 
wherein they received the responses from 170 centres in 40 different countries, a wide 
variation in staining methods and use of classification criteria were noted. While 
staining of the specimens was not performed in 7.6%, 11 different staining methods 
were used in the rest of the 157 centres. It is well known that different staining methods 
have variable effects on sperm dimensions and therefore none would be considered 
accurate even if the WHO sperm classification criteria were used without the 
recommended staining procedure. In the UK, similar to our centre,  it was noted that a 
significant proportion of centres (47% - 8/17) did not use any staining method though 
the WHO criteria for sperm classification were often used (57.8%). 
 
To assess sperm morphology 100 motile sperm were counted in our centre. In a survey 
by Keel et al. (2002) in the United States, responses from 536 centres were received and 
15% of the centres did not routinely perform sperm morphology. In the centres that 
undertook sperm morphology assessment, 83% counted less than the recommended 200 
sperm to report normal morphology. 
 
More recently in the UK, a survey done by Riddell et al. (2005) has revealed that only 
5% (2/37) of the centres which participated were fully compliant with WHO 
recommendations for sperm morphology assessment. Unstained preparations were used 
in 43% of the centres, concurring with Ombelet’s survey findings. Among the labs 
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which used stained preparations only 68% used the WHO recommended staining 
methods. Despite the common use of unstained smears or staining methods outwith the 
WHO recommendations, the majority of the centres (32/37) followed the WHO criteria 
for sperm classification. It was interesting to note that majority of the centres (69%) 
chose to classify 100 or fewer sperm. 
 
There was a global lack of compliance by laboratories with the WHO recommendations 
for  sperm morphology in the 1992 guidelines (Ombelet et al., 1997) and the problem 
continued to persist in UK with the 1999 guidelines, (Riddell et al., 2005) when again 
the importance of compliance and the need for education and training initiatives were 
emphasized.  
 
As our centre’s specialist laboratory undertakes semen analyses for assisted conception 
treatments in addition to routine semen analysis for preliminary infertility assessment, 
we noted with interest in the UK survey suggestion that District General Hospital 
(DGH) laboratories were arguably closer to compliance with WHO recommendations 
than specialist laboratories. It was suggested that the difference in approach was 
possibly due to the type of staff performing the analyses (mainly embryologists and 
PhD scientists in specialist laboratories versus mainly biomedical scientists at the 
District General Hospitals) who had different training pathways, or alternatively to the 
culture in the specialist laboratories of avoiding the use of unnecessary volatile solvents 
to prevent contamination of the atmosphere where embryos are cultured. The precise 
reason is not entirely clear.   
 
 It is accepted that the methodology for sperm morphology for samples included in our 
study was not the most accurate available, however was approved at the time based on 
the centre’s logistics. It is well known that the Quality Assurance (QA) is an essential 
method of maintaining the accuracy of semen analyses (Pacey, 2006). The centre has 
regularly participated in the National External Quality Assurance Scheme (NEQAS) and 
as the results were comparable to national standards, the approved methodology in the 
centre continued to be used.     
 
Sperm morphology was the only semen parameter which showed significant seasonal 
variation (i.e. better in Winter and Spring) in our study. Levine et al. (1992) in their 
prospective longitudinal study revealed that there was considerable deterioration of 
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sperm concentration, motile concentration and percentage of morphologically normal 
sperm in Summer (in both outdoor workers and indoor workers) compared to Winter, 
however after adjusting for the confounders, there was statistically significant reduction 
only in the percentage of morphologically normal sperm, similar to our study findings.  
 
The actual improvement was however low in our study, whilst in Levine et al’s study 
the sperm morphology deteriorated by 14% in Summer compared to Winter 
(Unadjusted values of percentage of morphologically normal sperm in Winter vs. 
Summer was 52.4% vs. 45.1%). The percentages of normal morphology in both seasons 
are strikingly very high compared to our study as there was a significant difference in 
the sperm morphology classification used. In Levine et al’s study 10 distinct abnormal 
forms such as large head, two heads, two tails were described and the remaining were 
labelled as normal. In contrast, in our study only sperm that fulfilled WHO criteria for 
normal sperm morphology as described in the methods were assigned as normal. 
 
Few studies similarly reported improved sperm morphology in Winter and/or Spring 
(Levine et al., 1988; Andolz et al., 2001; Chen et al., 2003; Sobreiro et al., 2005), 
however an improvement in other semen parameters (sperm concentration and or 
motility but not semen volume) was also reported. Swatowski et al. (1994) in their 
retrospective study including 200 semen samples showed that sperm morphology was 
the only parameter showing seasonal variation. However in contrast, they found that the 
proportion of abnormal sperm was higher in Spring compared to Summer and Winter. 
Notably many studies investigating seasonal variation in semen parameters did not 
study sperm morphology (Tjoa et al., 1982; Reinberg et al., 1988; Saint Pol et al., 1989; 
Levine et al., 1990; Gyllenborg et al., 1999; Chia et al., 2001). 
 
Interestingly in the study by Centola and Eberly (1999), where men attending a fertility 
clinic and also semen donors were recruited, the pattern of seasonal variation varied 
between the two groups. Whilst in the semen donors the sperm count was lower in 
Summer, the motility was lower in Summer and also Spring. However similar to our 
study, in men attending the fertility clinic there was no seasonal variation in semen 
volume, count or motility but the percentage of tapered forms were significantly higher 
in Autumn than Spring. As the semen parameters in fertile semen donors was subject to 
greater seasonal variation than ‘suspected infertile’ men the authors suggested that 
possible pathology might not be affected by season. Furthermore in a recent study by 
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Levitas et al. (2013), where semen samples from men undergoing basic fertility 
investigations were included, the authors analysed the seasonal variation in 
normozoospermic samples (≥ 20 million/ml) separately to oligozoospermic samples and 
noted that the significant seasonal variation seen in normozoospermic samples (sperm 
concentration, rapid motility and morphology were better in Winter and Spring) was not 
seen in oligozoospermic samples (sperm concentration and rapid sperm motility did not 
reveal seasonal variation).   
 
However other studies conducted on men attending a fertility clinic did show seasonal 
variation (Andolz et al., 2001; Chen et al., 2003). Observed seasonal changes in semen 
parameters are not restricted to semen donors (Saint Pol et al., 1989; Gyllenborg et al., 
1999) or men attending infertility clinics, but have also been seen in volunteers from the 
general population (Levine et al., 1990; Levine et al., 1992), men prior to vasectomy 
(Tjoa et al., 1982; Sobreiro et al., 2005) and infertile men (Politoff et al., 1989).  
 
Our study showed that there was no seasonal variation in semen volume which is 
consistent with several other studies (Levine et al., 1992; Andolz et al., 2001; Chen et 
al., 2003; Sobreiro et al., 2005), although Reinberg et al in their study on pre-vasectomy 
men reported higher semen volumes in Spring (Reinberg et al., 1988). 
 
A retrospective study including semen analyses from men attending an infertility clinic 
in Edinburgh which has similar temperate climate to the catchment area of our centre in 
the North East of the UK, revealed an absence of seasonal variation in all semen 
parameters, but noted a pattern of increased sperm counts in late Winter and early 
Spring (Mortimer et al., 1983). Furthermore the majority of studies in temperate 
climates did show seasonal variation with a trend towards improved sperm parameters 
in Winter and Spring (Levine et al., 1988; Gyllenborg et al., 1999; Levine, 1999; 
Calonge et al., 2009).  
 
In view of the lack of seasonal variation in sperm count and motility seen in our study 
the following reasons may be considered.  
 
There are some methodological differences in semen analysis in studies investigating 
seasonal variation. Two methods, manual and CASA are widely used.  CASA is 
objective and  more reproducible than the manual method (Centola, 1996; Larsen et al., 
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2000) and the variation in semen parameters between the two methods is well known 
(Macleod et al., 1994). It is well known that CASA moderates extreme values of sperm 
count and therefore has the potential to minimise the differences in the counts between 
seasons, leading to a false conclusion of an absence of seasonal variation (Levine et al., 
1990).  
 
A previous study done at our centre confirmed the variation between CASA and the 
manual method in sperm count and motility assessment. There was significant 
underestimation of sperm count and over estimation of motility when the sperm 
concentration was above 80 million/ml (Spiropoulos, 2001). CASA methodology in our 
study may have contributed to the lack of seasonal variation in sperm count and 
motility, however other studies which used CASA still revealed considerable seasonal 
variation in sperm count and/or motility (Levine et al., 1990; Centola and Eberly, 1999; 
Chen et al., 2003; Chen et al., 2004; Moskovtsev and Mullen, 2005). Finally the effect 
of genetics, lifestyle factors and environmental factors on regional trends cannot be 
ruled out. 
  
The large study size and duration over three years may have contributed to minimise the 
effect of confounders on the results. In addition the semen analysis methodology 
remained consistent throughout the study period and only five laboratory technicians 
(who all regularly participated in Quality Control checks with results confirming the 
maintenance of standards) were involved in the analysis of semen samples. 
 
4.9   Limitations of the study 
There are several limitations to the study. 
The lack of information on abstinence and sample loss at collection may confound the 
association between season and semen parameters. This relevant data could not be 
retrieved from the database and therefore was unavailable for the analysis.  
 
It is well known that abstinence affects not only semen volume, sperm count and 
motility, but also morphology with a longer than 7 day duration (Mortimer et al., 1982; 
Pellestor et al., 1994). However as studies have shown that period of abstinence did not 
vary with season (Levine et al., 1988; Gyllenborg et al., 1999), even though this data 
cannot be extrapolated universally, it seems likely that it was consistent. The effects of 
abstinence on the semen analysis may be minimal as the men are also given written 
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instructions on recommended period of abstinence (2-7days) prior to sample production 
and the instructions are followed majority of the times. Although no internal audit has 
been done, observations by the senior Andrology staff at NFC confirm this. In addition 
in our vitamin D study (Chapter 6, Section 9), out of the 87 participants who returned 
for follow up only 1 did not follow the recommended abstinence, confirming suitability 
of the instructions given.  
 
It was interesting to note in a study done by Levine et al. (1988) to assess the seasonal 
variation of semen parameters in men attending an infertility clinic, the reduction of 
semen parameters in Summer remained the same before and after adjusting for 
abstinence. 
  
Some men in the study have produced more than one semen sample, which is presumed 
to be a small proportion. Although the exact percentage of this is unknown, it is unlikely 
to have adversely affected the conclusions.  
 
The inherent limitations of a retrospective study include being unable to retrieve 
information on other factors (i.e. smoking and recent fever), which may potentially 
affect semen parameters, is applicable to our study.  
 
Intra-individual variation in semen parameters is well known and therefore a single 
semen sample is considered insufficient to estimate semen quality (Carlsen et al., 2004; 
World Health Organisation, 2010). As it is a cross sectional association study, this 
element, of not adjusting for intra-individual variation of semen parameters affecting the 
results, cannot be ruled out. 
 
The samples included in the study were from men being investigated for infertility and 
despite including fertile and infertile men, may not be representative of general 
population. 
 
All semen parameters essentially follow non-Gaussian distribution. In the statistical 
analysis, semen parameters were not transformed to normalise the data although it is 
generally recommended (Berman et al., 1996; Handelsman, 2002; Sánchez-Pozo et al., 
2013). Application of non-parametric tests is a reasonable approach for non-normally 
distributed data, although powerful and flexible parametric tests following 
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transformation are commonly preferred (Handelsman, 2002; Sánchez-Pozo et al., 2013).  
We note that in similar retrospective studies to our study, with a large sample size (1159 
samples) (Levine et al., 1988) 10,877 samples (Andolz et al., 2001), and also in 
prospective longitudinal studies involving up to 142 men (Levine et al., 1990; Levine et 
al., 1992), the findings following the application of non-parametric tests on 
untransformed, non-normally distributed variables were similar to the findings 
following the application of parametric tests on transformed variables. Non-parametric 
tests were generally carried out to avoid the secondary effect of the artefact of 
transformation on the results. 
 
Based on the above limitations we recommend caution in interpreting the results. 
 
4.10 Conclusion 
In men attending our fertility centre, seasonal variation is seen only in sperm 
morphology. This was significantly better in samples produced in Winter and Spring, 
however this is not a clinically significant improvement. No difference was seen in 
other semen parameters.  
 
It is well known that despite the fact that only men with optimal semen parameters are 
recruited as donors, the fecundity of sperm donors is variable. Is this related to the 
month or season of donation?  With regards to season of original sperm donation, we 
further investigated, and described in the next section, the distribution of conceptions 
achieved by donor insemination (DI) treatment, with a view to find out if there was any 
seasonal variation.
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Chapter 5 Seasonal variation in donor conceptions 
 
5.1 Introduction 
Apart from the seasonal variation in semen parameters, it is worthwhile investigating 
the effect of seasonality of sperm on the chances of conception as this would reinforce 
the argument for the seasonal recruitment of sperm donors. Studies investigating this are 
sparse in literature. In this chapter we studied DI treatments with a view to identify any 
seasonal influence on the outcome.  
 
5.2 Aim 
We aimed to analyse the distribution of conceptions achieved by DI treatments, with a 
view to ascertain if there was a variation in relation to the seasonal timing of the original 
sperm donation.  
 
5.3 Objectives 
The objectives were to determine  
1. The distribution of conceptions by the season of sperm production. 
2. The distribution of conceptions by the season of treatment. 
3. The association between the number of inseminations and pregnancy outcome. 
4. Seasonal variation in donor semen parameters. 
5. The association between season of sperm production and cryopreservation. 
 
5.4 Outcome measures 
The outcome measures were 
1. Is sperm functionally better in any particular season? i.e. are more pregnancies 
achieved by sperm produced in any particular season? 
2. Is cryopreservation of sperm (number of straws of sperm frozen and post thaw 
parameters) improved in any particular season?  
 
5.5 Subjects and Methods 
5.5.1 Subjects  
This includes patients and donors as described below.
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5.5.1.1 Patients 
 All the patients who had DI (natural cycle intra-cervical insemination) treatment from 
2005 to 2010 are included in the study. This study period was selected as prior to 2005 
the records did not allow us to track the season of semen sample production. DI 
treatment was offered to couples where the male partner had azoospermia and surgical 
sperm retrieval was either not an option, was unsuccessful or was declined by the 
patient. DI treatment was also offered to same sex couples and single women.  The 
treated female partners were generally healthy, ovulating regularly and at low risk for 
any tubal disease. 
 
5.5.1.2 Donors  
All the sperm donors of NFC whose sperm was used for the treatments in the study 
period mentioned above were included. The recruitment of sperm donors at the centre 
was detailed in Chapter 3 (Section 3.5.2). 
  
5.5.2 Donor insemination treatment (DI) 
For natural cycle intra-cervical donor insemination women are monitored by trans-
vaginal ultrasound to track follicular growth. Once the dominant follicle reaches a 
mature size (≥ 16 mm) arrangements are made for insemination. Two straws of the 
appropriate donor sperm are removed from storage and thawed at room temperature for 
5 minutes. The patient’s name is entered in the donor sperm straw consumption sheet, 
when the sperm to be used for treatment is handed over to the nurse. The ends of the 
straws are cut and the sample emptied into a container to be loaded into the 
insemination catheter (Insemicath, Cook). Intracervical insemination is carried out by 
inserting the tip of the catheter into the endo-cervical canal and injecting the fluid. The 
woman returns the following day for ultrasound follicular tracking. The inseminations 
are done every day till ovulation is proven (disappearance of the follicle and/or presence 
of free fluid) by ultrasound or a maximum of 4 inseminations are done. 
 
When a batch of straws of donor sperm is released, the release date is recorded in the 
donor release file adjacent to the date of sample production. A new batch is released 
only after all the straws are used for the treatment. Therefore all the patients treated until 
a new batch is released, are treated with sperm produced in the same season. 
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5.5.3  Laboratory processing of the semen from recruited sperm donors 
5.5.3.1 Pre freeze analysis 
When donors produce a semen sample, a routine semen analysis is performed as 
previously detailed in Chapter 4 (Section 4.5.4), unless there is gross evidence of 
contamination or abundant leucocytes. If the semen parameters are inferior to the 
eligibility criteria for a sperm donor, the samples are deemed not suitable for freezing. 
The parameters recorded are semen volume, sperm concentration, motile concentration, 
progressive motile concentration, progressive and total motility. Sperm morphology was 
recorded for donor samples produced at the centre only from 2006 onwards. As the 
donors in this study were producing samples from 1995, morphology was not recorded 
for 915 out of 1114 samples. Therefore sperm morphology could not be included in the 
statistical analysis. 
 
5.5.3.2 Process of cryopreservation 
If the semen parameters meet the criteria, the semen volume is diluted with cryo-
protectant (1:0.7 ratio, volume:volume), containing physiologic salts, glycine, dextrose 
monohydrate, lactate, glycerol, sucrose, and human serum albumin (3.95g/litre) 
(SpermFreeze, FertiPro)  and the total volume is divided into 250 µl straws (Rocket 
Medical) each. Once the straws are sealed they are placed in vapour of liquid nitrogen 
for 20 – 30 minutes. Finally they are labelled, divided into a number of holding tubes 
and transferred to liquid nitrogen tanks (-196º C) (Statebourne Cryogenics (Model; Bio 
36) for storage. 
 
5.5.3.3  Post thaw analysis 
At the time of cryopreservation, a single straw is reserved for post-thaw analysis and is 
thawed at room temperature for 5 minutes. Routine semen analysis is performed and if 
the sample reveals poor survival, all the straws frozen from that semen sample are 
discarded. If there is good post thaw survival, a record of the date of sample production 
and the number of straws frozen and stored is made. 
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5.5.4 Methodology 
We performed a retrospective review of all the DI treatments for a period of 6 years. 
The following sources of information were used to collate the information needed for 
this study: 
 
1. Laboratory database of donor sperm use for treatment 
The database of donor treatments comprises the patient details, donor code, cycle of 
treatment, first date of insemination for each cycle and outcome. All the records 
previously erroneously entered in the database (13 records) were identified and 
excluded by cross checking with the database and records maintained for the sperm 
donor programme outcomes and consumption sheets (described below). Likewise 
missing records (5 records) were entered onto the database retrospectively. The 
number of patients, number of DI cycles, season of treatment and outcome were 
obtained from this database. 
 
2. Database and records maintained for sperm donor programme outcomes 
The treatment database holds patient details with date and type of the treatment and 
treatment and pregnancy outcomes. This database was used to cross check the 
information obtained from laboratory database mentioned above. 
 
3. Weekly donor sperm straw consumption sheets 
The weekly donor sperm straw consumption sheets were used to cross check the 
date of commencing treatment, to obtain the additional dates of treatment and also 
the number of inseminations. The season of treatment and number of inseminations 
per treatment cycle were obtained from this information. 
 
4 A donor release file  
The donor release file records the donor code, donation date of each sample, the 
number of straws frozen and also the release date of the sperm straws. This was 
used to track the sample used for treatment back to the date and season of sample 
production. Where this information was not recorded, an andrology database of 
donors (described below) was used to retrieve the information. The season of 
original sperm production of the thawed sperm used for treatment was obtained 
from this information. 
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5 An andrology database of donors. 
The andrology database of donors holds information about donor code, semen 
parameters (both pre freeze and post thaw) with the date of sample production, 
number of straws of sperm frozen and the release date of the straws for use. The 
information on donor semen parameters and the number of straws of sperm 
cryopreserved by season were obtained from this database. 
 
5.5.5 Study size 
All the information was collated in an EXCEL file for analysis. A total of 496 DI 
treatments were recorded on to the database.  The seasons are classified as Winter 
(December –February), Spring (March-May), Summer (June-August) and Autumn 
(September-November). When semen samples produced in different seasons was used 
for sequential inseminations in the same treatment cycle (10 cycles), the sample used for 
the last day/days of treatment which most likely led to the conception in pregnancy 
positive cases was recorded as the season of sperm sample production. The outcome of 
the treatment cycle was taken as pregnant if the pregnancy test was positive. 
  
5.6 Statistical Analysis 
The variables are expressed as mean ± SD and median ± centiles. The distribution of all 
the continuous variables was checked with the Anderson Darling normality test. To 
investigate the association between DI treatment pregnancy outcome and season of 
sperm sample production / season of treatment / number of inseminations, chi square 
tests were applied. As the donor semen parameters, both pre freeze and post thaw were 
not normally distributed (Anderson Darling test>0.05), the Kruskal Wallis test with post 
hoc multiple comparison test was applied to investigate the difference between the 
seasons. The association of season of semen sample production with efficiency of 
cryopreservation (number of straws of sperm frozen) was verified using analysis of 
variance ANOVA. 
 
5.7 Results  
A total of 241 patients underwent 496 DI cycles of treatment between 2005 and 2010. 
The age range of the women was 22 to 43 years with a median at 33 years. Each patient 
had an average of 2 DI cycles of treatment which is consistent with the centre’s donor 
programme (detailed in Chapter 3, Section 3.5.3) which generally offers 3 cycles of DI 
treatment. 
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5.7.1 Is the pregnancy rate following DI treatment higher when sperm produced in 
a particular season was used? 
There were 496 DI treatments undertaken between 2005 and 2010. 16 out of 496 cycles 
of treatment could not be included in the section. The reason for this was more than one 
batch of straws were released at the same time with different dates or seasons of semen 
sample production and the records did not allow further clarification to track down the 
precise season of sample production for these treatments. Therefore 480 DI treatment 
cycles were included in this section.  
 
Most of the treatment cycles (42.2%) were carried out with semen samples produced in 
Spring (probably because most of the donor semen samples were produced in Spring as 
elaborated later in section 5.7.4.1) and only 15.2% were carried out with samples 
produced in Autumn. 22.2% and 20.2% of the treatment cycles were with semen 
samples produced in Winter and Summer respectively. 
 
 55 pregnancies were recorded including biochemical pregnancies (4), miscarriages 
(10), still birth (1), live birth (36) and also unknown outcomes following positive 
pregnancy test (4). The positive pregnancy rate per treatment cycle was 11.3% during 
this time period (56 pregnancies from 496 cycles). The pregnancy rate per cycle varied 
from 9.3% from semen samples produced in Winter to 15.1% in Autumn but  there was 
no statistical difference in the outcome of DI treatment by the season of semen sample 
production (p=0.67) (Table 14).
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  Season of semen sample production 
                    Pregnant 
Total           No        Yes 
 Winter Count            97        10     107 
% within          90.7%       9.3%  
Spring Count          179        24     203 
% within          88.2%      11.8%  
Summer Count           87        10      97 
% within          89.7%     10.3%  
Autumn Count          62        11     73 
% within           84.9%      15.1%  
Total Count          425        55     480 
% within          88.5%      11.5%  
 
Table 14:  Donor insemination treatment outcome by the season of semen sample 
production 
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5.7.2 Is the pregnancy rate following DI treatment higher when treatment occurs in 
a particular season? 
 
All 496 DI cycles were included in this section and 56 pregnancies were recorded. The 
DI treatment cycles performed were lowest in Winter (21.5%) with a slight 
compensatory rise seen in the Autumn (28.2%) earlier. DI cycles were carried out 
uniformly through the rest of the year with 24.7% and 25.4% of cycles carried out in 
Spring and Summer respectively. The lowest number of treatment cycles in Winter is 
likely to be due to the 3 week shutdown of laboratories for maintenance at Christmas. 
The rise just before Christmas is likely due to patients’ preference to avoid treatment at 
Christmas. 
 
The pregnancies included biochemical pregnancies (4), miscarriages (10), still birth (1), 
live birth (37) and also unknown outcomes following positive pregnancy test (4). The 
pregnancy rate per treatment cycle varied from 10.3 % with treatments carried out in 
Winter and Summer to 13.8% in Spring with 10.7% in Autumn. There was no 
significant difference in the outcome of the DI treatment by the season of treatment 
(p>0.79). The results are shown in the Table 15.  
 
 
Season of DI treatment 
Pregnant 
Total No Yes 
         Winter  Count         96            11       107 
% within         89.7%         10.3%  
Spring Count       106          17       123 
% within        86.2%       13.8%  
Summer Count        113         13       126 
% within        89.7%       10.3%  
Autumn Count         125         15       140 
% within        89.3%       10.7%  
Total Count        440        56        496 
% within        88.7%      11.3%  
 
Table 15: Treatment outcome by the season of donor insemination
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5.7.3 Is the outcome of DI treatment dependent on the number of inseminations? 
Out of the 496 DI cycles, most of the treatment cycles (40.3%) received 2 inseminations 
(22.6% had one insemination, 27.2% had 3 and only 9.9% had 4 inseminations). In 
other words 63% of the treatment cycles had 1-2 inseminations as expected for DI 
treatments with ultrasound monitoring. The pregnancy rate per cycle varied from 7.1% 
with one insemination to 14.3% with four inseminations, although the number of 
treatment cycles with 4 inseminations was low (12.5% pregnancy rate per cycle with 2 
inseminations and 11.9% with 3 inseminations). As expected with ultrasound monitored 
DI cycles there were no statistical difference with number of inseminations and DI 
treatment pregnancy outcome (p 0.44). The data are shown in Table 16. 
 
 
 
  
 
No: of inseminations 
Total 
Chi 
square 1 2 3 4 
Pregnancy No Count 104 175 119 42 440  
%   
92.9% 
 
87.5% 88.1% 85.7% 88.7% 
 0.44 
Yes Count 8 25 16 7 56 
%   
7.1% 
 
12.5% 11.9% 14.3% 11.3% 
Total Count 112 200 135 49 496 
       
 
Table 16: Association between number of inseminations and pregnancy outcome of 
DI treatment
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5.7.4 Donor semen parameters 
Samples from 32 donors were used for DI treatments between 2005 and 2010. These 
donors produced a total of 1114 samples from 1995 to 2009 (Table 17). Sperm was 
frozen from 906 samples. No attempt was made to freeze 124 samples as the parameters 
were either sub-optimal with regard to the freezing criteria or an excess of round cells or 
leucocytes were seen. 84 samples were discarded as the samples did not thaw well. 
There was missing data on the number of straws frozen for 2 samples.  
 
 
 
Total semen samples 1114 
Samples frozen 
(No: of frozen sperm straw information was not recorded in 
2 samples) 
906 
Samples not suitable for freezing 124 
Samples discarded because of poor survival on thawing 
(Thaw analysis was recorded only for 75 samples) 
84 
         
           Table 17:  Details of the donor semen samples
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5.7.4.1 Is there a seasonal variation in the pre-freeze donor semen parameters? 
Out of the 1114 samples produced for donation over the study period, 6 samples did not 
have a record of full semen analysis. Four of them were discarded because of a high 
percentage of round cells or leucocytes, one for low volume and one for low motility. 
Therefore 1108 samples were investigated for seasonal variation in semen parameters. 
 
Most of the semen samples were produced in Spring (33.8%), whilst the number was 
least in Winter and Autumn with 19.9% and 19% respectively.  The Summer was the 
second most popular season in which to donate samples with 27.3% of samples 
produced (Table 18).  
 
The semen volume was not recorded for 71 samples out of which 65 samples were 
eventually not frozen. The decimal point was adjusted for five semen volumes as the 
volume was recorded as above 10mls (10 to 113mls) despite the number of straws 
frozen being between 6 and 20.  
 
Semen volume was significantly higher in Spring compared to Winter but not compared 
with Summer or Autumn. Sperm concentration, total motile concentration and 
progressive motile concentration in Summer and Autumn were significantly lower 
compared to Winter and Spring. The total motility in Autumn was significantly lowest 
than the other three seasons. The progressive motility was again significantly lower in 
Autumn compared to Spring and Summer but not Winter Table 18.  
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Semen parameters  
N=1108 samples; Median  (25-75 centile) 
 
 
 
 
Winter (N=220) Spring (N=374) Summer (N=303) Autumn (N=211) Kruskal 
Wallis test 
Semen volume (ml) 2.2 (1.8-2.8) 2.5 (1.9-3.0) 
 
2.4 (1.8-3.5) 
 
2.2(1.6-3.0) 
 
0.04 
Sperm concentration (millions/ml) 132 (97-186) 
 
127 (89-163) 
 
103 (72-137) 
 
100 (80-141) 
 
<0.005 
 Total Motile  concentration (millions/ml)   96 (67-142) 92 (63-125) 76 (51-109) 73 (55-103) <0.005 
Progressive motile concentration (millions/ml)   89 (65-131) 86 (57-118) 
 
69 (45-99) 
 
65 (49-95) 
 
<0.005 
Total motility (%) 74 (66-81) 
 
74 (68-81) 
 
75 (68-82) 
 
72 (66-78) 
 
0.01 
Progressive motility (%) 66 (58-74) 
 
68 (60-74) 69 (60-76) 
 
65 (57-71) 
 
0.001 
 
Table 18: Pre freeze semen parameters of donor samples by season of sample production (N= 1108 samples)
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5.7.4.2 Is there a seasonal variation in the post thaw semen parameters? 
There was no difference in the outcome of DI treatment by the season of semen sample 
production (p=0.67; Table 14) even though the pre-freeze donor semen parameters 
showed significant seasonal variation. Therefore we analysed the post-thaw semen 
parameters of the cryopreserved samples which could have potentially been used for 
treatment. 906 semen samples were included in this section Table 19. 
 
Similar to the pre-freeze sperm concentration, post-thaw sperm concentration continued 
to be significantly lower in Summer and Autumn compared to Winter and Spring.  The 
post-thaw total motile and progressive motile concentrations also are significantly lower 
in Summer and Autumn compared to Winter, but not Spring. There is no statistical 
difference in the post-thaw progressive and total motility between the seasons. 
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Semen parameters 
 N=906 samples; Median  (25-75 centile) 
 
Winter (N=190) Spring (N=317) Summer (N= 227) Autumn (N= 172) Kruskal Wallis 
test 
Sperm concentration (millions/ml) 81 (62-114) 
 
77 (59-107) 
 
65 (49-88) 65 (50-91) 
 
<0.005 
Total Motile  concentration (millions/ml)   42 (29 -72) 40 (24-68) 36 (20-56) 32 (23-52) 0.001 
Progressive motile concentration (millions/ml)   36 (23-56) 
 
32 (20-53) 29 (18-43) 
 
27 (19-44) 
 
0.001 
Total motility (%) 54 (42-67) 
 
53 (39-67) 
 
57 (42-68) 
 
52 (39-63) 
 
0.07 
Progressive motility (%) 45 (34-53) 
 
44 (35-52) 
 
46 (37-53) 
 
44 (33-52) 
 
0.09 
 
Table 19: Post thaw semen parameters of cryopreserved donor samples by season of sample production (N= 906 samples) 
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5.7.5 Is the cryopreservation of sperm more effective in any particular season? 
There were 906 semen samples frozen from the 32 donors. The number of straws frozen 
was not documented in 2 samples. Semen volume was not recorded in a further 5 
samples. Overall we had 899 semen samples with season of sample production, semen 
volume and number of straws of sperm frozen recorded. The details are shown in  
Table 20. 
 
Semen volume was similar in Spring and Summer but was significantly higher 
compared to Winter (Post-hoc Tukey test p=0.03 for Winter vs. Spring and 0.01 for 
Winter vs. Summer). As expected by the semen volume, there was a significantly higher 
number of straws of sperm frozen in Summer compared to Winter (Post-hoc Tukey test 
0.01 for Winter vs. Summer) but there was no statistical difference between Winter and 
Spring in the number of straws frozen. 
 
 
 
 
N=899 
Median (25th -75th 
centile) 
 
Winter 
N=189 
 
Spring 
N=314 
 
Summer  
N=226 
 
Autumn 
N=170 
 
ANOVA 
test 
Semen Volume (ml) 2.2 (1.8-2.8) 2.5 (2.0-3.1) 2.4 (1.8-3.2) 2.2 (1.8-3.0) 0.01 
Cryopreservation 
(No: of straws of 
sperm) 
14 (12-19) 16 (12-20) 16 (12-22) 14 (11-20) 0.01 
 
Table 20: Association between season of sample production and cryopreservation
 126 
5.8 Discussion 
In this chapter, we investigated 496 DI treatment cycles performed between 2005 and 
2010. Also the donor semen parameters were evaluated for seasonal variation. 
 
Most of the donor semen samples were produced in Spring (33.8%) and therefore most 
of the treatment cycles (42.2%) were done with semen samples produced in Spring. 
Likewise the lowest number of semen samples was produced in Autumn with the least 
number of treatments carried out with Autumn semen samples. 
 
 As the semen samples produced in one particular season have not yielded better 
pregnancy rates, it implies there is no seasonal variability in the function of sperm. Very 
few studies in the literature investigated the seasonal variation in donor conceptions. A 
study by Paraskevaides et al. (1988), showed that donor conceptions in the artificial 
insemination programme of their clinic were highest between October and March. 
However in this study both fresh and frozen sperm was used for treatment and results 
were not presented separately for each method. As the highest sperm counts occurred 
from February to May in their study (and not October to March), the authors suggested 
the possible role of female factors to explain the seasonal variation. 
 
In another study by Ronnberg (1989), including 677 donor insemination cycles 
conducted in Northern Finland (sub-Arctic region) using only frozen sperm, found a 
similar increase in conceptions from October to March. As frozen sperm was used the 
authors did not consider the contribution by seasonality of sperm parameters to the 
conception and suggested a possible variation in female factors again. 
 
 In contrast to the mentioned two studies and similar to our study,  study by Mayaux and 
Spira (1989), a large French epidemiological survey on couples treated by artificial 
insemination (using only frozen sperm) did not find any seasonal variation in donor 
conceptions. This is the only study in literature which investigated donor conception by 
the month or season of sperm collection. In this study there was no seasonal variation in 
donor conceptions either by the season of sperm collection or season of treatment, 
similar to our study. 
 
There is an assumption in our study that the female factors are reasonably constant. 
Even though the women are spontaneously ovulating and at low risk of tubal disease, 
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factors such as variability in egg quality and endometrial receptivity cannot be ruled out. 
However, as there is no significant difference in the outcome of the DI treatment by the 
season of treatment, it suggests that there were no significant season dependent female 
factors (such as egg quality and endometrial receptivity) influencing the success of 
treatment. 
 
There was no association between the number of inseminations and pregnancy outcome 
in DI cycles, which is similar to other studies (Paraskevaides et al., 1988). In contrast, 
some studies investigating intra-cervical insemination revealed an increased chance of 
conception with increasing number of inseminations (Deary et al., 1997; Carroll and 
Palmer, 2001). Among other variables (such as concentration of inseminated sperm), 
the methods used to decide on the day of ovulation (ultrasound, urinary LH) for timing 
of insemination may have contributed to the variation in results. 
 
Although donor semen parameters appear to be optimal in all seasons and semen 
parameters exceed the minimal accepted standards for a sperm donor considerably, 
significant seasonal variation has been noted in this study. The semen volume was 
significantly higher in Spring compared to Winter. The concentration parameters (sperm 
concentration, total motile and progressive motile) also are significantly better in Winter 
and Spring compared to Summer and Autumn. The motility parameters appear to be 
lowest in Autumn.  
 
There are major differences in these results compared to our previous results from the 
retrospective study on seasonal variation in semen parameters (Chapter 4, Section 4.7), 
which revealed a seasonal variation only in sperm morphology but not volume, count 
and motility. However there are significant differences between the two studies. The 
study group in the retrospective study was men undergoing preliminary fertility workup 
whilst this cohort study consists of donors with proven fertility. Although the cohort 
study was not as large as retrospective study (4067 samples) it is still large with 1108 
semen samples and had the advantage of accounting for intra-individual variation (as 
the samples were from 32 donors only with average of 34 semen samples from each 
donor). Of note, there was no semen analysis methodology related bias between the 
studies.   
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Seasonal variation in semen parameters has been discussed extensively (Chapter 1, 
Section 1.3; Chapter 4, Section 4.8). Briefly, similar to our study, seasonal variation was 
noted more in sperm donors than men attending an infertility clinic suggesting that the 
possible pathology in the ‘suspected infertile’ may not be affected by the season to the 
same extent (Centola and Eberly, 1999). Our retrospective study included 
oligozoospermic samples whilst in the cohort study despite semen donors having had 
few sub-optimal semen samples the majority were normal. It was shown by Levitas et 
al. (2013) that significant seasonal variation exists in normozoospermic samples 
compared to oligozoospermic samples. 
 
Seasonal variation noted in donor semen parameters is similar to the seasonal variation 
reported in several temperate climates with poorer sperm parameters (sperm count and 
or motility) in Summer and or Autumn (Tjoa et al., 1982; Levine et al., 1988; Reinberg 
et al., 1988; Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; Levine et 
al., 1992; Gyllenborg et al., 1999; Andolz et al., 2001; Jørgensen et al., 2001; Chen et 
al., 2003; Chen et al., 2004; Moskovtsev and Mullen, 2005; Calonge et al., 2009; 
Levitas et al., 2013).  
 
Seasonal variation however, is also seen in semen volume in our study which has not 
been reported much in the literature except in a couple of studies which revealed similar 
finding to our cohort study of increased semen volume in Spring in semen donors 
(Zhang and Yao, 2010) and also men pre-vasectomy (Reinberg et al., 1988). It has to be 
acknowledged though that semen volume was missing in 71 of our samples and may 
have affected the results. 
 
Even after thawing, donor sperm concentration appears better in Winter and Spring, but 
there is no difference in the motility between the seasons after thawing. Similar to our 
study, Yogev et al. (2004), reported significantly higher post-thaw progressive motile 
sperm concentration  in Winter compared to Autumn and  Zhang and Yao (2010) 
reported higher progressive motile sperm counts in Spring. Zhang et al. (2012) in their 
further study revealed that progressive motility recovery rate (defined as % post-thaw 
progressive motility / % pre-freeze progressive motility x 100%) was lowest in semen 
samples donated in Summer compared to other seasons. Interestingly as a  higher 
progressive motility recovery rate was noted in the most fertile donors compared to least 
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fertile donors, it was suggested that it is an indicator of high fertility (Paraskevaides et 
al., 1991).  
 
In the Yogev et al. (2004) study, there was no seasonal variation in percentage of post-
thaw sperm motility; however there was no seasonal variation in pre-freeze motility 
either. Although in our study there was a statistically significant seasonal variation in 
pre-freeze motility with lower parameters in Autumn, the difference clinically between 
seasons was small. As cryopreservation does decrease sperm motility (Sharma et al., 
1997; Stanic et al., 2000), the seasonal differences in pre-freeze sperm motility appear 
to be lost with thawing. 
 
In our study a higher number of straws were frozen in Summer. In the study by Yogev 
et al. (2004), freezability of sperm was more effective in Winter and Spring. However 
the cryopreservation method in this study is different to our study. As neat specimens 
were cryopreserved in our study with no pre-determined progressive motile 
concentration of sperm per each straw, cryopreservation straw number is dependent on 
the semen volume. Whilst in Yogev et al. (2004) study, the aim of cryopreservation was 
to obtain 8-12 million/ml of progressive motile sperm concentration in each straw and 
the freezability was judged on the total cryopreserved, progressive motile sperm count 
(i.e. product of number of straws and progressive motile sperm concentration. 
Surprisingly in their further study  (including a much longer study period), they reported 
the absence of a consistent seasonal trend in the freezability of sperm (Yogev et al., 
2012). 
 
5.9  Limitations of the study 
It has been shown that different methods of cryopreservation have varying recovery 
rates (sperm motility / vitality) and effect on functional characteristics of sperm 
(Vutyavanich et al., 2010; Isachenko et al., 2011). Therefore our results are limited to 
the cryopreservation method used in this study. 
 
The ultimate aim of our project is to investigate if seasonality of sperm can improve 
recruitment of sperm donors and whether it provides increased conceptions (i.e. with 
frozen sperm), however  it is not valid to extrapolate the results of this frozen data to 
fresh semen samples and their contribution to seasonality of natural conception. 
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5.10 Conclusion 
Despite a significant seasonal variation in donor semen parameters (both pre-freeze and 
post-thaw), there was no seasonal variation in the outcome of donor conception by the 
season of original sperm donation. 
In the next section we will consider another potential external factor influencing semen 
parameters i.e. vitamin D.
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Chapter 6 Association of vitamin D and semen parameters 
 
6.1 Introduction 
For decades, animal studies have shown a role for vitamin D in male reproduction. 
Vitamin D deficient rats and VDR knockout mice show reduced sperm counts, motility, 
and adverse effects on the testis and fertility (Kwiecinski et al., 1989a; Sood et al., 
1992; Kinuta et al., 2000). Replacement of vitamin D in these animals restores fertility 
and improves testicular function (Uhland et al., 1992; Sood et al., 1995).  
 
It has been suggested that vitamin D contributes to spermatogenesis by various 
mechanisms, including by normalising calcium levels (Uhland et al., 1992), affecting 
oestrogen synthesis in the testis via its influence on aromatase activity and gene 
expression (Kinuta et al., 2000);  and by up-regulating testis-specific genes in Sertoli 
cells (Hirai et al., 2009) although the precise mechanism(s) remains unclear. 
 
In humans, VDR and vitamin D metabolising enzymes are widely expressed in the male 
reproductive tract suggesting that in sperm, 1,25(OH)2D is locally produced, 
emphasizing the potential for autocrine –paracrine responses (Aquila et al., 2009; 
Blomberg Jensen et al., 2010; Foresta et al., 2011). 
 
In vitro human studies have shown that vitamin D enables sperm capacitation, improves 
sperm survival, increases intracellular calcium levels in sperm, improves sperm motility 
and induces the acrosome reaction (Aquila et al., 2008; Aquila et al., 2009; Blomberg 
Jensen et al., 2011). 
 
6.2 Aim 
         To investigate the hypothesis that vitamin D has an important role in male fertility. 
 
6.3 Objectives  
1. To investigate the correlation between serum levels of VD and semen 
parameters. 
2. To investigate the effect of a seasonal rise in VD levels in men without VD 
deficiency on semen parameters. 
3. To investigate the effect of VD supplementation in VD deficient patients, on 
semen parameters. 
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6.4 Outcome measures 
To determine 
1. If there is a link between serum vitamin D levels and semen parameters. 
2. If a rise in serum vitamin D levels in vitamin D deficient participants with 
supplementation or in vitamin D non deficient participants with seasonal rise 
improves semen parameters. 
 
6.5 Subjects and Methods 
6.5.1 Subjects 
Men attending NFC for investigations and/or fertility treatment were recruited to the 
study. Ethical approval for the study was obtained from County Durham and Tees 
Valley Regional Ethics Committee. 
 
6.5.2 Study design / size 
 Male partners of the couples attending NFC from November 2010 to May 2011 were 
approached to participate in a prospective, longitudinal, observational study and 125 
were recruited. 
 
6.5.3 Recruitment  
Couples attending for IVF / ICSI treatment were primarily targeted. The reason for this 
is that couples are usually seen at least 5 times over a 15 days period (for ultrasound 
monitoring of ovarian stimulation, egg collection and embryo transfer). Figure 9 shows 
the sequence of events in an IVF treatment cycle. These visits enabled us not only to 
gradually introduce the idea of participation in the research, but also to give patients 
adequate time to reflect on participation. Moreover the participants would produce a 
semen sample on the egg collection day for their treatment, which could also be used for 
research and thereby avoiding the need to produce a semen sample specifically for 
research. 
 
A patient information sheet containing a brief introduction to the study (Appendix A) 
was given to the couple when they attended for the down regulation scan. When the 
couple attended for the next scan about a week later, a research nurse counselled them 
with respect to enrolling in the study. When the couple attended for egg collection, this 
researcher (MG) saw them if they had already expressed interest in participating in the 
study. 117 men from couples following this pathway were recruited. 
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Information leaflets were given to the men when booking their semen analysis at the 
centre and 4 further men were recruited when they attended the centre for semen 
analysis. 1 patient was recruited from clinic who had submitted the semen sample for 
analysis on the same day. 2 men were recruited when attending with their partners for 
IUI (intra-uterine insemination) treatment.1 man was recruited when his partner 
attended for follicle reduction prior to IUI treatment. 
 
 Overall, 125 men were recruited to the study. One participant had to be excluded later 
(participant 14: 25(OH)D=179nmol/l) when he revealed that he had been taking cod 
liver oil supplements at the time of recruitment.
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Figure 9: Sequence of events in IVF  
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6.5.4 Eligibility  
Males aged over 18 years who were competent to give informed consent were eligible 
to participate in the study. Patients from all ethnic groups were included.  
 
6.5.5 Exclusion Criteria  
Men with azoospermia and those taking vitamin D supplements were excluded from the 
study. 
 
6.5.6 Procedure 
All the men who verbally consented to participate were seen for a consultation where 
the research study was discussed in detail by MG and a questionnaire about 
demographics, fertility, diet and lifestyle was completed (Appendix B).  
Ethnicity included only 2 groups: Caucasian and non-Caucasian. Regarding fertility, 
information on the type of subfertility (primary/secondary) and the cause of subfertility 
was obtained. The cause of subfertility was divided into 3 groups - male factor only 
(idiopathic sub-optimal semen quality, primary testicular failure etc.), combined male 
and female factors (sub-optimal semen quality and tubal or ovarian reserve/ovulation 
problems) and non-male factor (which included unexplained subfertility and sole female 
factor subfertility).  
 
The presence of possible risk factors for male subfertility [such as medical conditions, 
previous genital surgery, sexually transmitted infections, use of recreational drugs 
(including anabolic steroids)], consumption of alcohol, smoking, fever in the previous 3 
months, intake of regular medications and intake of vitamins or nutrients other than 
vitamin D were noted. The average intake of alcohol in units per week was noted. Men 
smoking occasionally were also included as smokers. However we do acknowledge that 
it has been shown that common life style factors do not significantly affect semen 
parameters (Povey et al., 2012).  
 
Diet and lifestyle questions included factors which influence serum vitamin D levels 
such as being a vegetarian, intake of margarine and oily fish, recent travel to hot 
countries or tropical places in the previous 3 months, hours of indoor activity (such as 
time spent watching TV or using a personal computer (PC) etc.) per day, hours spent 
outdoor per day in the previous month and use of sun protection in the form of the 
topical application of creams on sunny days either in the UK or on holiday.  
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The questions on frequency of the consumption of vitamin D rich food (such as daily, 
weekly or less than weekly), the use of sun protection and the timings spent indoors and 
outdoors (<2h, 2-3h, and >3h) were derived from the questionnaire used in a nationwide 
cohort study on diet and lifestyle predictors of vitamin D status in the UK (Hyppönen 
and Power, 2007). 
 
The participant’s weight and height were measured and BMI calculated. Obesity was 
defined as a BMI above 30. Written informed consent (Appendix C) was obtained. A 
copy of the consent form was filed in the notes a second in the research file and a copy 
was given to the patient. A blood sample was taken to assess serum 25(OH) D levels 
and the participant informed that the results of the analysis of the semen sample 
produced by him for their treatment (IVF/ ICSI/ IUI) or investigation would be utilised 
for the research study, apart from samples analysed further to obtain additional 
necessary parameters as required.  
 
The season when the samples (i.e. blood and semen) were obtained was also noted and 
the classification of seasons used was as detailed in the Chapter 4 (Section 4.5.7). The 
participant was informed that a reminder for their next appointment 6 months later 
would be sent to them by their preferred contact method as indicated in the consent 
form, about 3 weeks prior to the scheduled date. 
 
6.5.7 Follow up clinics 
An invitation letter (Appendix D), e-mail or text message was sent to remind the patient 
to attend the follow up clinic appointment. There were 2 follow up clinics every week 
(Monday and Friday). The aim of the follow up clinics was to review men seen initially 
in the Autumn, 6 months later in Spring. Similarly men seen in Winter and Spring were 
to be reviewed in Summer and Autumn respectively as shown in the following Table 
21. 
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Season Recruitment 
phase 
No: of men 
recruited 
Season Follow up 
phase 
Autumn November 21 Spring May 
Winter December 9 Summer June 
 January 17  July 
 February 28  August 
Spring March 34 Autumn September 
 April 14  October 
 May 2  
 
         Table 21: Follow up clinics
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If the couple had a scheduled routine clinic appointment or were coming to the centre 
for a further treatment cycle around the time of their planned research follow up, the 
couple were advised to inform MG so that the arrangements to see them regarding the 
research at the same time were made.  
 
When in the first couple of weeks, significant numbers of men either did not attend or 
rescheduled their appointments, changes to the follow up approach were made to 
improve the efficiency. The changes were – 
1. The option of attending the centre at weekend or evening clinics was offered. 
2. The option of producing the sample at home was given, although none of the 
participants utilised this option. 
3. Invitation letters were sent out 4-6 weeks before the scheduled appointment, 
with a reminder by text message the day before the appointment.  
Men who did not attend the clinic appointment were telephoned on the same day for a 
discussion. This replaced the earlier plan of sending standard ‘did not attend’ letters.  
 
Prior to the review clinic appointment the couple’s notes were checked for further 
information which included the medical history for any risk factors for sub-fertility 
which the participant may not have volunteered, the indication for fertility treatment, the 
details (such as fertilisation and embryo quality) and the outcome of the IVF treatment 
cycle (120 participants) undertaken at their initial recruitment.  
 
At the follow up appointment the questionnaire was reviewed again to note any major 
changes in the previous 6 months. Blood and semen samples were collected on the same 
day. All the semen samples were analysed by MG within 60 min of production. The 
blood and semen samples were dealt with as described below.  
 
6.5.8  Laboratory Procedures 
6.5.8.1 Blood sample  
4.5mls blood was taken by standard venepuncture technique into a plain tube (yellow 
top where in the blood is clotted) and labelled with participant’s unique identification 
code and date of birth to obtain serum 25(OH)D levels. 25(OH)D was measured by an 
automated assay at the Biochemistry laboratories, Royal Victoria Infirmary Hospital, 
Newcastle upon Tyne (RVI). The Liaison 25-OH Vitamin D TOTAL assay (DiaSorin 
Liaison 2) method is a competitive chemiluminescent immunoassay (CLIA) where a 
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polyclonal goat antibody to 25(OH)D is used to coat magnetic particles and 25(OH)D is 
linked to an isoluminol derivative. During the incubation, 25(OH)D is dissociated from 
its binding protein and competes with isoluminol-labelled 25(OH)D for binding sites on 
the antibody (Roth et al., 2008).  The unbound material is removed with a wash cycle 
and reagents are added to initiate a flash chemiluminescent reaction. The light signal is 
measured by photomultiplier and is inversely proportional to the concentration of 
25(OH)D present in calibrators, controls or samples. 
 
The measuring range of the Liaison 2 assay is from 10-375nmol/L with linearity up to at 
least 155nmol/l. The intra-assay coefficient of variation (CV) is 7.2% and 5.1%, at 
25(OH)D levels of 37.57 and 125.7nmol/l respectively. The inter-assay CV is 12.6% 
and 7.4% at 25(OH)D levels of 36.9 and 123.1nmol/l. The assay has a cross reactivity 
of 100% with 25-hydroxyD3 and 25-hydroxyD2 on an equimolar basis. 
 
6.5.8.1.1 External Quality Assurance 
The variability in the results of different vitamin D assays is well known. Since 1989, 
the Vitamin D external Quality Assessment scheme (DEQAS) has been monitoring the 
performance of vitamin D assays internationally with more than 100 participants 
registered in 18 countries. The scheme offers the opportunity to determine the accuracy 
of the various methods used (Carter et al., 2004). The participants are sent 5 samples of 
serum every 3 months for analysis of 25(OH)D levels. The participants return the 
results within 6 weeks. From all the results received, statistical analysis is performed 
and an all-laboratory trimmed mean (ALTM) is calculated. Results are also pooled for 
each method and a method mean (MM) calculated. Accuracy of the result is defined by 
percentage bias, which is the deviation from the ALTM. Assessment of the overall 
accuracy of the method used is calculated by the percentage bias of the method mean 
from the ALTM (MM-ALTM / ALTM) × 100. The labs at the RVI are enrolled with 
DEQAS for quality checks which confirm that standards are maintained and are done 
once every 3 months.  
 
 
6.5.8.1.2 Vitamin D status classification 
The differing recommendations in defining adequate levels of vitamin D and the 
classifications are well known and are detailed in the Chapter 1 (Section 1.5.9). The 
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most widely recognised and used classification of D status as described below is used 
for our study (Pearce and Cheetam, 2010; Blomberg Jensen et al., 2011)  
• < 25nmol/l - Deficiency 
• 25-50nmol/l –Insufficiency 
• 51-75nmol/l – Adequate 
• >75nmol/l – Optimal 
 
6.5.8.2 Semen sample 
6.5.8.2.1 Reasons for semen sample production   
In the recruitment phase of the study, the majority of the participants (120/125) 
produced the sample for their treatment (IVF/ICSI/IUI) while the rest (5/125) produced 
the sample for their routine preliminary investigations. The semen analysis results were 
utilised for the study. In the follow up phase, the majority of the participants (73/87) 
produced the semen sample only for the research study while the rest (14/87) produced 
the semen sample for their further treatment cycle.  
 
6.5.8.2.2 Staff performing the semen Analysis   
Semen samples produced for treatment are routinely analysed by embryologists while 
the Andrology laboratory technicians perform the routine semen analysis submitted for 
investigations.  
 
All the semen samples done solely for the research study were analysed by MG. 
Furthermore, the samples submitted for the fertility treatment in the recruitment phase 
(113) and follow up phase (14) were also analysed by MG for the sperm count using a 
Neubauer counting chamber as per the WHO 2010 recommendation, as otherwise sperm 
counts are usually done on a wet preparation slide for the treatment purposes. Wet 
preparation analysis is less accurate as it does not include the dilution technique 
(described in Section 6.5.8.2.3.2.) or utilise fixed volumes compared to a sperm count 
performed using a counting chamber, however it suffices for IVF/ICSI treatment. Wet 
preparation sperm count was the only method possible in 7 participants in the 
recruitment phase where the entire sample had to be used for their treatment.  
Once semen analysis was done, MG was blinded to the results till the second semen 
analysis was completed at the follow up 6 months later. 
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All the staff performing the semen analyses, which were included in the research study 
(including MG) undertook regular quality control checks, both internal and external 
(UK National External Quality Assessment service UK NEQAS) on a regular basis.  
 
6.5.8.2.3 Semen analysis 
The details of initial assessment; sample collection, liquefaction and volume are 
described in Chapter 4 (Section 4.5.4). All participants produced their semen sample at 
the centre and semen analysis was completed within one hour of sample production, 
although in the majority of cases analysis was undertaken soon after liquefaction.  
 
6.5.8.2.3.1 Abstinence and sample loss  
Whilst all participants were advised to avoid ejaculation for between 2 and 7 days prior 
to sample production, as per the WHO laboratory manual – fifth Edition (World Health 
Organisation, 2010), the actual period of abstinence for each was documented only in 
the follow up phase when recommended abstinence was noted in 86/87 patients. Sample 
loss was also documented in the follow up phase only. 3/87 participants in the follow up 
phase recorded partial sample loss. Presumably there would have been similar 
proportion of participants with sample loss in the first phase as well however, and more 
importantly as this information was not available for one phase of the study, it was not 
taken into consideration in the statistical analysis. 
 
6.5.8.2.3.2 Sperm concentration 
10µl of the semen sample was loaded onto a fixed depth micro-cell slide. After allowing 
it to settle for few minutes the number of sperm per field of view was noted using a 
phase contrast microscope at a magnification of ×400 (×40 objective). The criteria in 
Table 22 were used to calculate the required dilution. The semen sample was diluted 
with a specific volume of sterile distilled water in an Eppendorf tube. 
 
The sample was agitated using the vortex for 10 seconds to ensure homogeneity. Using 
a positive displacement pipette, both sides of the C-Chip disposable Neubauer slide 
were loaded with sample from the Eppendorf tube. Whilst pipetting, care was taken to 
avoid under or over filling the chambers. Once the chamber was full, it was allowed to 
settle for 5 minutes. The number of complete sperm (heads and tails) in focus in one 
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large square of the Neubauer counting chamber was counted using the phase contrast 
microscope at a magnification of ×400 (×40 objective). Using the criteria in the  
Table 23, the number of large squares to be counted was determined. 
 
Apart from the sperm completely in the square, the sperm lying on the left and the lower 
edge of the square were also counted. The average of counts from the two sides of the 
Neubauer was calculated. This number was divided by the conversion factor which can 
be derived from Table 24 to give the sperm concentration of the original semen sample 
in millions per millilitre. 
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Sperm per field of 
view 
Dilution (Semen + 
diluent) 
Volume of 
water µl 
Volume of 
sample µl 
<15 1:5  (1+ 4) 100 25 
15-40 1:10 (1+ 9) 225 25 
40-200 1:20 (1+ 19) 475 25 
>200 1:50 (1+ 49) 1225 25 
 
Table 22: Calculation of dilution for sperm concentration 
 
 
 
 
Number of sperm seen in one large 
square 
Number of large squares to count 
<10 25 
10-40 10 
>40 5 
 
Table 23: Determination of squares to count by number of sperm seen 
 
 
 
 
 
Dilution applied to 
the sample 
Number of large squares counted 
25 10 5 
1:5 20 8 4 
1:10 10 4 2 
1:20 5 2 1 
1:50 2 0.8 0.4 
 
 Table 24: Conversion factor to obtain sperm concentration in millions per 
millilitre   
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6.5.8.2.3.3 Sperm motility  
 Sperm motility is analysed soon after liquefaction as it deteriorates with time. If the 
liquefaction had not occurred within half an hour, the sperm motility assessment was 
still completed. 10µl of the undiluted semen sample was loaded on to a fixed depth 
micro-cell slide and allowed to settle. Using a phase contrast microscope at a 
magnification of ×400 (×40 objective) 100 sperm were counted as per the following 
criteria using a Celltrac counting chamber to derive the percentages of sperm motility. 
 
Progressive motility (PM): Actively moving spermatozoa either linearly or in big circles 
irrespective of the speed. 
 
Non-motile (NM): All other forms of motility with lack of forward progression for 
instance moving in small circles or when only the flagellar beat is observed. 
 
Immotile (IM): Sperm with no movement. 
 
6.5.8.2.3.4 Sperm Morphology 
The methodology is described in detail in the Chapter 4 (Section 4.5.4.5.) For this study 
however, the recent  classification of sperm morphology based on 2010 World Health 
Organisation criteria is used (World Health Organisation, 2010). Similar to WHO 1999 
criteria, sperm are classified as normal or abnormal and all borderline sperm are 
considered abnormal. 
 
6.5.8.2.3.4.1 Normal Sperm 
This is described as follows- 
Sperm head: The head should be regular contoured and oval in shape. A well-defined 
acrosome occupying 40-70% of the sperm head area should be present. The acrosome 
should not contain any large vacuoles but small vacuoles, 2 or less occupying less than 
20% of the head are considered normal. There should not be any vacuoles in the post 
acrosomal region of the head. The form of the head is more important than the 
dimensions, except when these are grossly abnormal. 
 
Mid piece: This should be regular, slender, approximately same length as the sperm 
head and should be aligned to the longitudinal axis of the sperm head. Residual 
cytoplasm is considered abnormal if it is more than 30% of the sperm head size. 
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Principle piece: This should be uniform along the length, thinner than mid piece, 45µm 
long with no sharp angle. 
 
6.5.8.2.3.4.2 Abnormal sperm  
Any deviations of normal forms are considered abnormal. Apart from head, neck and 
mid piece and principal piece defects, another abnormality, excess residual cytoplasm is 
described (ERC). ERC is a result of defective spermatogenesis and is characterised by 
large amounts of irregular cytoplasm, one third or more of the head size and usually 
associated with mid piece defects. 
 
6.5.8.2.4 Quality Control  
The intra- and inter-individual variation in the analysis of semen samples is well known 
(Auger et al., 2000). The reproducibility of a semen analysis can be assessed by 
analysing the same sample several times. This principle is used in quality control to 
assess intra-technician variability (same technician performing several analyses on the 
same blinded sample) and inter-technician variability (various technicians performing 
the analysis on a single sample). 
 
 The laboratory at our centre runs an internal quality control programme and also 
participates in the UK National External Quality Assessment service (UK NEQAS). UK 
NEQAS is a scheme facilitated by the Department of Reproductive Medicine, St. 
Mary's Hospital, Manchester since 1994 (World Health Organisation, 2010). Aliquots of 
liquid semen (fixed in 10% formalin) are sent from Manchester to the participating 
fertility centres for the assessment of sperm concentration and sperm morphology. For 
the assessment of sperm motility a DVD and online web link [in collaboration with 
Gamete Expert (www.gamete-expert.com), an online training website for the 
assessment of gametes] are sent. The online web link is also used to assess sperm 
morphology. Four samples are sent to the labs every 3 months and the results are 
returned to NEQAS within 3 weeks.  
 
The percentage of bias and the bias index score (BIS) are calculated for each semen 
parameter as detailed in Appendix E. Accuracy of the test result performed can be 
derived from BIS score. If the BIS score is outside -100 to 100, it indicates an 
unacceptable result. The details of interpretation of the results are available in Appendix 
E. All laboratory staff performing the semen analyses including MG participated in the 
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internal quality control which follows the principles of external quality for assessment, 
to ensure that the standards are maintained. UK NEQAS results reveal the centre’s 
satisfactory performance during the study period. 
 
6.5.8.2.5 Training in Semen Analysis  
I had formal hands on training in semen analysis, under the supervision of two 
embryologists, over a period of 3 months. Training commenced with watching online 
videos (for sperm parameters). During the training various steps in performing the 
semen analysis were observed and the results of the sperm parameters were compared 
with that of the trainers. A training check list (Appendix F) which is a thorough 
systematic approach to conduct a semen analysis was completed.  When the procedure 
was performed as per the requirements on more than 5 occasions, and the results of the 
sperm parameters (semen volume, sperm count, motility and morphology) tallied with 
those of the trainers (<5% variation), I was deemed competent to perform the semen 
analysis independently. Although the training requirements for routine semen analysis 
were completed, the trainers continued to check my results with theirs for longer at my 
request which as shown in Table 25. The NEQAS accreditation paper work for MG is 
shown in Appendix G. 
 
Sperm parameter No: of occasions checked with trainer 
Semen volume 7 
Sperm count 26 
Motility  31 
Morphology 17 
 
                             Table 25: Training in semen analysis 
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6.5.9 Data Handling 
All the questionnaires and consent forms were placed in the research file. The 
participants were given unique identifier codes. The register maintaining the patient 
identifying information and their planned follow up visits was also in the research file. 
The research file was put in a secure and confidential place within the department. The 
request form for the blood test was labelled with the participant’s code and date of birth 
but no other identifying information and all the vitamin D reports were filed in the 
research file (as per the Trust Research and Development advice). Only blood results 
with vitamin D deficiency were decoded and filed in the couple’s case notes.    
 
6.5.10  Handling of results 
The results of serum 25(OH)D and semen analysis were entered in the questionnaire. 
All the questionnaire answers and results were uploaded on to the electronic database 
excluding any patient identifying information. 
 
6.5.11  Vitamin D deficiency  
Participants with low vitamin D level (< 25nmol/l) were informed of the result by letter 
(Appendix H) and advised to approach their General Practitioner (GP) for vitamin D 
supplementation therapy. The participant’s GP was also sent a letter (Appendix I) to 
request that they organise treatment with the general recommendation of a 6-8 week 
course of high dose Colecalciferol 20,000 IU, 3 capsules per week. Thereafter, men 
were advised either to go onto a maintenance vitamin D regime of 1,000 IU per day, or 
to modify their diet to increase vitamin D intake, e.g. to eat oily fish twice weekly. A 
vitamin D information leaflet (Appendix J) was also enclosed with the GP’s letter. 
Where possible the participants were informed of the result face to face. The letters 
were filed in the notes along with the decoded laboratory report. 
 
6.5.12  Vitamin D compliance 
Participants were sent a reminder (e-mail or text) 6 weeks after the initial letters were 
sent out regarding their low vitamin D levels with recommended treatment. Meanwhile 
if the couple were seen for a routine fertility clinic appointment, participants were 
encouraged to contact their GP for vitamin D supplementation if they had not already 
done so. The importance of vitamin D supplementation for bone and general health was 
discussed. 
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6.6 Statistical Analysis 
Statistical analysis was performed using SPSS (version 19) and Minitab (version 16). 
Variables were expressed as mean ± SD or SEM and median with centiles. 
 
The distributions were checked using the Anderson Darling normality test. The 
continuous variables BMI, vitamin D levels and semen parameters showed non-normal 
distribution whilst age showed normal distribution. The study group was divided into 4 
groups based on their vitamin D status. The significance of indicators of vitamin D 
status (recent travel, vegetarian, intake of margarine, oily fish intake, indoor activity, 
outdoor activity and use of sun protection) among the vitamin D groups was checked 
using chi square test. Vitamin D was used as a continuous variable and checked in the 
sub-categories of vitamin D indicators using either the Mann Whitney test (2 categories) 
or the Kruskal Wallis test (>2 categories). If significance was noted by the Kruskal 
Wallis test, the Levene statistic (Homogenity of variance) was checked to ensure >0.05 
to apply one way ANOVA with post-hoc analysis.  
 
To compare the characteristics of men in the vitamin D groups, chi square was used for 
categorical variables (type of subfertility, cause of subfertility, presence of risk factors, 
recent fever, consumption of alcohol, smoking, intake of regular medication and of 
vitamins or nutrients) and for continuous variables such as age and BMI, the ANOVA 
and the Kruskal Wallis test was used respectively. For the association study the 
significance of semen parameters between the vitamin D groups was checked using the 
Kruskal Wallis test. Spearman correlation test was used to analyse the correlation 
between vitamin D and the semen parameters. 
 
For each semen parameter, multiple regression modelling was employed to establish the 
significance of vitamin D when viewed alongside selected covariates.  Candidate 
covariates chosen for the modelling procedure had a univariate association with an 
outcome of p<0.15 – recognising the fact that a covariate showing a weak univariate 
association with outcome may have a stronger association with outcome when viewed 
alongside other predictors (Hosmer and Lemeshow, 2000; Labopin and Iacobelli, 2003; 
Blomberg Jensen et al., 2011). The candidate covariates were then entered into a 
variable selection procedure alongside vitamin D entered as a continuous variable 
(p=0.05 was chosen for variable entry and p=0.1 for variable removal).  The covariates 
considered were age, BMI, season, ethnicity, type of subfertility, cause of subfertility, 
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presence of risk factors, recent fever, alcohol, smoking, intake of regular medication and 
of vitamins or nutrients. All the covariates were categorised as described in Table 28. 
for regression analysis except cause of subfertility and alcohol consumption. These were 
re-categorized to 2 groups instead of three [cause of subfertility (male/non-male) and 
alcohol consumption (<21 units/wk or >21 units/wk)] for regression analyses. 
 
 For vitamin D versus treatment regimens, since the distribution of vitamin D was 
normal, one way ANOVA was applied to compare the improvement between the 
treatment groups. In the longitudinal study, the association of vitamin D levels and 
semen parameters was verified by applying Wilcoxon signed ranks test.  
 
The comparison of vitamin D between seasons was tested using Kruskal Wallis and 
Multiple comparison tests. A p value of <0.05 was considered significant. 
 
 
6.7 Results 
6.7.1 Recruitment 
 A total of 273 patients were approached during the study period. 42 (15.3%) patients could not be recruited as 
could not be recruited as they were on vitamin D supplements whilst 106 patients (38.8%) declined to 
(38.8%) declined to participate in the study. The main reasons quoted for declining to participate were: not 
participate were: not interested in the study (76/106, 71.6%), unable to return for follow up (17/ 106, 16%) and 
up (17/ 106, 16%) and needle phobia (13/106, 12.2%). 125 (45.7%) patients were recruited to the study. The 
recruited to the study. The recruitment details are shown in the  
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         Figure 10. 
 
Although all men were partners in a subfertile couple, 54 (43.2%) had male factor 
subfertility whilst 71(56.8%) had non-male factor subfertility, therefore the study group 
was heterogeneous. The male factor subfertility details are shown in Table 26. 
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         Figure 10: Participant’s recruitment and follow up 
* Revealed at the follow up phase to be on cod liver oil since prior to recruitment. 
Investigation results were excluded from the analysis, therefore only 124 results 
available for cross sectional association study. 
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Cause No: of participants 
Idiopathic male factor 41 
Primary testicular failure 1 
Undescended testis (includes unilateral 
and bilateral) 
7 
Unilateral Orchidectomy  2 
Previous chlamydia (with sub optimal 
semen quality) 
2 
Testicular cancer, unilateral 
orchidectomy, chemotherapy 
1 
 
         Table 26:  Male factor subfertility
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6.7.2 Prospective observational association study 
Vitamin D levels were deficient in 52 men (41.9%), insufficient in 51 (41.1%), adequate 
in 15 (12.1%) and optimal in 6 (4.8%).These four vitamin D groups are used for the 
majority of the analysis. A review of the participants in the optimal vitamin D group 
revealed that 3 of them had been on recent holidays to sunny places and one participant 
used a sunbed once a week. Only 2 of the participants had true optimal vitamin D 
levels. The prevalence of vitamin D deficiency was 47.1% (49/104) during Winter and 
Spring in the study group whilst 42% (38/90) in Caucasians only. 
 
Hypovitaminosis D as defined in the large scale British survey (i.e. <than 40 nmol/l of 
serum vitamin D) was also calculated for comparison. In Winter the level of 
hypovitaminosis D in was 79.6% (43/54) while it was 64% (32/50) in Spring. Only if 
Caucasians were included it was 77.7% (35/45) and 60% (27/45) respectively. 
 
6.7.2.1 Vitamin D and Ethnicity 
109 (88%) participants were Caucasians whilst 15 (12%) were non-Caucasians. The 
prevalence of vitamin D deficiency in non–Caucasians was significantly higher 
compared to Caucasians [80 % (12/15) versus 36.7% (40/109); Fisher's exact p value = 
0.002]. 
 
6.7.2.2 Vitamin D and BMI 
There was no statistical difference in vitamin D levels in the obese group (BMI>30) 30 
(14-41) and non-obese group 29 (15-43.5) nmol/l [Median (25th-75th centiles); Mann 
Whitney p=0.19]. Furthermore BMI is comparable in all the vitamin D groups (Kruskal 
Wallis test p= 0.51). Though the actual BMI was not recorded for 18 participants, the 
category (obese or non-obese) was recorded for all the participants. 
 
6.7.2.3 Factors influencing vitamin D levels  
The results are shown in Table 27. 
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Were the vitamin D levels higher in participants who had travelled abroad within 
the previous 3 months? Recent travel was significantly different between the vitamin 
D groups (Chi square p value = 0.03; Table 27). Participants who had travelled in the 
previous 3 months to sunny places had significantly higher levels of vitamin D than 
those who had not [41.5nmol/l (30.5- 52.4) versus 30.1nmol/l (26.3-33.8); mean (95% 
CI); Independent samples test p=0.03)]. 
 
Was vitamin D deficiency more common in vegetarians? There were only 2 
vegetarians in the entire study group and both had vitamin D deficiency. One participant 
was Caucasian whilst other the other non-Caucasian. As expected there was no 
significant difference in the number of vegetarians seen in the 4 vitamin D groups 
(p=0.65; Table 27) but the numbers were too low to investigate the effect of being 
vegetarian on vitamin D status.  
 
Was intake of oily fish and or margarine higher in participants with adequate / 
optimal vitamin D levels? The intake of oily fish and margarine were uniform among 
the vitamin D groups (p=0.76;Table 27). Also the vitamin D levels were comparable in 
men consuming margarine (n=84, daily, weekly or less than weekly) and men who had 
it occasionally or never (n=40); [32 ± 21.6 vs.32 ± 20.1, (Mean ± SD; Mann Whitney 
p=0.8)]. Furthermore the vitamin D levels were comparable in men consuming oily fish 
regularly (weekly and less than weekly, n=97) and who had it rarely or never (n=27) 
[31.4 ± 22.5 vs.31.4 ± 20, Mean ± SD; Mann Whitney p=0.6) 
 
Was vitamin D lower in participants with longer hours of indoor activity? Hours of 
indoor activity were significantly different between the vitamin D groups (p=0.01;Table 
27). Participants who spent more time indoors watching television or using a PC  (> 
three hours per day) had significantly lower levels of vitamin D nmol/l compared to 
participants who spent less than three hours doing the same [28.3,  (24.1 – 33.5) versus 
38.2, (31.5 - 44.9) Mean, (95% CI); Independent sample test p=0.01]. 
  
Was vitamin D higher in participants with longer hours of outdoor activity? Daily 
hours of outdoor activity were significantly different between the vitamin D groups 
(p=0.001; Table 27). Participants who spent less than 1 hour  outdoors  had significantly 
lower levels of vitamin D nmol/l compared to spending one to three hours [Mean, (95% 
CI)  21.9 (30-42.7) versus 36.9 (30- 43.7); ANOVA post-hoc tukey p0.002] or more 
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than three hours at 36.3 (30-42.7) (ANOVA post-hoc tukey p=0.004). There was no 
significant difference in vitamin D levels between participants who spent 1 to 3 hours 
outdoors (per day) and those who spent over 3 hours.  
 
 
Was vitamin D lower in participants who used sun protection?  The use of sun 
protection was similar in all the vitamin D groups (p=0.71; Table 27) and did not alter 
the vitamin D status. Men who used sun protection (n= 73) had comparable vitamin D 
levels to men who rarely or never use sun protection (n=51) [31.7 ± 18.7 vs. 32.4 ± 23, 
Mean ± SD; Mann Whitney p=0.6). 
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               Table 27: Indicators of vitamin D status in the various groups 
               (Recent travel was to sunny places in the previous 3 months) 
Indicators of vitamin D 
status / Vitamin D group 
  
Vitamin D 
Deficiency 
<25nmol/l 
Vitamin D 
Insufficiency 
26-50nmol/l 
Vitamin D 
Adequate 
51-75nmol/l 
Vitamin D 
Optimal 
>75nmol/l 
P value 
Chi 
2
 
Recent travel 
 
Yes 6 (28.5%) 7 (33.3%) 5 (23.8%) 3 (14.2%)  0.03 
Vegetarian Yes   2 (100 %)  0  0 0   0.65 
No  50 (40.9%)  51 (41.8%)  15 (12.2%)  6 (4.9%) 
Margarine 
 Daily   13 (35.1%)  18 (48.6%)  4 (10.8%)  2 (5.4%)  0.94 
Weekly  8 (36.3%)  11 (50.0%)  2 (9.0%)  1 (4.5%) 
Less than wkly  13(52.0%)  8 (32.0%)  3 (12.0%)  1 (4.0%) 
Never  18 (45.0%)  14 (35.0%)  6 (15.0%)  2 (5.0%) 
Oily fish intake 
Weekly 14 (36.8%)  17 (44.7%) 4 (10.5%) 3 (7.8%)  0.76 
Less than wkly 26 (44.0%) 25 (42.3%) 7 (11.8%) 1 (1.6%) 
Occasional/ 
never 
 12 (44.4%) 9 (33.3%) 4 (14.8%) 2 (7.4%) 
Indoor activity < 3 hrs / day  13 (28.2%) 21 (45.6%) 9 (19.5%) 3 (6.5%) 0.01 
> 3 hrs / day  39 (50.0%) 30 (38.4%) 6 (7.6%) 3 (3.8%) 
Outdoor activity 
<1 hr / day  27 (69.2%) 9 (23.0%) 3 (7.6%) 0  0.001 
1 -3 hrs / day  12 (27.2%) 24 (54.5%) 4 (9.0%) 4 (9.0%) 
> 3 hrs / day  13 (31.7%) 18 (43.9%) 8 (19.5%) 2 (4.8%) 
Sun protection 
Usually   16 (51.6%) 9 (29.0%) 4 (12.9%) 2 (6.4%) 0.71 
Sometimes  15 (35.7%) 20 (47.6%) 6 (14.2%) 1 (2.3%) 
Rare / never  21 (41.1%) 22 (43.1%) 5 (9.8%) 3 (5.8%) 
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6.7.2.4 Characteristics of men in the vitamin D groups  
 
The characteristics of the men in the four vitamin D groups are shown in the Table 28. 
Age and BMI were comparable between vitamin D groups. The type of subfertility 
(primary or secondary), cause of subfertility (male factor, combined male and female 
factors and non-male factor), fever in the previous 3 months, alcohol consumption, 
smoking and intake of regular medication were comparable between the 4 vitamin D 
groups (p>0.05). 33 men in the study had risk factors potentially affecting semen 
parameters (Table 29) and some of them had more than one risk factor, however they 
were comparable in numbers in the four vitamin D groups.  14 men took vitamins or 
nutrients other than vitamin D, but none were in the vitamin D optimal group, however 
number of participants in this group was low. Vitamins C, E, selenium and zinc were 
the most common supplements, whilst the intake of omega fatty acids, carnitine, 
largitine, lycopene, B complex vitamins and folic acid was also noted. Eight men (8/14; 
57%) were on more than one nutrient, yet the frequency of intake of nutrients was not 
statistically different between the vitamin D groups.
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Variable  Vitamin D 
Deficiency 
<25nmol/l 
Vitamin D 
Insufficiency 
26-50nmol/l 
Vitamin D 
Adequate 
51-75nmol/l 
Vitamin D 
Optimal 
>75nmol/l 
P value 
Participants N=124 
 
  
 52 (41.9%) 51 (41.1%) 15 (12.1%) 6 (4.8%)  
Age (years) (Mean ± SD)  34 ± 4.3 35 ± 6.6  32.8 ± 5.5 30.8 ± 5.4  0.24 (ANOVA) 
BMI (Kg/m2) (Mean ± SD)  27.3 ± 3.6 28.2 ± 3.8 26.3 ± 2.9 24 ± 1.8 0.51 (Kruskal Wallis) 
 Subfertilty 
 n (%) 
Primary 38 (39.5%) 39 (40.6%) 14 (14.5%)  5 (5.2%) 0.44 (chi
2 
) 
Secondary 14 (50.0%) 12 (42.8%) 1 (3.5%) 1 (3.5%)  
Cause of subfertility n (%) Male factor 14 (36.8%) 16 (42.1%) 5 (13.1%)  3 (7.8%) 0.91 (chi
2 
) 
Male + female 
factors 
7 (46.6%) 6 (40.0%) 1 (6.6%) 1 (6.6%) 
Other factors 31 (43.6%) 29 (40.8%) 9 (12.6%) 2 (2.8%) 
Recent fever  5 (71.4%) 2 (28.4%) 0 0 0.38 (chi
2 
)  
Alcohol None 18 (54.5%) 13 (39.3%) 2 (6.0%) 0 0.22 (chi
2 
)  
<21 IU / wk 32 (37.6%) 34 (40.0%) 13 (15.2%) 6 (7.0%) 
>21 IU / wk 2 (33.3%) 4 (66.6%) 0  0 
Smokers  8 (50.0%) 5 (31.2%) 3 (18.7%) 0 0.54 (chi
2 
)  
Intake of Regular medication  9 (40.9%) 7 (31.8%) 4 (18.1%) 2 (9.0%) 0.50 (chi
2 
)  
Intake of vitamins / nutrients  5 (35.7%) 8 (57.1%) 1 (7.1%) 0 0.53 (chi
2 
)  
Other risk factors    n (%)  13 (39.3%) 14 (42.4%) 4 (12.1%) 2 (6.0%) 0.98 (chi
2 
)  
Table 28:  Characteristics of 124 men by serum vitamin D groups 
BMI was missing in 18 participants; Sub fertility – primary / secondary; Recent fever– in the past 3 months; Intake of vitamins / nutrients: other than 
vitamin D; continued… 
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(continued: Other risk factors include – medical problems like primary testicular failure, cystic fibrosis carrier, surgical problems like orchidopexy, 
orchidectomy, vasectomy reversal, varicocele inguinal hernia repair,  sexually transmitted infections like chlamydia, gonorrhoea, non-specific 
urethritis and use of recreational drugs in the recent past).
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Risk factors Number of participants 
Past chlamydial infection 11 
Undescended testis / Orchidopexy 11 
Inguinal hernia operation 5 
Orchidectomy  3 
Previous gonorrhoea  1 
Nonspecific Urethritis  1 
Cystic fibrosis carrier 1 
Vasectomy reversal  1 
Varicocele 1 
Previous chemotherapy 1 
Primary testicular failure 1 
 
Table 29: Risk factors in the participants.
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6.7.2.5 Vitamin D and semen parameters 
 
The semen parameters of men in all the vitamin D groups are shown in Table 30. There 
was no significant difference in the various parameters i.e. semen volume, sperm 
concentration, total sperm count, motile concentration, progressive motile 
concentration, progressive motility, total motility and morphology between the vitamin 
D groups. 
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Semen parameters 
Median  (25 -75 
percentile) 
 
 
Vitamin D 
Deficiency 
<25nmol/l 
 
Vitamin D 
Insufficiency 
26-50nmol/l 
 
Vitamin D 
Adequate 
51-75nmol/l 
 
Vitamin D 
Optimal 
>75nmol/l 
 
Kruskal 
Wallis 
test 
P value 
Spearman 
Correlation 
P value  
Multiple 
linear 
regression 
P value 
Participants   N=124  52 (41.9%) 51 (41.1%) 15 (12.1%) 6 (4.8%)    
Semen volume (ml) 2.9 (2.0-3.8) 2.5 (2.0-3.5) 3.3 (2.0-4.5) 2.6 (1.8-3.8) 0.75 0.69 0.89 
Sperm concentration 
(millions/ ml) 
71 (32- 133) 54 (24-112) 78 (3-123) 19 (2- 51) 0.12 0.13 0.41 
Total sperm count 
(millions/ml) 
233 (77- 356) 144 (55-260) 220 (7-416) 42 (6- 204) 0.12 0.15 0.49 
Motile concentration 
(millions/ml) 
51 (25- 92) * 36 (10-77) 37 (2 – 89) 12 (1-37) 0.11 0.08 0.41 
Progressive motile 
concentration 
(millions/ml)  
44 (17-79) * 31 (9-65) 31 (1-66) 9 (1-32) 0.10 0.07 0.37 
Progressive motility (% ) 62 (43-69) * 55 (45-64) 49 (24-65) 55 (29-68) 0.39 0.29 0.58 
Total motility (% ) 72 (55-79) * 67 (58-75) 67 (53-72) 63 (49-79) 0.57 0.36 0.57 
Morphology (% ) 9 (3-11) 8 (3-11) 7 (0-9) 4 (0-8) 0.15 0.21 0.17 
 
 
Table 30: Semen parameters of 124 men divided by the vitamin D groups  
(* motility parameters were missing for 1 participant in vitamin D deficient group); Details of the co-variates in the following page. 
 
 163 
 
 The relevant co- variates (i.e. p ≤ 0.15) for each semen parameter used in the regression models are: semen volume: age and BMI; sperm 
concentration: ethnicity, cause of sub fertility, presence of risk factors, and alcohol consumption; total sperm count: age, cause of sub fertility, 
presence of risk factors, alcohol consumption, smoking, and intake of vitamins/nutrients; total motile concentration: ethnicity, cause of sub fertility, 
presence of risk factors, alcohol consumption and intake of vitamins/nutrients; Progressive motile concentration: ethnicity, type of subfertility cause of 
sub fertility, presence of risk factors, alcohol consumption and intake of vitamins/nutrients; progressive motility: type of subfertility, cause of sub 
fertility, presence of risk factors, and recent fever; total motility: type of subfertility, cause of sub fertility recent fever and intake of vitamins/nutrients; 
morphology: age, type of subfertility, cause of sub fertility, presence of risk factors and alcohol.
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6.7.3 Follow up   
87/125 (69.6%) of the participants returned for follow up. 8/87(9%) participants were 
reviewed when they attended their scheduled clinic follow up and 13/87 (15%) 
participants were on their subsequent IVF treatment cycle at follow up and were seen on 
their egg collection day. The remaining participants 66/87 (76%) were reviewed in the 
research clinic. 
 
6.7.3.1 Participants who did not return for follow up 
38 participants did not return for follow up. On reviewing the notes the factors 
identified are detailed in Table 31. 
 
Overall, 31 (81.5%) of the participants who failed to return for the follow up 
appointment did not need, decided against or could not afford further IVF treatment and 
so decided to drop out of the study. 2 participants (5.2%) moved out of the area for 
work reasons. Only 5 (13.1%), were still receiving treatment at the centre, but decided 
not to return for the research follow up.
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Reason Number of participants 
Partner pregnant 11 
Completed NHS funding  8 
Couple on a break from treatment 4 
Lost to follow up from clinic 3 
Self-funded treatment 3 
No response when contacted 3 
Couple split up 2 
Others* 4 
 
          Table 31: Participants failing to return for follow up 
 
* Return to Army-1, moved to China-1, Opted out of the research because of         
needle phobia – 1, Unable to attend -1.
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6.7.4 Cohort study 
For further analysis, all the participants who returned for follow up were stratified into 
two groups based on their initial vitamin D level. These were: vitamin D deficient group 
i.e. <25nmol/l (37/ 87) and vitamin D non-deficient group i.e. > 25nmol/l (50/87). The 
return rate was comparable between vitamin D deficient participants (37/52) and 
vitamin D non-deficient participants (50/73) (71% vs. 68.4% Fisher's exact test: p value 
= 0.8) 
 
6.7.4.1 Vitamin D deficient participants 
 
6.7.4.1.1 Improvement in vitamin D levels with various treatment regimens 
37/52 (71%) of vitamin D deficient participants returned for follow up. Amongst the 37 
participants, 36 received vitamin D supplementation. The one participant who did not 
receive supplementation had a seasonal improvement in his vitamin D level from 
11nmol/l (November) to 29nmol/l (May). The average interval between the two visits in 
this group was 175.6 ± 14.3 days (Mean ± SD). 
 
The GPs of the vitamin D deficient participants were recommended to prescribe a 
supplementation regime with loading dose of 20,000 IU  Cholecalciferol three times a 
week for 6 – 8 weeks, followed by a maintenance dose of Cholecalciferol 1000 IU per 
day  (Treatment Group 1, 12 participants). The suggested regime was only a 
recommendation and some of the GPs preferred their own regime which was essentially 
prescribing the loading dose only (Treatment Group 2, 16 participants) or eliminating 
high dose vitamin D  loading treatment and prescribing  vitamin D 800IU per day with 
calcium (Treatment Group 3, 8 participants). Some participants preferred to buy their 
own over the counter vitamin preparations and are also included in treatment group 3. 
 
 
All treated participants had an improved vitamin D with supplementation, with levels 
rising to above 25nmol/l except one participant, where the rise was from <10nmol/l to 
17 nmol/l only. This participant was a non-Caucasian student who used over the counter 
preparations. The vitamin D levels nmol/l (Mean ± SEM) were significantly lower in 
treatment group 3 (45.7 ± 7.9) compared to treatment group 1 (105 ± 5.8) and treatment 
group 2 (93.1 ± 9.4) (One way ANOVA p <0.005) as shown in Figure 11. There was no 
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significant difference between treatment group 1 and treatment group 2 participants in 
each of which received the vitamin D loading treatment. 
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Figure 11:  Serum vitamin D levels achieved in vitamin D deficiency participants in 
various treatment groups 
Shows serum vitamin D levels achieved in vitamin D deficiency participants in various 
treatment groups. Mean levels of each group are shown by shaded circle. Each box plot 
(First Quartile to third quartile) shows the median and whiskers represent lowest to 
highest values. (Treatment group 1: Vitamin D loading with maintenance dose, 
Treatment group 2: Vitamin D loading without maintenance dose and Treatment group 
3: GP regime or over the counter vitamin preparations) 
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6.7.4.1.2 Semen parameters following vitamin D supplementation in vitamin D 
deficient participants 
 
In the 36 men who received vitamin D supplementation, serum 25(OH)D levels  
improved significantly from 14 (9.9-16.7) to 82 (63.2-114.2) (nmol/l; Median with 25
th
 
and 75
th
 centiles p<0.005). The semen parameters at the diagnosis of vitamin D 
deficiency and after vitamin D supplementation are shown in the Table 32. Sperm 
concentration, total count, motile concentration, progressive motile concentration, 
progressive motility, total motility and morphology declined significantly with 
supplementation whilst there was no significant difference in semen volume. A single 
participant reported an abstinence of less than 24 hours in the follow up phase. After 
excluding the participant from the analysis the conclusions still remained the same as 
above.
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         N=36; Variables 
 
First phase 
Median  (25 -75 percentile) 
After  vitamin D supplementation 
Median  (25 -75 percentile) 
Wilcoxon signed 
rank test 
Vitamin D (nmol/l) 
 
14.0 (9.9-16.7) 82.0 (63.2-114.2) <0.005 
Semen volume (ml) 2.5 (2.0-4.0) 2.4 (1.5-3.5) 0.33 
Sperm concentration (millions/ml) 85 (34-136) 52 (16-88) <0.005 
Total sperm count (millions/ml) 262 (88-416) 108 (24-233) 0.001 
Motile concentration (millions/ml) 63 (26-97) 31 (7-58) <0.005 
Progressive motile concentration (millions/ /ml)  53 (18-79) 25 (4-53) <0.005 
Progressive motility (% ) 62 (43-69) 49 (31-60) 0.002 
Total motility (% ) 72 (53-79) 60 (43-71) 0.001 
Morphology (% ) 8 (2-11) 5 (1-10) 0.001 
 
Table 32: Vitamin D and Semen parameters in the 36 vitamin D supplemented men  
 
Table shows serum vitamin D and semen parameters at initial recruitment in 36 vitamin D deficiency participants and following vitamin D 
supplementation 6 months later are shown. 
  
(Motility parameters were missing for participant 68 in the first phase i.e. at the diagnosis of vitamin D deficiency, therefore N=35 for motility 
parameters)
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6.7.4.2 Vitamin D non-deficient participants 
 
68.4% (50/73) of vitamin D non-deficient participants returned for follow up. Two 
participants had to be excluded from the analysis as one follow up vitamin D sample 
was lost in transit to the laboratories and the other participant revealed that he was on 
cod liver oil capsules at the time of initial recruitment (although he had stopped by the 
time of follow up). The average time interval between the first (Winter/Spring) and 
follow up (Summer/Autumn) visit was 180 ± 23 days (Mean ± SD). There were 7 
participants whose duration between the appointments was outside the mean ± 1SD 
(157 to 203 days).  The duration between the appointments for these participants was 
70, 133, 153, 156, 207, 209 and 217 days respectively. 
 
Semen parameters with seasonal rise in vitamin D levels in Vitamin D non deficient 
participants 
 
There was a significant seasonal rise in serum 25(OH)D levels (Median, 25th-75th  
centile ) from Winter/Spring to Summer/Autumn (41 (31-59) vs. 62 (52-76) nmol/l 
p<0.005). The results of the semen parameters following the seasonal rise in vitamin D 
levels are shown in the Table 33. 
 
Sperm concentration, total count, motile concentration, progressive motile 
concentration, progressive motility, total motility and morphology declined significantly 
with seasonal rise in serum vitamin D levels whilst semen volume did not change.
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            Table 33: Semen parameters with seasonal rise in vitamin D levels 
 
Serum vitamin D and semen parameters at the initial recruitment in winter / spring in 48 vitamin D non deficient participants and 6 months 
later in summer / autumn are shown.
N=48 
 
Variables 
Season 1 (Winter / spring)  
 
Median  (25 -75 percentile) 
Season 2 (Summer / 
Autumn)   
Median  (25 -75 percentile) 
Wilcoxon 
signed rank test 
Vitamin D (nmol/l)  
 
41 (31-59) 62 (52-76) <0.005 
Semen volume (ml) 2.6 (2.0-3.4) 2.6 (2.0-4.0) 0.97 
Sperm concentration (millions/ml) 54 (16-92) 29 (4-67) <0.005 
Total sperm count (millions/ml) 162 (37-279) 97 (10-228) 0.002 
Motile concentration (millions/ml) 36 (10-70) 16 (2-41) <0.005 
Progressive motile concentration (millions/ ml)  31 (7-63) 12 (2-36) <0.005 
Progressive motility (% ) 54 (45-68) 43 (34-59) 0.01 
Total motility (% ) 68 (57-74) 56 (492-70.7) 0.01 
Morphology (% ) 7 (3-9) 5 (2-8) 0.008 
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All the participants had two sets of vitamin D levels and semen variables in 
Winter/Spring (season 1) and Summer/Autumn (season 2) each, except for four 
participants (seasonal mismatch). Two participants who were first seen in Autumn 
(November) were followed up with a slight delay in Summer instead of Spring (June 
instead May). The other two who were first seen in Winter (December, February) were 
followed up slightly earlier in Spring (May) instead of Summer. The samples from these 
four participants were allocated to the appropriate seasons (1/2) depending on the 
maximum exposure of the season.  Statistical analysis lead to similar conclusions even 
after excluding these four participants from the analysis (n=44) (Results not shown). 
  
Ten participants went on holidays abroad to sunny places in the previous 3 months of 
their recruitment which could have potentially increased their serum vitamin D levels at 
the time. Exclusion of these 10 participants from the analysis (n=38) also revealed 
similar results. Similarly excluding participants with seasonal mismatch and who had 
been on holidays concurrently (n=35) also revealed results as above.  
 
6.7.5 Annual seasonal variation of vitamin D  
 
We combined the results of the longitudinal study to investigate annual seasonal 
variation of vitamin D. Potentially we had 176 results, 125 results from the initial 
recruitment study and 51 results from the follow up study after excluding men who 
received vitamin D supplementation (36).The participant who had been on cod liver oil 
was excluded, even though he informed that he discontinued the preparation for at least 
4 months prior to the follow up. There was one missing vitamin D level lost in transit to 
the laboratories. Finally there were 173 vitamin D results from 124 participants.  
 
The monthly vitamin D levels gradually increased from January to July and decreased 
thereafter till January as shown in Figure 12. The serum vitamin D levels are 
significantly higher in Summer compared to Winter and Spring (p<0.005) [Table 34]. 
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Figure 12: Monthly variation of serum vitamin D levels 
Monthly variation of the median vitamin D is shown in box-plot graph. Each box plot 
(First Quartile to third quartile) is bisected by the median. The upper whisker extends to 
the highest data value within the upper limit [Q3 + 1.5 (Q3 - Q1)] and the lower 
whisker extends to the lowest value within the lower limit [Q1- 1.5 (Q3 - Q1)]. 
 
The details of the outliers are Month 3: participant used a sunbed once a week; Month 
11: Holiday within 3 months to a sunny place; Month 12:  no obvious cause. 
 
 
 
 
 
Season Number of 
vitamin D results 
Serum vitamin D level (nmol/l)  
Median (25
th
-75
th
 centiles) 
Winter (Dec- Feb) 54 17.5 (12.7-34) 
Spring (Mar-May) 61 36 (21-58.5) 
Summer (Jun-Aug) 17 65 (57.5-87.5) 
Autumn (Sep-Oct) 41 52 (39.5-67) 
 
  Table 34: Seasonal variation of vitamin D levels – Annual pattern  
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6.7.6 Is there a threshold for Vitamin D to be achieved to influence semen 
parameters? 
We hypothesized that serum vitamin D may need to improve to optimal levels to affect 
semen parameters. We did a subgroup analysis of the vitamin D deficient participants 
whose vitamin D levels improved to optimal levels (≥ 75nmol/l), however the limitation 
was a smaller sample size.  There were 23 participants in this group. The vitamin D 
levels [nmol/l, Median (25th -75th centile)] in this group improved significantly from 
16 (12-18) to 106 (84-128). There was a significant deterioration in the sperm 
concentration, motile concentration, progressive motile concentration, progressive 
motility, total motility and morphology with improvement in vitamin D levels to 
optimal levels (Table 35). There was no significant difference in the semen volume. 
Although the total count deteriorated with the improvement in vitamin D levels, this did 
not reach statistical significance which is most likely due to the small sample size.  
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N=23 
Variables 
First phase 
Median (25
th
-75
th
 centile) 
After  vitamin D 
supplementation  
Median (25th-75th centile) 
 
Wilcoxon 
Signed Ranks 
test 
Vitamin D (nmol/l) 
 
16 (12-18) 106 (84-128) <0.005 
Semen volume (ml) 2.3 (2.0-3.5) 2.5 (1.5-3.6) 0.70 
Sperm concentration (millions/ml) 89 (47-134) 53 (19-103) 0.01 
Total sperm count (millions/ml) 261 (81-335) 161 (48-234) 0.06 
Motile concentration (millions/ml) 66 (27-101) 34 (12-66) 0.004 
Progressive motile concentration (millions/ml)  63 (19-96) 27 (8-62) 0.01  
Progressive motility (% ) 62 (47-72) 19.5 (31-60) 0.01 
Total motility (% ) 74 (58-79) 64 (47-71) 0.009 
Morphology (% ) 9 (3-12) 6 (1-10) 0.01 
 
Table 35: Semen parameters in men with vitamin D deficiency that improved to optimal levels with supplementation
 176 
 
6.7.7 Is high vitamin D (>125nmol/l) associated with a negative impact on semen 
parameters? 
 
A study from USA has shown that high serum vitamin D levels (>125nmol/l) were 
associated with poor semen parameters (Hammoud et al., 2012). There were 6 
participants in the vitamin D supplemented men with serum vitamin D levels above 
125nmol/l. As analysing the variation in semen parameters in this small group before 
and after vitamin D supplementation will not give us any valid conclusions, we instead 
excluded them from the vitamin D supplemented men (n=36, section7.4.1) to 
investigate if the deterioration in semen parameters seen in this group of men was not so 
obvious. 
 
We therefore had 30 participants in this analysis who had a rise in serum vitamin D 
levels with supplementation for deficiency, but not to above 125nmol/l. The serum 
vitamin D level [nmol/l, Median (25
th
 -75
th
 centile)] improved significantly from 13 
(9.9-16.2) to 76.5 (53.7-95.7). All the semen parameters still deteriorated significantly 
(except semen volume) with rising vitamin D levels as shown in the Table 36.
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N=30 
Variables 
 
First phase 
Median (25
th
 -75
th
 centile) 
After  vitamin D supplementation  
Median (25th -75th centile) 
 Wilcoxon Signed 
Ranks Test 
Vitamin D (nmol/l) 13.0 (9.9-16.2) 76.5 (53.7-95.7) <0.005 
Semen volume (ml) 2.5 (2.0-4.0) 2.2 (1.4-3.2) 0.053 
Sperm concentration (millions/ml) 81 (34-131) 49 (14-66) <0.005 
Total sperm count (millions/ml) 236 (80-382) 104 (20-215) <0.005 
Motile concentration (millions/ml) 54 (25-93) 24 (6-45) <0.005 
Progressive motile concentration (millions/ml)  47 (17-77) 20 (2-43) <0.005 
Progressive motility (% ) 59 (42-67) 46 (28-61) 0.008 
Total motility (% ) 71 (53-79) 61 (41-70) 0.005 
Morphology (% ) 8 (2-11) 4 (1-10) 0.001 
 
Table 36: Vitamin D and Semen parameters in the 30 vitamin D supplemented men 
 
Table shows the serum vitamin D and semen parameters in 30 vitamin D supplemented men with improvement in vitamin D levels up to 125nmol/l. 
 
(Motility parameters were missing for participant 68 in the first phase, therefore N=29 for motility parameters); (First phase is at the diagnosis of 
vitamin D deficiency)
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6.8 Discussion 
We investigated the correlation between semen parameters and serum vitamin D in a 
cross sectional association study involving 124 participants attending our infertility 
clinic and also examined the change in semen parameters with a rise in serum vitamin D 
level, both with seasonal rise and vitamin D supplementation. This is the first 
longitudinal study involving serum vitamin D and semen parameters. 
 
It is well known that participation in semen studies is generally low (Meeker et al., 
2006) and sometimes necessitates  financial incentives to improve recruitment 
(Hammoud et al., 2012). Furthermore longitudinal semen studies are sparse as they can 
be expensive and challenging with high dropout rates as they need substantial 
participant time and cooperation (Mortimer et al., 1983; Sánchez-Pozo et al., 2013). 
45.7% of the men approached for participation in this study were recruited which is 
considered high for semen studies (Ramlau-Hansen et al., 2011) as generally the 
recruitment rate is in the range of 13-19% (Cooper et al., 2010). The return rate for the 
study population was just under 70%. As the majority of our participants were National 
Health Service (public) patients and were not paid expenses to cover the costs of the 
visits, we feel that our return rate is creditable. A couple of longitudinal seasonal semen  
studies have shown return rates of up to 85%, where financial incentives were used 
(Levine et al., 1990; Levine et al., 1992). 
 
The only two exclusion criteria for recruiting men were azoospermia or already using 
vitamin D supplements. Men with severe oligospermia were included as a change in 
semen parameters in this group could be clinically significant. 
 
There was significant vitamin D deficiency in men attending our fertility centre. The 
prevalence of vitamin D deficiency in Winter and Spring was almost three times the UK 
national prevalence of 16% (Hyppönen and Power, 2007). Although the prevalence of 
hypovitaminosis D  increases as one moves north in the UK, with the highest rates seen 
in Northern Ireland, Scotland and northern England (including the catchment area of our 
clinic) (Hyppönen and Power, 2007), the prevalence of  hypovitaminosis D (i.e. serum 
vitamin D  <40nmol/l) is higher in men attending the fertility clinic in Winter and 
Spring (79.6% and 64%) when compared to the reported regional prevalence (50-60% 
in winter and 30-40% in spring). A confounding factor however is that the national 
British survey included only white British participants, whilst in our study 12% were 
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non-Caucasians. However after excluding the at risk non-Caucasian population, we still 
identified a very high prevalence of hypovitaminosis D in the Caucasian population 
at77.7% and 60% in Winter and Spring respectively. Whether men attending the 
fertility clinic are also a risk group for hypovitaminosis D needs further study. 
 
 As expected men who spend less time indoors (<than 3 hours a day), more time 
outdoors (>1 hour) had significantly higher levels of serum vitamin D. It is estimated 
that two to three exposures to sun light of thirty minutes duration per week to the face 
and forearms at midday between April to October is sufficient to achieve healthy 
vitamin D levels (Department of Health, 1998). However, as the majority of the 
participants were recruited in Winter and Spring, there was no difference in the vitamin 
D levels in participants who spent between 1 and 3 hours outdoors, and those who spent 
over 3 hours. In our study participants who had travelled to sunny places in the recent 
past had significantly higher levels of serum vitamin D, similar to previous findings 
(Gagnon et al., 2010). 
 
As oily fish is a rich source of vitamin D, its consumption can significantly raise 
vitamin D levels (Holvik et al., 2004), however this was not shown in our study. This is 
most likely due to small sample size. The consumption of margarine (fortified with 
vitamin D) also did not significantly improve the levels, which was consistent with a 
large scale British survey, although the survey did note that the risk of vitamin D 
deficiency was much less in the cohort consuming margarine daily (Hyppönen and 
Power, 2007). The use of sun protection did not alter the vitamin D status in our study 
similar to other studies where sunscreen use was self-reported (Gagnon et al., 2010).  
Sun protection is  generally associated with reduced vitamin D synthesis (Matsuoka et 
al., 1987). In contrast, studies have shown increased vitamin D levels in the cohort 
using sun protection (Hyppönen and Power, 2007), suggesting that the level of sun 
exposure is also high in individuals using sun protection in turn contributing to 
increased production. Also improper (not thick) or infrequent sunscreen use may also 
not block vitamin D production (Macdonald, 2013). 
 
It has to be acknowledged however that the information on some factors influencing 
vitamin D levels (time spent indoors or outdoors, intake of vitamin D foods, use of sun 
protection) are a crude estimation by the participant at the time of the questionnaire and 
this may have affected the results. Furthermore, the study size is also small which again 
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may have affected the results. A couple of participants used a sunbed once per week and 
had good levels of serum vitamin D (74 and 114nmol/l). Studies have shown that 
regular use of a sun bed that emits UVB between 290-315nm increases vitamin D levels 
and bone mineral density (Tangpricha et al., 2004; Armas et al., 2007). 
 
Vitamin D levels improved gradually from January to July and thereafter gradually 
declined to December. The highest vitamin D levels were seen in July, whilst in the 
British survey it was September (Hyppönen and Power, 2007).This variation is possibly 
due to smaller sample size in our study, although seasonal variation of vitamin D was 
consistent with the survey. 
 
Participants with vitamin D deficiency (<25nmol/l) were treated with supplementation. 
Vitamin D levels above 75nmol/l are optimal for bone health and profound vitamin D 
deficiency can lead to osteomalacia (Souberbielle et al., 2006; Hyppönen and Power, 
2007; Pearce and Cheetam, 2010). As patients with vitamin D deficiency are generally 
advised supplementation to protect against bone disease (DeLuca, 2004; Dawson-
Hughes et al., 2005), so were the participants in this study. Vitamin D levels improved 
significantly when a loading dose was given with or without a maintenance regime, as 
this restores body stores. In the absence of a maintenance dose, participants appear to 
have utilised lifestyle advice as serum levels of vitamin D were maintained. The loading 
dose of vitamin D significantly improved the serum levels compared to just receiving 
maintenance vitamin D therapy, although a maintenance dose also improved the levels 
considerably. 
 
There is no previous completed study which has investigated the effect of vitamin D 
supplementation on semen parameters. There has been a single randomised, double 
blind, placebo controlled study investigating the potential use of vitamin D on semen 
parameters using Elocalcitol, a vitamin D3 analogue intended primarily to treat benign 
prostatic hyperplasia and the overactive bladder. As the manufacture of Elocalcitol was 
terminated by the company producing it, (in view of the disappointing results found in 
its treatment of the over active bladder), the trial for male subfertility ended early in 
phase IIa (Tiwari, 2009). A clinical trial is currently underway by Blomberg et al’s 
group to investigate the effect of vitamin D supplementation on semen parameters in 
subfertile men (Clinical Trials.gov Identifier: NCT01304927). 
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In the cohort study, vitamin D levels improved not only with vitamin D 
supplementation but also with the seasonal rise. The vitamin D levels with 
supplementation improved to 82 (63.2-114.2) as opposed to the seasonal improvement 
of 62 (52-75.7) (nmol/l; Median with 25th and 75th centiles). As supplemented men 
also would have benefitted with season and generally there is an increase of 1nmol in 
25(OH)D for each µg of supplementation (Heaney, 2008), it appears that the men in the 
supplemented group received approximately an additional 20µg (800IU) per day of 
vitamin D compared to seasonal rise group. 
 
In the association study there was no significant difference in the various semen 
parameters between the vitamin D groups, although the numbers of men with adequate 
(15) and optimal levels (6) of vitamin D were low. Sperm counts and morphology were 
lower in the optimal (>75nmol/l) vitamin D group compared to other three groups but 
this did not reach statistical significance. These findings are similar to the cross 
sectional association study by Ramlau-Hansen et al. (2011) on 307 young healthy 
Danish men aged between 18-21 years, which showed no association between serum 
vitamin D levels and semen parameters. 
 
 Conversely in another association study on Danish men of similar study size and group, 
there was a weak positive but significant association between serum vitamin D level and 
sperm motility (both progressive and total motility). The motility was significantly 
better in men with optimal levels of vitamin D compared to vitamin D deficient men, 
but not compared to men with insufficient or adequate vitamin D levels. It appeared that 
vitamin D deficient men had a low percentage of normal sperm, but after adjusting for 
the confounders this was non-significant. There was no association between vitamin D 
and semen volume or sperm count in this study (Blomberg Jensen et al., 2011). 
 
Of note, our association study has a higher number of participants with vitamin D 
deficiency when compared to subjects recruited in other vitamin D/semen parameters 
association studies (Blomberg Jensen et al., 2011; Ramlau-Hansen et al., 2011; 
Hammoud et al., 2012). The semen parameters in this vitamin D deficient group were of 
higher quality compared to the participants in the rest of the three vitamin D groups. 
Ramlau-Hansen et al. (2011) study suggested that low vitamin D (i.e. between 8-
62nmol/l in their study group) was not a risk factor for poor semen parameters, however 
the study only had 19 participants with vitamin D deficiency i.e. <25nmol/l in this 
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group. From our study it does appear that serum vitamin D deficiency (<25nmol/l) is 
not associated with reduced semen parameters. 
 
Sperm count, motility and morphology deteriorated significantly with increased serum 
vitamin D levels secondary to vitamin D supplementation and seasonal rise. Vitamin D 
supplementation improved vitamin D status essentially from deficient to optimal levels 
and with seasonal rise, the vitamin D levels improved essentially from insufficiency to 
adequate vitamin D status in a gradual manner. However both these interventions led to 
a similar deterioration in semen parameters. 
 
There is some evidence that higher serum vitamin D levels are associated with lower 
sperm parameters. In Ramlau-Hansen et al. (2011) study it appeared that men with high 
vitamin D (i.e. between 94- 227nmol/l in their study group) had lower sperm counts and 
a lower percentage of normal sperm morphology, but after transforming the data and 
adjusting for the confounders as mentioned previously there was no association between 
serum vitamin D and semen parameters. In another association study by Hammoud et 
al. (2012), conducted in Salt Lake, Utah involving 147 healthy men with no male factor 
subfertility; sperm concentration, progressive sperm motility, sperm morphology and 
the total progressive motile sperm count were lower in men with high concentrations of 
vitamin D, but this group included only men with a serum vitamin D levels above 
125nmol/l. Unlike our study, they also found worse sperm parameters (total progressive 
motile sperm count and total sperm count) in men with a serum vitamin D of less than 
50nmol/l. They suggested a ‘U’ shaped association between vitamin D levels and semen 
parameters similar to the association seen between vitamin D and some non-skeletal 
conditions such as  cardiovascular disease and pancreatic cancer  (Ross et al., 2011; 
Hammoud et al., 2012; Rosen et al., 2012). 
 
All the above association studies recruited healthy young men whereas we recruited 
men attending an infertility clinic. Some form of male factor (by itself or combined with 
a female factor) was noted in 43% of the study group, and whether this is the reason for 
such a marked deterioration in most of the semen parameters is unclear. Analysing this 
group separately would further decrease the study size, making the validity of any 
results uncertain. Studies have shown that subfertile men display variability in the 
expression of VDR or response to vitamin D when compared to fertile men. Subfertile 
men have a lower expression of VDR and vitamin D metabolizing enzymes in testis and 
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sperm compared to normal men (Aquila et al., 2009; Foresta et al., 2011; Blomberg 
Jensen et al., 2012). In the study by Foresta et al. (2011) men with normal testicular 
function had significantly higher levels of CYP2R1 gene expression in the testis 
compared to men with oligoazoospermia. 
 
In a further small cross sectional association study by Blomberg Jensen et al. (2012), of 
70 men (involving 25 sub-fertile and 45 young men), progressive sperm motility was 
significantly higher in the vitamin D non-deficient group (>25nmol/l) at 60% compared 
to the vitamin D deficiency group at 51%. There was no statistical difference in other 
semen parameters (i.e. sperm concentration, total motility and morphology) between the 
groups. Although they had only 2 vitamin D groups in this study and included fertile 
and subfertile men, the results corroborated with  their previous study involving 300 
healthy young men (Blomberg Jensen et al., 2011).  
 
In a large recent cross sectional association study by Yang et al. (2012) both subfertile 
(314) and fertile (195) men were included. Subfertile men included men who never 
fathered a child with time to pregnancy (TTP) longer than 12 months. Men whose 
partners had female factor subfertility were excluded and therefore this group comprised 
of subfertile men. Of note, idiopathic male factor subfertility was not an exclusion 
criterion. This is different to infertility clinic recruits who are a heterogeneous cohort of 
normal and subfertile men, as recruited in our study and Blomberg’s subset of 
participants in their immunocytochemistry study as mentioned above (Blomberg Jensen 
et al., 2012).  
 
Contrary to expectation from a potential lower VDR/enzyme expression in subfertile 
men, a significant positive association between serum vitamin D and sperm motility, 
sperm morphology, but not sperm concentration was seen in the subfertile men group. 
Surprisingly this positive association was seen only between vitamin D and sperm 
motility in fertile men. There was no association between sperm concentration and 
vitamin D in the fertile male group either. However in another small study recruiting 90 
men attending an infertility clinic, there was no correlation between vitamin D and 
semen parameters (Knopf et al., 2011). 
 
In a recent immunocytochemistry study by Blomberg Jensen et al. (2012), 77 men from 
infertility clinics and 53 healthy nineteen year old males (unknown fertility) were 
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recruited. Vitamin D inactivating enzyme (CYP24A1) expression in sperm correlated 
positively with semen parameters. A significantly higher proportion of sperm (25%) 
expressed CYP24A1 in the healthy control group compared to only 1% in the infertility 
clinic recruits. Furthermore a threshold of 3% sperm with positive CYP24A1 expression 
distinguished young men from infertility clinic recruits with a sensitivity of 66%, 
specificity of 78% and positive predictive value (PPV) of 98%. When men from couples 
with female factor subfertility were excluded from the infertility clinic recruits, the 
sensitivity, specificity and PPV increased even further. 
  
CYP24A1 expression gives an indirect estimate of adequate vitamin D levels for 
spermatogenesis as 1,25(OH)2D leads to transcription of CYP24A1 (by binding to 
VDRE’s in the CYP24A1 promoter region) as a part of the feedback mechanism 
(Haussler et al., 2011). However as serum vitamin D was similar in men with low 
(<3%) and high (>3%) CYP24A1 expression, it was suggested that the local vitamin D 
metabolism may influence CYP24A1 expression in sperm rather than systemic vitamin 
D levels (Blomberg Jensen et al., 2012). Cellular vitamin D responsiveness however is 
complex and not as tightly regulated as systemic vitamin D metabolism (Blomberg 
Jensen, 2012). Furthermore, in vitro experiments conducted by Blomberg Jensen et al. 
(2012) on 40 men, (22 young, 18 sub-fertile men) revealed that 1,25(OH)2D increased 
sperm motility in young men but not in sub-fertile men. 
 
The significant proportion of subfertile men (42.7%) may explain the lack of a positive 
association between vitamin D and semen parameters seen in our study. However, this 
still cannot explain the significant deterioration of all the semen parameters seen with a 
rise in serum vitamin D levels.  
 
Overall from the association studies published so far, the association between vitamin D 
and semen parameters appears to be inconsistent, varying from a positive association 
(Blomberg Jensen et al., 2011; Blomberg Jensen et al., 2012; Yang et al., 2012) to a ‘U’ 
shaped association (Hammoud et al., 2012) or to no association (Knopf et al., 2011; 
Ramlau-Hansen et al., 2011). Although association studies on subfertile men also 
showed a positive association, there is some in vitro experimental evidence that there is 
less expression of VDRs and related enzymes and a lack of improvement in sperm 
motility with vitamin D in subfertile men (Aquila et al., 2009; Foresta et al., 2011; 
Blomberg Jensen et al., 2012). 
 185 
Concomitant expression of receptors and metabolizing enzymes in Leydig cells 
suggests a possible role for vitamin D in hormone production (Blomberg Jensen et al., 
2010). As there was a positive association shown between serum vitamin D levels and 
androgens (Wehr et al., 2010a) it is possible that the effect on semen parameters could 
be androgen mediated. However four other studies showed no link or a negative 
association between serum vitamin D levels and androgens (Blomberg Jensen et al., 
2011; Ramlau-Hansen et al., 2011; Hammoud et al., 2012; Yang et al., 2012). In 
Knopf’s study a positive correlation between vitamin D and testosterone was noted, but 
only in men with low testosterone levels (Knopf et al., 2011). 
 
There is some supporting evidence for the negative association seen in our study from 
lab based studies. The association between vitamin D and sperm function (acrosin 
activity or sperm motility) in the in vitro studies appears to be dose dependent and 
importantly with higher concentrations of vitamin D these responses became either 
ineffective or inhibitory (Aquila et al., 2008; Blomberg Jensen et al., 2011). Although 
the vitamin D concentrations inducing the positive reaction in sperm in the in vitro 
experiments are close to physiological levels of serum vitamin D levels, it is possible 
that different concentrations of vitamin D can elicit varied responses in sperm. A 
possibility of receptor down regulation with higher levels of vitamin D hormones has 
also been suggested (Aquila et al., 2009).  
 
Importantly the functional significance of vitamin D induced sperm motility and 
acrosome reaction depends on the concentrations of vitamin D in seminal plasma 
(Blomberg Jensen, 2012) and little is known about seminal plasma vitamin D 
concentrations and their correlation to serum vitamin D levels. A discrepancy between 
serum and semen vitamin D cannot be ruled out. 
 
The variation in 25(OH)D measurements due to differences in the utilized assay 
technology is well known (Roth et al., 2008; Thienpont et al., 2012). Cut off 
measurements for vitamin D groups vary between studies also. Some divide study 
groups by the commonly used clinical classification of vitamin D status (Blomberg 
Jensen et al., 2011) as used in our study, whilst the study by Hammoud et al. (2012), 
merged vitamin D deficiency and insufficiency groups together and also created another 
group with a vitamin D higher than 125nmol/l. Ramlau-Hansen et al. (2011) divided 
men by tertiles of vitamin D levels. So variations in measurement techniques and 
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vitamin D group stratification may also have contributed to the variation in results seen 
between previous studies. As spermatogenesis starts about 72 days prior to semen 
sample collection, it has been suggested that serum vitamin D levels be checked a few 
months prior to the semen analysis to investigate the association  (Blomberg Jensen et 
al., 2011).  
 
The deterioration in semen parameters seen in our study associated with a rise in serum 
vitamin D level could be just due to a seasonal effect on semen parameters, independent 
of vitamin D, although whether semen parameters is subject to seasonal variation 
remains controversial and is discussed in detail in Chapters 4 and 5. The negative 
association seen in our study is intriguing and warrants future research to clarify. The 
presence of VDR and metabolising enzyme expression in the male genital tract raises 
the possibility of a role for vitamin D in human male reproduction, however the 
importance of these receptors and the role of vitamin D in spermatogenesis and the 
function of the male reproductive tract is still not completely understood and therefore 
the biological mechanisms are speculative.  
 
One of the hypotheses tested was that vitamin D should cross a threshold (≥ 75nmol/l 
i.e. on optimal level) before semen parameters improved, but a significant deterioration 
in semen parameters was still seen in patients achieving this level. 
 
6.9 Limitations of the study 
1. Semen sample: A high intra-individual variation in semen parameters (Carlsen et al., 
2004; World Health Organisation, 2010) and particularly in male partners of sub-fertile 
couples (Leushuis et al., 2010) is known.  Only one semen sample from each participant 
on each occasion (i.e. at recruitment and follow up) was collected, therefore potential 
intra-individual variability was not accounted for. Considering the difficulty in 
recruiting men for semen studies and particularly cohort studies (Sánchez-Pozo et al., 
2013), we anticipated problems with recruitment if four semen samples were to be 
requested from participants.  
 
The information on abstinence was not collected at the recruitment phase, although all 
men were given verbal and written instructions to maintain an abstinence of 2-7 days. It 
is important to acknowledge that couples attending for IVF treatment are known to 
follow the instructions given to them effectively. This is proven in the follow up phase, 
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as even though they were mainly attending for the research (where you can expect non-
compliance with instructions) and not their treatment, 86 of 87 participants maintained 
the recommended abstinence. Despite the effect of abstinence on semen volume, sperm 
concentration, motility and possibly morphology (Mortimer et al., 1982; Carlsen et al., 
2004), as it is not correlated to vitamin D levels, it was  argued that abstinence is not a 
true confounder in this association (Hammoud et al., 2012).  
 
Sample loss at the collection of semen was not recorded at the recruitment, however 
when recorded at the follow up phase was noted only in a small percentage of 
participants (3/87). The duration between times from ejaculation to sperm motility 
assessment was not recorded, however all the samples were assessed for sperm motility 
soon after liquefaction or at half an hour at the latest. As described in Methods, the 
samples were completely analysed (all the parameters) within one hour starting with 
semen volume and sperm motility.  
 
2. The observational association study had four groups divided by their vitamin D status 
(deficiency, insufficiency, adequate and optimal), however in the cohort study, the study 
group was divided in to only 2 groups (vitamin D deficient and non-deficient). This was 
done to avoid very small groups and results which would have been difficult to validate. 
  
3. The vitamin D supplementation treatment protocol was not uniform in the study as at 
the time, there were no licensed high dose vitamin D preparations and different GPs 
preferred their own regime, despite a standard recommendation from us.  
 
4. As the participants are male partners of sub fertile couples, the results may not be 
extrapolated to the general population. 
 
 
6.10 Conclusion 
The study suggests that vitamin D deficiency is very common in men attending our 
infertility clinic, but is not associated with poor semen parameters. Despite limitations, a 
negative association between vitamin D and semen parameters is noted. Based on the 
results from our preliminary study vitamin D supplementation may be harmful to semen 
parameters for male partners of subfertile couple and therefore we advise caution and 
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suggest monitoring the semen parameters when supplemented. A well-designed RCT to 
evaluate this further is warranted. 
 
 In the next chapter we investigated the association between vitamin D and semen 
quality, and also IVF treatment outcomes.
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Chapter 7 Vitamin D and male fertility  
7.1 Introduction 
The WHO criteria for semen parameters are used worldwide and the recent evidence 
based WHO 2010 reference values for semen characteristics are based on a large cohort 
of men whose partners had a time to pregnancy (TTP) of less than 12 months (Cooper et 
al., 2010). Table 37 shows the 5th centiles of the semen parameters with their 95% 
confidence intervals that provided the lower reference limits (World Health 
Organisation, 2010). 
 
 
Semen Parameters 
 
5th centiles (95% confidence intervals) 
Semen volume (ml) 1.5 (1.4-1.7) 
Total sperm number (million/ejaculate) 39 (33-46) 
Sperm concentration (million/ml) 15 (12-16) 
Vitality (% live) 58% (55-63) 
Progressive motility (%) 32 (31-34) 
Total motility (%) 40 (38-42) 
Morphologically (%) 4 (3-4) 
 
Table 37: WHO 2010 criteria for semen parameters 
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For this chapter, if semen parameters met the WHO 2010 requirements, the sample was 
defined as being of “optimal semen quality” and if it failed to meet at least one of the 
above criteria it was defined as “sub-optimal semen quality”. This was done to 
investigate the association between vitamin D and “semen quality” (in addition to the 
association between serum vitamin D and individual semen parameters in Chapter 6). 
 
A significant positive or negative correlation between individual semen parameters and 
serum vitamin D may not alter the overall semen quality from a clinical perspective, if 
the individual semen parameters remain within the normal range. For instance if the 
sperm concentration alone deteriorated from 120 million/ml to 60 million/ml (bearing in 
mind that other parameters were normal) the “semen quality” would still remain optimal 
(WHO 2010 criteria) despite this deterioration and therefore may not adversely affect 
the chances of conception. Hence it is worth investigating the impact of serum vitamin 
D on overall “semen quality” and not just individual semen parameters.  
 
Many studies have investigated the association of serum vitamin D and individual 
semen parameters such as semen volume, sperm concentration, motility and 
morphology as detailed in Chapter 6. The impact of vitamin D on overall “semen 
quality” has not been evaluated in studies so far. 
 
“Optimal semen quality” however does not guarantee fertility success as the semen 
parameters are surrogate markers for sperm function which can only be demonstrated 
fully by the sperm’s ability to fertilise an egg and subsequent pregnancy and live birth.  
Therefore further study investigating the association between serum vitamin D and male 
fertility would explore the role of vitamin D in male reproduction in another potentially 
useful dimension. 
 
Studies have shown that vitamin D deficiency in male rats adversely affects the 
reproductive potential of vitamin D replete female rats. Fertility (defined as successful 
pregnancies in sperm positive female rats) was significantly reduced by 73% in the 
litters from vitamin D deficient male rat inseminations compared to inseminations by 
vitamin D replete rats (Kwiecinski et al., 1989a). Furthermore in vitro studies have 
shown that vitamin D enabled sperm capacitation, sperm survival and the acrosome 
reaction (Aquila et al., 2008; Aquila et al., 2009; Blomberg Jensen et al., 2011).  
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Although these processes may not be relevant to the same extent in standard assisted 
reproduction techniques such as IVF and ICSI as in natural conception, analysing the 
IVF treatment cycles allows us to consider fertilisation rates, embryo quality and 
ultimately conception rates (if not live birth rates) in relation to participant’s vitamin D 
levels. We hypothesize that a variation in serum vitamin D in men may alter fertilisation 
rates and affect embryo quality in assisted reproduction with IVF. 
 
7.2 Aim 
      To investigate if there is correlation between serum vitamin D and 
1. Semen quality (defined by WHO 2010 criteria)  
2. IVF treatment outcomes (as detailed in objectives). 
 
7.3 Objectives 
      To investigate 
1. If there is a difference in semen quality between men in various vitamin D 
groups. 
2. The difference (improvement or deterioration) in semen quality with vitamin D 
supplementation in vitamin D deficient participants and with the seasonal rise in 
vitamin D levels in non-vitamin D deficient participants. 
3. To compare the fertilisation rates, embryo quality, conception and 
cryopreservation rates between IVF treatment cycles in Winter/Spring and 
Summer/Autumn, with rise in serum vitamin D in the male partner. 
 
7.4 Outcome measures 
To determine if serum vitamin D levels in the male partner affect semen quality 
and the chances of conception in their female partner by assisted reproductive 
techniques. 
 
7.5 Subjects and Methods 
This section has been detailed in Chapter 6 (Section 6.5) and summarised here 
apart from detailing the additional relevant points. 
 
7.5.1 Subjects 
124 men attending NFC for fertility investigations / treatment are included in this 
section. 
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7.5.2 Study design 
It is a prospective longitudinal observational study. 
 
7.5.3 Investigations 
7.5.3.1 Blood sample 
All participants provided a blood sample to analyse their serum 25(OH)D levels. 
Participants were stratified into four groups based on their 25(OH)D levels as follows 
• < 25nmol/l - Deficiency 
• 25-50nmol/l –Insufficiency 
• 51-75nmol/l – Adequate 
• >75nmol/l – Optimal 
 
7.5.3.2 Semen sample 
All participants produced a semen sample and were analysed as detailed in Chapter 6 
(Section 6.5.8.2.3). Normal semen parameters as defined by WHO 2010 criteria are 
shown in Table 37. As described earlier in introduction if semen parameters met the 
WHO 2010 requirements, the sample was defined as being of “optimal semen quality” 
and if it failed to meet at least one of the above criteria it was defined as “sub-optimal 
semen quality”. However semen volume and vitality parameters were not included in 
defining the “semen quality” for this work as sample loss was not recorded at the 
recruitment phase and also sperm vitality was not assessed in the analysis. 
 
7.5.4 Study method 
At recruitment phase, the above investigations were obtained from the 124 participants 
and all of them were invited to return six months later for repeat investigations. 
Participants seen in Winter and Spring were to be reviewed in Summer and Autumn 
respectively. Meanwhile vitamin D deficient participants were notified of the result and 
recommended treatment with vitamin D supplementation (detailed in Chapter 6 Section 
6.5.11). 87 participants returned for follow up, however 84 participants could be 
included in the cohort study (1 participant’s blood sample was lost in transit; 1 
participant excluded when he revealed to be on cod liver oil supplements and 1 vitamin 
D deficient participant did not receive vitamin D supplementation.  
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For further analysis, all the participants who returned for follow up were stratified into 
two groups based on their initial 25(OH)D level (detailed in Chapter 6, Section 6.7.4) as 
follows: 
 Vitamin D deficient (< 25nmol/l) 
 Vitamin D non-deficient (>25nmol/l) 
The details of vitamin D deficient and non-deficient participants are described in 
Chapter 6 Sections 6.7.4.1 and 6.7.4.2 respectively. 
This chapter investigates:  
 The “semen quality” in the 124 recruits stratified by the four groups. 
 The semen quality before and after supplementation in the 36 vitamin D 
deficient men who received vitamin D supplementation. 
 The semen quality in Winter/Spring and Summer/Autumn in the 48 vitamin D 
non-deficient men exhibiting a seasonal rise in vitamin D levels.  
 
The flow diagram detailing the recruitment for vitamin D and semen quality study is 
shown in the Figure 13. 
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Figure 13: Participant’s flow chart for Vitamin D and “Semen quality” study 
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7.5.4.1 Male fertility (IVF/ICSI treatment)   
14/87 participants were going through IVF treatment cycle at follow up and were seen 
on their partner’s egg collection day. Two of these participants (2/14) were initially 
recruited from clinic i.e. their partner was not going through an IVF treatment cycle at 
recruitment. One (1/14) was excluded as he later was revealed to have been on cod liver 
oil. Another (1/14) participant’s partner had a poor ovarian response and was unsuitable 
for oocyte retrieval and therefore IUI treatment was done instead of IVF. 
 
Finally there were 10 participants whose partners had egg collection at the initial 
recruitment stage and also at 6 month follow up. The phases were divided into two 
based on the season of treatment i.e. Winter/Spring and Summer/Autumn. 
 
The procedure of IVF has been briefly explained in Chapter 3 (Section 3.5.3) in relation 
to D-IVF. A flow chart with sequence of events in IVF is shown in Chapter 6 (Section 
6.5.3). In addition, fertilisation in IVF involves a few 100,000 prepared sperms 
inseminated with the oocytes in the culture medium in the laboratory, whilst ICSI 
involves injecting a sperm into each oocyte.  
 
The variables compared were the number of mature oocytes retrieved at egg collection, 
the number of oocytes fertilised (by IVF / ICSI), the fertilisation rate (number of 
oocytes fertilised/number of oocytes ×100), the number of normally fertilised embryos 
(embryos with two pronuclei) and the percentage of normal fertilisation (number of 
oocytes normally fertilised /number of oocytes × 100). The quality of the embryos has 
also been compared. The grading of the embryos is based on the blastomere number, 
size and fragmentation and shown in Appendix K. The number of top, good, slow and 
other quality embryos was noted and their percentage (out of normally fertilised 
embryos) was calculated. Clinical pregnancy rates (including missed miscarriages and 
viable intrauterine pregnancies at 7 week scan) were compared. All the participants with 
two or more spare top and or good quality spare embryos after embryo transfer were 
eligible for cryopreservation of their embryos. Cryopreservation rates were also 
compared between Winter/Spring and Summer/Autumn.
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7.6 Statistical analysis 
Statistical analysis was performed using SPSS (version 19) and Minitab (version16). 
Variables were expressed as percentages and median with centiles. Vitamin D levels 
showed non-normal distribution. Semen quality was compared between vitamin D 
groups by applying the chi square test. The change in the semen quality (improvement 
or deterioration) with vitamin D supplementation and seasonal rise in vitamin D was 
investigated by the McNemar test. 
 
Vitamin D and IVF /ICSI outcome:  The distributions of continuous variables were 
checked using the Anderson Darling normality test. Vitamin D, number of mature 
oocytes, total oocytes fertilised, number of normally fertilised oocytes, percentage of 
normally fertilised oocytes, percentage of good quality embryos and percentage of other 
quality embryos were normally distributed. The remaining variables fertilisation rate, 
the number of top quality embryos, percentage of top quality embryos, number of good 
quality embryos, number of slow quality embryos, percentage of slow quality embryos 
and other quality embryos were not normally distributed. Both parametric (paired tests) 
and non-parametric (Wilcoxon rank test) were applied to compare the fertilisation rates 
and embryo quality during the treatment cycles in Winter/Spring and Summer/Autumn 
yielded similar results. To ease the reading and retain uniformity in reporting, non-
parametric test results are shown. The Independent sample t test was used to 
demonstrate the difference in vitamin D levels. The McNemar test was applied to 
examine the differences in conception results and numbers of embryos for freezing. A p 
value of <0.05 was considered significant. 
 
7.7 Results 
7.7.1 Semen quality in four vitamin D groups 
The semen quality (Optimal or suboptimal) as per the WHO 2010 criteria was not 
significantly different among the men in the four vitamin D groups (Table 38). 
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Semen 
quality 
N=124 
Vitamin D 
Deficiency 
<25nmol/l 
N=52 
Vitamin D 
Insufficiency 
26-50nmol/l 
N=51 
Vitamin D 
Adequate 
51-75nmol/l 
N= 15 
Vitamin D 
Optimal 
>75nmol/l 
N=6 
(Chi 
square 
test) 
P value 
Sub optimal 
semen 
quality (%) 
 
13 (25)  15 (29)   6 (40) 3 (50) 0.49  
 
Optimal 
semen 
quality (%) 
 
39 (75) 
 
36 (71) 
 
9 (60) 
 
3 (50) 
 
Table 38: Semen quality by vitamin D group
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7.7.2 Semen quality with vitamin D supplementation 
Among the 36 vitamin D supplemented men, 29 had semen quality unchanged before 
and after vitamin D supplementation. Although this deteriorated in 6 participants to sub-
optimal quality and improved to optimal quality in one participant, there was no 
statistically significant change in the semen quality with a rise in serum vitamin D 
levels on supplementation (McNemar p=0.12) as shown in Table 39. 
 
 
 
 
 
Phase / vitamin D [nmol/l; 
Median  (25 -75) 
percentile] 
 
               Semen quality Total Mc 
Nemar 
test 
P value 
Suboptimal 
Semen 
quality 
 
Optimal 
semen 
quality 
At the diagnosis of vitamin 
D deficiency  
14 (9.9-16.7) 
 
11 
 (30.6%) 
25  
(69.4%) 
36  
(100.0%) 
0.12 
Following  
vitamin D supplementation  
 82 (63.2-114.2) 
 
16  
(44.4%) 
20  
(55.6%) 
36  
(100.0%) 
 
Table 39: Semen quality with vitamin D supplementation
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The details of semen quality deterioration and improvement with vitamin D 
supplementation are discussed in the following sections. 
 
7.7.2.1 Semen quality deterioration (optimal to suboptimal) with vitamin D 
supplementation 
Among the six participants with semen quality deterioration following vitamin D 
supplementation one participant had a lowered count but partial sample loss was 
recorded; two participants had a decline in all semen parameters but one of them was 
known to have variable semen quality; three participants had worsened morphology and 
interestingly two of them had history of poor fertilisation with IVF. All the details are 
shown in the Table 40.
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Participant First 
Vitamin D   
Following 
supplementation 
Semen parameters / (Quality) 
before supplementation 
Semen parameters / ( Quality) 
After supplementation 
Comments 
46 9.9 32 80 million/ml        (Optimal) 
55% prog. motile 
9% normal 
8 million/ml            (Sub-optimal) 
19% prog. motile 
2% normal 
Known variable 
semen quality 
65 13 47 137 million/ml      (Optimal) 
55% prog. motile 
11% normal 
57.4 million/ml       (Sub-optimal) 
41% prog. motile 
2% normal 
 
66 9.9 17 34 million/ml        (Optimal) 
63% prog. motile 
8% normal 
10 million/ml          (Sub-optimal) 
45% prog. motile 
10% normal 
Partial sample loss 
91 20 112 56 million/ml        (Optimal) 
77% prog. motile 
6% normal 
53 million/ml          (Sub-optimal) 
51% prog. motile 
0% normal 
Poor fertilisation 
with IVF 
105 22 93 91 million/ml       (Optimal)  
77% prog. motile 
10% normal 
51.5 million/ml        (Sub-optimal) 
60% prog. Motile 
3% normal 
1
st
 cycle: good fert*, 
2
nd 
cycle: poor fert* 
with IVF 
108 16 104 134 million/ml      (Optimal) 
59% prog. motile 
10% normal 
9.5 million/ml           (Sub-optimal) 
18% prog. motile 
0% normal 
 
 
Table 40:  Serum vitamin D levels and semen parameters before and after supplementation in 6 participants with change in semen quality 
from Optimal to suboptimal  
 
(prog.motile – progressive motility;* fert- fertilisation) 
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7.7.2.2 Semen quality improvement with vitamin D supplementation 
In one participant, semen quality improved to optimal (sperm morphology 3 to 10%) 
with vitamin D supplementation. 
 
7.7.3 Semen quality with seasonal rise in vitamin D  
 
Among the 48 non vitamin D deficient participants, 45 had unchanged semen quality 
(optimal or suboptimal) in Winter/Spring and Summer/Autumn.  In one participant the 
semen quality improved to optimal quality whilst in two participants this deteriorated to 
sub-optimal quality from Winter/Spring to Summer/Autumn. Overall there was no 
difference in the semen quality with seasonal rise in vitamin D levels (Table 41). 
 
 
 
 
 
Season / vitamin D 
[nmol/l; Median  (25 
-75) percentile] 
 
                Semen quality Total Mc Nemar 
test P 
value 
Suboptimal 
Semen 
quality  
Optimal semen 
quality 
Winter / Spring 
41 (31-59) 
16 (33.3%) 32 (66.7%) 48 (100.0%) 1.0 
Summer / Autumn 
62 (52-75.7) 
17 (35.4%) 31 (64.6%) 48 (100.0%) 
 
Table 41:  Semen quality with seasonal rise in vitamin D
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The details of semen quality deterioration and improvement with seasonal rise in serum 
vitamin D are discussed in the following sections. 
 
7.7.3.1 Semen quality improvement from Winter/Spring to Summer/Autumn 
In one participant (Table 42) the semen sample in Spring was of sub-optimal quality 
when the 25(OH)D level was 101nmol/l. In Autumn the semen quality improved to 
optimal when the 25(OH)D level, (although appearing lower at 97nmol/l) was in the 
same range. It is notable that monthly median serum 25(OH)D levels (Chapter 6, 
section 6.7.5, Figure 12) in May were higher than November, although the levels were 
overall lower in Spring compared to Autumn (Chapter 6, Section 6.7.5, Table 34). 
Interestingly, although the semen sample for this participant appeared to be better in 
Autumn, it did not prepare well for treatment and the couple required ICSI. Furthermore 
whilst this treatment was ultimately unsuccessful the couple went on to conceive 
naturally. 
 
 
 
 
 
P
ar
ti
ci
p
an
t 
Vitamin D 
Winter/Spring   
Vitamin D 
Summer/Autumn 
Semen parameters 
(Quality) 
Winter/Spring 
 
Semen parameters 
(Quality) 
Summer/Autumn 
7 101 (May) 97 (Nov) 7 million/ml 
2% normal 
(Sub-optimal) 
16 million/ml 
6% normal 
(Optimal) 
  
Table 42: Serum vitamin D levels and semen parameters in a participant with 
change in semen quality (suboptimal to optimal) from Winter/Spring to Summer/ 
Autumn 
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7.7.3.2 Semen quality deterioration from Winter/Spring to Summer/Autumn 
In one participant the deterioration in semen quality seems to be mainly because of 
sperm morphology. The partial sample loss recorded for this participant may not explain 
the decline in sperm morphology but interestingly the couple had a spontaneous 
conception during the course of the study. The other participant in this group had both 
sperm count and morphology which were markedly lower in association with improved 
serum vitamin D levels and interestingly there was history of poor fertilisation in their 
previous IVF cycles. The details of the semen quality are shown in Table 43. 
 
 
 
 
  
  
  
  
P
ar
ti
ci
p
an
t 
Vitamin 
D 
Winter/ 
Spring 
Vitamin 
D 
Summer/ 
Autumn 
Semen 
parameters 
(Quality) 
Winter/Spring 
Semen parameters 
(Quality) 
Summer/Autumn 
Comments 
56 29 73 200 million/ml 
52% prog. 
motile 
7% normal 
(Optimal) 
137 million/ml 
51% prog. motile 
3% normal 
(Sub-optimal) 
Partial sample loss in 
summer/autumn 
semen sample; 
Spontaneous 
conception prior to 
summer/autumn 
sample. 
87 40 90 127 million/ml 
65% tot. 
motile 
5% normal 
(Optimal) 
3.5 million/ml 
41% tot. motile 
3% normal 
(Sub-optimal) 
History of poor 
fertilisation with IVF  
 
Table 43: Serum vitamin D levels and semen parameters in two participants with 
change in semen quality (optimal to suboptimal) from Winter/Spring to 
Summer/Autumn 
(prog motile – progressive motile; tot.motile – total motility) 
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7.7.4 Vitamin D and IVF/ICSI outcome 
 
Ten participant couples undertook 2 cycles of treatment Winter/Spring and 
Summer/Autumn over the period of the study (Figure 14). 2 of these men were deficient 
in vitamin D and received vitamin D supplementation. 1 couple had a history of poor 
fertilisation with IVF in their first cycle and therefore had ICSI in the subsequent cycle. 
The remaining participants had similar treatment (i.e. IVF or ICSI) in both cycles. As 
has been shown, 25(OH)D levels [nmol/ l; Median (25
th
 -75
th
 centiles)] increase 
significantly from Winter/Spring to Summer/Autumn [52 (28-61.5) vs.82 (42.7-96.5) 
p=0.03)].  
 
 
 
 
          
 
 
         
          
          
          
          
          
          
          
          
          
          
           
Figure 14: Participant’s flow chart for vitamin D (VD) and IVF/ICSI study
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There was no significant difference in the fertilisation rates and embryo quality with the 
rise of serum vitamin D levels in the male partners. These results were similar even after 
excluding the one participant where treatment changed from IVF to ICSI in the second 
cycle (results not shown).  
There were 2 pregnancies (both missed miscarriages) in Winter/Spring treatment cycles, 
whilst the Summer/Autumn treatment cycles resulted in 1 viable pregnancy. One couple 
in each season were able to freeze spare embryos. Therefore, as expected there was no 
significant difference in the pregnancy rates and freeze rates between the two groups of 
treatments carried out in Winter/Spring and Summer/Autumn. These results are shown 
in  
Table 44 and Table 45.  
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Variables 
N=10 
Median (25
th
 -75
th
 centiles) 
Winter / Spring Summer / 
Autumn  
Wilcoxon 
Signed 
Rank  test  
P value 
Vitamin D (nmol/l )  52.0 (28.0-61.5) 82.0 (42.7-96.5) p=0.03 
(Mann 
Whitney 
test) 
No: of mature oocytes  5.0 (2.0-9.7) 6.0 (4.0-9.0) 0.9 
Total no. oocytes fertilised  4.0 (1.7-9.2) 5.0 (3.0-7.5) 0.9 
Fertilisation rate (%) 81.5 (73.0-100.0) 91.5 (65.7-100.0) 0.8 
No. embryos normally 
fertilised  
 
3.5 (1.5-4.7) 3.5 (2.0-5.5) 0.7 
% normally fertilised  77.5 (50.0-100.0) 69.0 (41.2- 75.7) 0.4 
No. top quality embryos  0 (0-0) 0 (0-1) 0.5 
% of top quality embryos  0 (0-0) 0 (0-11) 0.3 
No. of good quality embryos  1.0 (0.0-2.0) 1.0 (0.0-2.2) 0.8 
% of good quality embryos  27.0 (0.0-45.5) 29.0 (0.0-52.5) 0.9 
No. of slow quality embryos  0.5 (0.0-2.2) 0.0 (0.0-1.0) 0.2 
% of slow quality embryos  16.5 (0.0-69.0) 0.0 (0.0-16.7) 0.1 
No. of other quality embryos  1.0 (0.0-3.0) 2.0 (1.0-3.0) 0.4 
% of other quality embryos  37.5 (0.0-81.2) 50.0 (28.0-76.2) 0.7 
 
Table 44: Comparison of fertilisation and embryo quality between Winter/Spring 
and Summer/Autumn
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Variables 
n=10 
 
Winter/ 
Spring 
 
Summer/ 
Autumn 
 
McNemar test 
 P value 
 
 
 
Pregnancy (pregnant / non 
pregnant) 
 
2/8 
 
1/9 
 
1.0  
 
Embryos for freezing (yes 
/ no) 
 
1/9 
 
1/9  
 
1.0  
 
Table 45: Comparison of pregnancy and embryo freezing rates between 
Winter/Spring and Summer/Autumn 
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7.8 Discussion 
In this chapter, we have investigated the association between serum vitamin D and 
semen quality (not individual semen parameters), the variation in semen quality with 
vitamin D supplementation and also with the seasonal rise in serum vitamin D levels. 
The association between the male partner’s serum vitamin D levels and IVF outcomes 
were also evaluated. 
 
Semen quality was not significantly different among the vitamin D groups. This is 
similar to the finding in the previous chapter (Chapter 6, section 6.7.2.5) where there 
was no association between serum vitamin D and individual semen parameters.  In cross 
sectional studies investigating the association between serum vitamin D and semen 
parameters, despite the varied potential associations such as a positive association 
(Blomberg Jensen et al., 2011; Blomberg Jensen et al., 2012; Yang et al., 2012) or a  
‘U’ shaped association (Hammoud et al., 2012) or no association (Ramlau-Hansen et 
al., 2011) suggested, semen parameters were generally normal (WHO 2010 criteria) in 
men whatever their vitamin D status. Thus it is debateable how clinically relevant such 
associations may be. 
 
Although a significant negative association was seen between serum vitamin D levels 
and individual semen parameters with vitamin D supplementation and seasonal rise in 
vitamin D levels in Chapter 6, there was no significant change in the overall semen 
quality with the same.  
 
In men with optimal semen quality, the rise or fall of individual semen parameters with 
vitamin D may not be of much clinical significance as long as the semen parameters are 
in normal range, however in men with borderline semen parameters, a rise or fall in 
semen parameters can be very significant as it can change the overall semen quality to 
optimal or suboptimal respectively and affecting their fertility potential. A double-
blinded randomized clinical trial is underway by Blomberg et al to investigate the effect 
of vitamin D supplementation in infertile men, (as their previous cross sectional 
association study revealed a positive association between vitamin D and semen 
parameters) and we await the results with interest (Clinical Trials.gov Identifier: 
NCT01304927). An improvement in the overall semen quality to optimal with vitamin 
D could potentially be a useful and easy therapeutic option in the management of 
idiopathic oligospermia, however our results do not support the use of this intervention. 
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In individual participants where a variation in semen quality (optimal to suboptimal or 
vice versa) was seen, this seems mainly due to change in sperm morphology. In 
participants with semen quality deterioration in their subsequent samples, it was 
interesting to note that there was history of poor fertilisation in three participants and of 
semen samples not preparing well for IVF necessitating ICSI, in one participant. It is 
important to note that researcher MG was blinded to the results of first semen analysis 
results until the second semen analysis was performed. 
 
There was no significant difference in the fertilisation rates, quality of embryos, 
pregnancy rates and embryos for freezing between the two treatments carried out in 
Winter/Spring and Summer/Autumn even though serum vitamin D levels increased 
significantly in the male partner. This could be because the processes involved in 
assisted reproduction, such as sperm washing and preparation may eliminate the effects 
of vitamin D on sperm function. However there are no human studies as yet 
investigating the association of male partner’s vitamin D levels with natural conception 
rates or outcomes of assisted reproduction and our study will contribute to the literature 
regarding the same for future. 
 
7.9 Limitations of the study  
To investigate the association of serum vitamin D in men and outcome of IVF treatment 
(i.e. fertilisation rates, quality of embryos, pregnancy rates and rates of cryo 
preservation), female partner’s demographics such as age and ovarian reserve are 
essential. Although this information is lacking in our study, we conducted paired test 
analysis where the woman acted as her own control and therefore eliminated the need to 
adjust for female variables. Whilst a similar seasonal variation of vitamin D in female 
partners is likely, possibly supporting the lack of any seasonal differences in treatment 
outcome, assessing their vitamin D status would have added to our understanding of the 
impact of vitamin D on reproduction. 
The study size (124) was small and particularly the subset investigating the IVF 
outcomes (n=10) and therefore we advise caution in interpreting these results. 
 
7.10 Conclusion 
There was no association between serum vitamin D status and semen quality (as per the 
WHO 2010 criteria). Furthermore the semen quality remained unchanged with vitamin 
D supplementation or the seasonal rise in serum vitamin D levels. A rise in male 
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partner’s serum vitamin D levels did not affect the IVF outcome in their female partner. 
Over all, this suggests vitamin D may not have a role in improving sperm function.
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Chapter 8 Discussion 
A national problem of sperm donor shortage leading to the cessation of donor sperm 
treatment services in some centres was recognised by the BFS in their Working Party 
report in 2008 (Hamilton et al., 2008a). At NFC, over the past few years increasing 
numbers of patients have had to wait over a year for donor sperm treatments. 
 
My study examining the donor programme at NFC from 2000 to 2010, to investigate if 
there was a true problem of donor sperm shortage, revealed a significant change over 
this time; with fewer donors recruited and a smaller pool of donors leading to fewer 
patients receiving treatment; a decline in the number of donor insemination cycles 
undertaken accompanied by rising donor IVF cycle numbers; increasing sperm imports 
and a longer waiting time for treatments (Chapter 3). 
 
There is a lack of published evidence in the literature about the experience of individual 
fertility centres in UK over the past decade; therefore information has been retrieved 
from the web news (Bionews) (Adams et al., 2006; Ahuja, 2008; Wardle, 2008) and 
surveys (BBC survey, 2006; British Fertility Society survey, 2006) to understand if 
there has been a similar problem with donor sperm shortages at other fertility centres. In 
addition national data is provided by the HFEA giving some insight into the issues 
although may in part be falsely reassuring.  
 
In the 1990s, the decline in the number of donor sperm treatment cycles tallied with 
increasing number of ICSI cycles, however this decline continued even after ICSI was 
well established in 2000 (Pacey, 2010). The possibility that the loss of anonymity in 
2005 contributed to the current shortage of donors has been extensively argued with 
contradicting views, but is confounded by the fact that the decline in donor recruitment 
was reported even before that came into effect (Pike and Pacey, 2005; BBC survey, 
2006; British Fertility Society survey, 2006; Witjens, 2007; Blyth and Frith, 2008; 
Wardle, 2008; Tomlinson et al., 2010). Interestingly however, HFEA data shows a rise 
in the number of sperm donors from 2005 and the numbers of patients treated / 
treatment cycles undertaken from 2007 (HFEA, 2011c; HFEA, 2011d).  
 
It is estimated that approximately 4000 patients need donor sperm treatment per year in 
UK and that 500 sperm donors are needed to meet this demand (Hamilton et al., 2008a). 
In 2010, 480 sperm donors were recruited, however the number of patients treated was 
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less in 2010 than in 2004 (2960 vs. 3712 patients) when there were only 239 donors, 
suggesting fewer patients per donor are being treated. Furthermore even though the 
number of sperm donors in 2010 (480) are near enough to the estimated need (500),  a 
shortage of sperm donors nationally is evident by increasing waiting times for 
treatment, sperm import, and the numbers of patients travelling abroad for treatment 
(Hamilton, 2010; Pennings, 2010; Shenfield et al., 2010; Culley et al., 2011; Hudson et 
al., 2011). It is suggested that the rise in donors is due to an increase in overseas and 
known donors (Hamilton, 2010; Tomlinson et al., 2010) and is supported by HFEA data 
confirming the rise in overseas donors from 11% in 2005 to 24% in 2010 (HFEA, 
2011e) and 16% of newly registered sperm donors in 2008 limiting their donation to 
one family (HFEA, 2011b).This improvement in sperm donor recruitment nationally is 
therefore an artefact since such donors benefit fewer patients overall. 
 
My data shows a rise in the proportion of D-IVF treatments to total donor sperm 
treatments, similar to the national HFEA data (HFEA, 2011c). The rise at our centre can 
be explained not only by strategies to improve the efficiency of donor sperm treatment, 
as has been suggested previously in the literature (Pike and Pacey, 2005; British 
Fertility Society survey, 2006), but also the increase in NHS funding for IVF treatment 
from two to three cycles in the majority of primary care trusts in the North East region. 
Hence there is an actual and proportional rise in D-IVF. 
 
Despite the absence of published evidence, it is felt that  many fertility centres are 
struggling to recruit sufficient sperm donors across the UK to meet demand and 
certainly the encouraging HFEA data do not reflect the experience of many centres  
including our own (Wardle, 2008; Hamilton and Pacey, 2008b). However it is certainly 
not universal, as some centres continue to be successful in the current framework 
(Adams et al., 2006; Ahuja, 2008; Tomlinson et al., 2010).  
 
In my opinion the increase in waiting times for treatment, sperm import and the request 
for known sperm donations seen at our centre reflects the sperm donor shortage 
following the abrupt loss of our large pool of anonymous sperm donors with removal of 
donor anonymity and the subsequent decline in sperm donor recruitment.  
 
One solution to the problem would be to revoke the legislation relating to donor 
anonymity. However the experience from other countries that moved from anonymous 
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to open donation has shown that the change did not negatively affect donor recruitment 
(Van den Akker, 2006; Blyth and Frith, 2008) although some recent reports have been 
conflicting (Ernst et al., 2007; Ekerhovd and Faurskov, 2008). Furthermore a sperm 
donor shortage is also seen in countries where donor anonymity is protected (Blyth and 
Frith, 2008) suggesting that removal of anonymity may not be only reason for the 
shortage. Even in countries where anonymous donation is allowed, a shift towards 
increasing numbers of non-anonymous donors is seen (Scheib and Cushing, 2007) 
suggesting a change in trend towards open donation and increasingly more countries are 
now adopting open donation. Therefore I would not support this stance. A review in 
2008 of the regulations regarding revoking the donor anonymity did not receive much 
support for change (Hamilton, 2010). 
 
Despite the fact that arguments for and against donor anonymity are still contentious, 
the donor conceived children’s rights to know the truth and their genetic origins have 
prevailed as it was it was deemed in their best interests. The long term psychosocial 
impact of removing donor anonymity on donor conceived children, donors and parents 
is unknown although, the initial research results reveal that majority of the contact 
experiences are positive (Freeman et al., 2009; Jadva et al., 2011). 
 
If the centre succeeds in reverting to donor recruitment levels similar to that seen prior 
to the removal of anonymity (40 in 10 years i.e. about four per year) (Paul et al., 2006), 
it would still take at least ten years to build the donor bank  to allow optimal choice and 
immediate treatment for patients. This is a problem which will take years to recover 
from unless other measures are taken to improve the sperm donor recruitment. This is 
vital so that the patients meanwhile do not suffer from the lack of treatment and an 
opportunity to create a family. 
 
We have seen that only 3.6% of potentially interested men are finally released as sperm 
donors (Paul et al., 2006).  Whilst many default in the early stages, the commonest 
cause of rejection of sperm donors is sub-optimal semen quality (Paul et al., 2006; 
Hamilton et al., 2008a). However, the notion of sub-optimal semen quality is poorly 
understood. Some external factors that may influence semen quality such as season and 
vitamin D have been widely studied in the literature and have been considered further in 
this project. A better understanding of their impact on semen quality (if any) may be of 
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value in improving the both efficiency of the sperm donor programme and of donor 
recruitment. 
 
Seasonal variation in semen parameters although variable and inconsistent has been 
demonstrated mostly in the Northern hemisphere (Levine, 1999) and generally in 
temperate climates rather than tropical climates (Chia et al., 2001). Studies from the UK 
are sparse, however a study done nearest to our centre geographically, in Edinburgh  
revealed a pattern of improved sperm counts in Winter and Spring (though not 
statistically significant) (Mortimer et al., 1983). The retrospective database review of all 
the semen analyses performed at NFC from men attending for infertility work-up 
between December 2006 and November 2009 to investigate the seasonal variation in 
semen parameters, revealed sperm morphology to be the only parameter significantly 
better in Winter and Spring compared with Summer and Autumn, but there was no 
significant seasonal variation in other semen parameters (Chapter 4). The actual 
improvement in sperm morphology however was low and of debateable clinical 
significance. 
 
In the following Chapter (5) however, a longitudinal investigation of the seasonal 
variation in semen parameters of 32 sperm donors used for DI treatments between 2005 
and 2010 revealed significant seasonal variations in semen parameters with semen 
volume being significantly higher in Spring compared to Winter. Sperm concentration 
parameters (sperm concentration, total motile and progressive motile) were all 
significantly higher in Winter and Spring compared with Summer and Autumn and the 
motility (progressive and total) parameters appeared to be lowest in Autumn.  
 
Interestingly there are major differences in the results on seasonal variation in semen 
parameters between the retrospective patient and the longitudinal donor studies.  Our 
longitudinal study showed greater seasonal variation in semen parameters compared to 
the retrospective study. The study group in the retrospective study comprised men 
undergoing preliminary fertility work-up whilst the cohort study consisted of donors 
with proven or likely fertility. Our retrospective study included sub-optimal semen 
samples (601 samples with count less than 15miilion/ml i.e. 14.7 %; 701 samples with 
total motility less than 40 i.e.17.2%) whilst in the cohort study despite some semen 
donors having had a few sub-optimal semen samples (3 samples with count less than 
15miilion/ml i.e. 0.2 %; 12 samples with total motility of less than 40 i.e.1%), the 
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majority were normal. Although the cohort study was not as large as the retrospective 
study (4067 samples), it was still of considerable size with 1108 semen samples and had 
the advantage of accommodating for intra-individual variation (as the samples were 
from 32 donors only with an average of 34 semen samples from each donor). Of note, 
there was no semen analysis methodology related bias between the studies.   
 
Most longitudinal studies of seasonal sperm parameters reveal a lack of seasonal 
variation (Mallidis et al., 1991; Ombelet et al., 1996; Carlsen et al., 2004), but not all 
(Levine et al., 1990; Levine et al., 1992). Similar to our study, seasonal variation was 
noted more in sperm donors (sperm count, motility) than in men attending infertility 
clinics (only sperm morphology) suggesting that the possible pathology in the 
‘suspected infertile’ male may not be affected by the season to the same extent (Centola 
and Eberly, 1999). Levitas et al. (2013) studied the seasonal variation in 
normozoospermic samples (≥ 20million/ml) and oligozoospermic samples 
independently and by way of confirmation it has shown that seasonal variation was  
more marked in normozoospermic samples compared to oligozoospermic samples.  
 
However other studies conducted on men attending fertility clinics did show seasonal 
variation (Andolz et al., 2001; Chen et al., 2003) and that seasonal changes in semen 
parameters were not restricted to semen donors (Saint Pol et al., 1989; Gyllenborg et 
al., 1999) or men attending infertility clinics, but were also seen in volunteers from the 
general population (Levine et al., 1990; Levine et al., 1992), men prior to vasectomy 
(Tjoa et al., 1982; Sobreiro et al., 2005) and subfertile men (Politoff et al., 1989). 
 
At NFC (in the Northern hemisphere with a temperate climate), the seasonal variation 
noted in donor semen with a deterioration of sperm parameters (sperm count and or 
motility) in Summer and/or Autumn is similar to the seasonal variation reported in 
several other temperate climates (Tjoa et al., 1982; Levine et al., 1988; Reinberg et al., 
1988; Politoff et al., 1989; Saint Pol et al., 1989; Levine et al., 1990; Levine et al., 
1992; Gyllenborg et al., 1999; Andolz et al., 2001; Jørgensen et al., 2001; Chen et al., 
2003; Chen et al., 2004; Moskovtsev and Mullen, 2005; Calonge et al., 2009; Levitas et 
al.).  In the NFC study however, I also demonstrated seasonal variation in semen 
volume. The majority of the above studies did not report a seasonal change in semen 
volume whilst a couple of studies revealed similar findings to our cohort study of 
increased semen volume in Spring in semen donors (Zhang and Yao, 2010) and also in 
  
216 
men pre-vasectomy (Reinberg et al., 1988). It has to be acknowledged however, that 
semen volume was missing in 71 of our samples which may have affected the results. 
The missing data could have led to the false positive finding of seasonal change in 
semen volume. 
 
Improving the efficiency of the donor programme was one of the main aims of this 
project. As only thawed sperm is used for donor insemination treatments, it was vital to 
investigate if the process of freezing and thawing [associated with deterioration of 
semen parameters / sperm function (Mahadevan and Trounson, 1984; Yogev et al., 
2004)] eliminated the seasonality of semen parameters. 
 
In my study, even after thawing, the sperm concentration continued to be significantly 
better in Winter and Spring (Chapter 5). Similar to our study Yogev et al. (2004), 
reported significantly higher post-thaw progressive motile sperm concentrations in 
Winter compared with Autumn and Zhang and Yao (2010) reported higher progressive 
motile sperm counts in Spring. Zhang et al. (2012) in their further study revealed that 
progressive motility recovery rate (defined as % post-thaw progressive motility / % pre-
freeze progressive motility x 100%) was lowest in semen samples donated in Summer 
compared to other seasons. 
 
 In my study there was no seasonal variation in post-thaw sperm motility. In Yogev et 
al. (2004) study, there was no seasonal variation in the percentage of post-thaw sperm 
motility. In that study however, there was no seasonal variation in pre-freeze motility 
either. Although in our study there was a statistically significant seasonal variation in 
pre- freeze motility with lower parameters in Autumn, the difference clinically between 
the seasons was small. As cryopreservation does decrease sperm motility (Sharma et al., 
1997; Stanic et al., 2000), this seasonality disappeared after thawing. 
 
Cryopreservation does not adversely affect sperm concentration, therefore the post-thaw 
sperm concentration parameters continued to be better in Winter and Spring similar to 
pre-freeze counts and  there lies an argument for the seasonal collection of semen 
samples from sperm donors.  
 
Several studies have shown a correlation between seasonal variation in sperm counts 
and birth rates (Fisch et al., 1997; Ossenbühn, 1998; Levine, 1999; Levitas et al., 2013); 
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therefore I investigated the effect of seasonality of sperm production on the chances of 
conception, to strengthen the argument for seasonal recruitment of sperm donors.  
 
There was no seasonal variation in the conceptions by donor insemination either by 
season of original sperm production or by season of treatment in 496 DI treatment 
cycles performed between 2005 and 2010 at NFC (Chapter 5). Few studies in the 
literature have investigated the seasonal variation in donor conceptions by artificial 
insemination which reinforces the fact that the seasonal changes in sperm parameters 
may not be clinically significant and weakens the argument that benefit is to be derived 
from seasonal donor collections.  
 
A couple of studies have suggested a seasonal variation in donor conceptions in 
artificial insemination programmes (Paraskevaides et al., 1988; Ronnberg, 1989). 
However Paraskevaides et al. (1988) study was limited by the fact that both fresh and 
frozen sperm were used and the results were not presented separately for each method.  
As the highest sperm counts occurred from February to May in their study (and not 
October to March when the donor conceptions were at highest), the authors suggested 
that female factors (egg quality / endometrial receptivity) may explain the seasonal 
variation. Ronnberg (1989), who found a similar increase in conceptions from October 
to March using only frozen sperm, considered frozen sperm as a constant factor and the 
contribution by seasonality of sperm quality to the conception was disregarded and it 
was suggested again that possible variation in female factors explained the seasonal 
variation in donor conceptions. In contrast to this (but similar to our study), Mayaux and 
Spira (1989), in a large French epidemiological survey (using only frozen sperm) did 
not find seasonal variation in donor conceptions. This is the only published study that 
investigated donor conceptions by the month or season of sperm collection as we have. 
In this study there was no seasonal variation in donor conceptions even by the season of 
treatment similar to our study, making us question the role of female factors in seasonal 
variation of donor conceptions. 
 
As there is significant seasonal variation in donor semen parameters (both pre-freeze 
and post-thaw) in this study with improved parameters in Winter and Spring (Chapter 
5), whilst there may be little clinical significance, it appears to be a reasonable strategy 
to aim to recruit applicants for sperm donation in these seasons to avoid potential 
rejection based on sub-optimal semen parameters. Particularly because even though  
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sperm donors overall had less than 1% of suboptimal semen parameters as per WHO 
2010 criteria, approximately 11% of the samples were not suitable for freezing as they 
did not meet criteria for freezing (Chapter 5, Section 5.7.4). Zhang et al. (2012) 
recommended that semen donation should be encouraged in seasons other than Summer 
to obtain improved progressive motility recovery rate. 
 
 However, importantly there was no seasonal variation in the outcome of the donor 
conceptions in my study by the season of original sperm production despite Spring 
being the most common season of sperm donation and most of the treatment cycles 
carried out with sperm produced in Spring. 
 
The reasons for significant seasonal variation in semen parameters not translating to 
improved pregnancy rates may be explained by the following couple of studies in 
addition to several other factors affecting conception. It has been shown that increasing 
sperm concentration improves the chance of conception but only up to 40 million/ml 
and a rise beyond that does not increase the likelihood of a pregnancy (Bonde et al., 
1998). Despite showing distinct differences in semen parameters between fertile and 
subfertile men in their study, Guzick et al. (2001) found an extensive overlap of fertile 
and sub-fertile ranges of semen parameters (count/motility/morphology) in both fertile 
and subfertile men and concluded that none of the semen parameters were powerful 
predictors of pregnancy. 
 
Interestingly some of the studies which showed a correlation with semen parameters 
and natural conception and birth rates compared the seasonal variation in those 
parameters in a cohort of men and correlated this to regional birth rates (Fisch et al., 
1997; Ossenbühn, 1998; Levine, 1999; Levitas et al., 2013). However in our study we 
investigated the seasonal variation in the artificial insemination conception rates and 
also the semen quality of the semen donors, whose sperm was used directly for those 
treatments, providing a potentially stronger link. 
 
Even though there is a seasonal difference in donor semen parameters but not donor 
conceptions, I do not believe that it is worthwhile restricting recruitment of sperm 
donors to certain seasons, particularly during these times of sperm donor shortage. 
Clearly donor convenience also overrides seasonal collection of semen samples as we 
have no strong argument in favour the latter. 
  
219 
In humans, a wide expression of VDR and vitamin D metabolising enzymes in the male 
reproductive tract (Aquila et al., 2009; Blomberg Jensen et al., 2010; Foresta et al., 
2011) along with  in vitro studies revealing that vitamin D enables sperm capacitation, 
improves sperm motility, survival and induces the acrosome reaction (Aquila et al., 
2008; Aquila et al., 2009; Blomberg Jensen et al., 2011) suggests a role of vitamin D in 
male reproduction. 
 
We investigated the correlation between semen parameters and serum vitamin D in a 
cross sectional association study and also a cohort study (which is the first ever 
longitudinal study undertaken) to examine the change in semen parameters with a rise in 
serum vitamin D level, both with seasonal rise (in vitamin D non-deficient participants) 
and vitamin D supplementation (in vitamin D deficient participants).  
 
There was a significant rate of vitamin D deficiency in men attending NFC. The 
prevalence of vitamin D deficiency in Winter and Spring was almost three times the UK 
national prevalence of 16% (Hyppönen and Power, 2007). Even though the prevalence 
of hypovitaminosis D increases as one moves north in the UK (Hyppönen and Power, 
2007), the prevalence in our study  is higher than that reported regionally (Hyppönen 
and Power, 2007) and persisted even after excluding our 12% high risk non-Caucasian 
participants. Whether men attending fertility clinic are also a specific risk group for 
hypovitaminosis D needs further study. 
 
In the cross sectional association study there was no significant difference in the various 
semen parameters between vitamin D groups, although the numbers of men with 
adequate (15) and optimal levels (6) of vitamin D were low. These low numbers were 
unexpected as the high prevalence of hypovitaminosis D in the Winter/Spring period 
when participants were recruited was unanticipated. 
 
Sperm counts and morphology were lower in the optimal (>75nmol/l) vitamin D group 
compared to other three groups but this did not reach statistical significance. These 
findings are similar to the cross sectional association study by Ramlau-Hansen et al. 
(2011), which showed no association between serum vitamin D levels and semen 
parameters. The authors, similar to our study suggested that serum vitamin D deficiency 
(<25nmol/l) is not associated with reduced semen quality. In another small study 
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recruiting 90 men attending an infertility clinic, there was no correlation between 
vitamin D and semen parameters (Knopf et al., 2011) 
 
Conversely, in another association study of Danish men, there was a weak positive but 
significant association between serum vitamin D level and sperm motility. However 
there was no association between vitamin D and semen volume, sperm count  and sperm 
morphology (Blomberg Jensen et al., 2011).  
 
In our cohort study, sperm count, motility and morphology deteriorated significantly 
with increased serum vitamin D levels secondary to vitamin D supplementation and also 
seasonal rise. There is some evidence that higher serum vitamin D levels are associated 
with lower sperm parameters. In Ramlau-Hansen et al. (2011) study, it appeared that 
men with high vitamin D (i.e. between 94- 227nmol/l in their study) had lower sperm 
counts and a lower percentage of normal sperm morphology, but after transforming the 
data and adjusting for the confounders, as mentioned previously they found no 
association between serum vitamin D and semen parameters. 
 
In another association study by Hammoud et al. (2012), sperm concentration, 
progressive sperm motility, sperm morphology and the total progressive motile sperm 
count were lower in men with high concentrations of vitamin D, but this group included 
only men with a serum vitamin D level above 125nmol/l.  Unlike our study, they also 
found worse sperm parameters (total progressive motile sperm count and total sperm 
count) in men with a serum vitamin D of less than 50nmol/l. They suggested a ‘U’ 
shaped association between vitamin D levels  and semen parameters, similar to the 
association seen between vitamin D and some non-skeletal conditions such as  
cardiovascular disease and pancreatic cancer  (Ross et al., 2011; Rosen et al., 2012). 
 
Male factor subfertility was seen in 43% of our study participants and may have had a 
significant impact on the results as it was shown that  subfertile men have a lower 
expression of VDR and vitamin D metabolizing enzymes in testis and sperm compared 
to normal men (Aquila et al., 2009; Foresta et al., 2011; Blomberg Jensen et al., 2012) 
and this may then contribute to the lack of improvement in the semen parameters with 
rising vitamin D levels. In vitro experiments conducted by Blomberg et al revealed that 
1,25(OH)2D increased sperm motility in young men but not in sub-fertile men 
(Blomberg Jensen et al., 2012).  
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However cross sectional association studies including fertile and subfertile men 
surprisingly still revealed a positive association between vitamin D and semen 
parameters. Blomberg Jensen et al. (2012) in their study of 70 men (involving  sub-
fertile and  young men),  demonstrated that progressive sperm motility was significantly 
higher in the vitamin D non-deficient group (>25nmol/l) compared to the vitamin D 
deficient group. Similarly, in a recent large cross sectional association study by Yang et 
al. (2012) again a significant positive association between serum vitamin D and sperm 
motility and also sperm morphology was seen in the subfertile men group. Surprisingly, 
in fertile men where a  more positive association is anticipated because of the 
abundance of receptor expression, this positive association was seen only between 
vitamin D and sperm motility and not sperm morphology. 
 
Vitamin D inactivating enzyme (CYP24A1) expression in sperm has been shown to 
correlate positively with semen parameters and distinguish young men from subfertility 
clinic recruits, however as serum vitamin D was seen to be similar in men with low and 
high CYP24A1 expression, it was suggested that the local vitamin D metabolism may 
influence CYP24A1 expression in sperm and may be more significant than systemic 
vitamin D levels (Blomberg Jensen et al., 2012). We did not check for this in our study.  
Furthermore cellular vitamin D responsiveness is complex and not as tightly regulated 
as systemic vitamin D metabolism (Blomberg Jensen, 2012).  
 
Overall from the association studies published so far, the association between vitamin D 
and semen parameters appears to be inconsistent, varying from a positive association 
(Blomberg Jensen et al., 2011; Blomberg Jensen et al., 2012; Yang et al., 2012) to a ‘U’ 
shaped association (Hammoud et al., 2012) or to no association (Knopf et al., 2011; 
Ramlau-Hansen et al., 2011). Our study has contributed to this uncertainty showing an 
apparent negative correlation.  
 
Variations in the study participants (healthy volunteers / men attending infertility clinic 
/ fertile and subfertile men), serum vitamin D measurement techniques and vitamin D 
group stratification (2 /3 /4 groups with different cut offs) may have contributed to the 
variation in results seen between studies. As spermatogenesis starts about 72 days prior 
to semen sample collection, it has been suggested that serum vitamin D levels be 
checked a few months prior to the semen analysis to investigate the true association  
(Blomberg Jensen et al., 2011). 
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The association between vitamin D and sperm function (acrosin activity or sperm 
motility) in in vitro studies appears to be dose dependent and importantly with higher 
concentrations of vitamin D these responses became either ineffective or inhibitory 
(Aquila et al., 2008; Blomberg Jensen et al., 2011). A possibility of receptor down-
regulation with higher levels of vitamin D has been suggested (Aquila et al., 2009).  
Such phenomena may have contributed to the marked deterioration seen in semen 
parameters with rising vitamin D in our study, but the effect of other seasonal factors 
independent of vitamin D cannot be ruled out. 
 
Studies have so far investigated the association of serum vitamin D and individual 
semen parameters; I further investigated the association between serum vitamin D and 
semen quality (divided into optimal and sub-optimal based on WHO 2010 criteria) as 
opposed to individual semen parameters, since a change in the semen quality (from 
optimal to sub-optimal or vice versa) may be clinically more relevant than an increase 
or decrease in individual sperm parameters.  In my study there was no significant 
difference in the number of participants with optimal and suboptimal semen quality in 
each of the four vitamin D groups (deficiency /insufficiency / adequate and optimal) 
(Chapter 7).  
 
Although a significant negative association was seen between serum vitamin D levels 
and individual semen parameters with vitamin D supplementation and seasonal rise in 
vitamin D levels (Chapter 6), there was no significant change in the numbers of 
participants with optimal and sub-optimal semen quality following vitamin D 
supplementation and seasonal rise in vitamin D levels [88% (74/84) had unchanged 
semen quality] (Chapter 7). This means that the impact of vitamin D on individual 
semen parameters mostly does not change the overall semen quality. In other words for 
the majority of the participants there were no obvious clinical implications. 
 
An improvement in the overall semen quality to optimal with vitamin D could 
potentially be a useful and easy therapeutic option in the management of idiopathic 
oligospermia, however our results do not support the use of this intervention, and we 
recommend caution, as it could cause a deterioration in semen parameters. A double-
blinded randomized clinical trial is underway by Blomberg et al to investigate the effect 
of vitamin D supplementation in subfertile men and we await the results with interest 
(Clinical Trials.gov Identifier: NCT01304927). 
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Whilst the assessment of the effects of season and vitamin D on sperm parameters and 
overall semen quality does not appear to have a clinical impact these are surrogate 
markers for sperm function. To investigate the hypothesis that a variation in the serum 
vitamin D in men may alter fertilisation rates and also affect embryo quality, the 
association between the male partner’s serum vitamin D levels and female partner IVF 
outcomes were evaluated (Chapter 7). Importantly there were no significant differences 
in the fertilisation rates, quality of embryos, pregnancy rates and numbers of embryos 
for freezing between the treatments carried out in Winter/Spring and Summer/Autumn 
even though serum vitamin D levels increased significantly in the male partner. This 
could be because the processes involved in assisted reproduction, such as sperm 
preparation, may eliminate the effects of vitamin D on sperm function. However there 
are no human studies as yet investigating the association of male partner’s vitamin D 
levels with natural conception rates or outcomes of assisted reproduction and our study 
contributes to the literature regarding this. 
 
Although vitamin D deficiency has been shown to be very common in men attending 
our centre, it is not associated with poor semen parameters. Based on the results from 
our preliminary study of the negative association between vitamin D and semen 
parameters, vitamin D supplementation may be harmful to semen parameters and I 
believe therefore that it should not be recommended. However vitamin D 
supplementation for other health reasons such as bone health is essential and should 
continue. The negative association seen in our study is intriguing and warrants further 
research to clarify the mechanism. 
 
 Interestingly the vitamin D study results (Chapter 6) are consistent with our seasonal 
variation in semen parameters (Chapter 5) which revealed improved parameters in 
Winter/Spring when serum vitamin D levels are lower than Summer/Autumn. Therefore 
I wonder if other effects of season (by the changes in temperature and photoperiod, 
although not proven; Chapter 1 Section 1.3) were more important to semen parameters, 
overwhelming any influence of vitamin D. This could be clarified by a study in which 
participants are recruited throughout the year and followed up throughout the following 
year as opposed to our study where participants were recruited in Winter/Spring and 
followed up in Summer/Autumn). This would have the potential advantage of more 
participants with adequate and optimal levels of vitamin D for comparison and 
eliminate the effect of season on an individual. Until further research clarifies, I 
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recommend vitamin D supplementation should not be given specifically for sperm 
quality. More studies are needed to confirm or refute the negative association seen in 
our study before such recommendations can be made. 
 
In conclusion I have confirmed that there is a problem of sperm donor shortage at 
Newcastle Fertility Centre, but to address this I do not recommend the seasonal 
recruitment of sperm donors to improve the efficiency of the sperm donor programme, 
or the use of vitamin D supplementation to improve semen quality. 
 
Meanwhile to improve sperm donor recruitment nationally, NGDT continues to raise 
the awareness of the problem of sperm donor shortages and the HFEA has introduced 
policies for improved donor compensation allowing a fixed sum of £35 per visit for 
sperm donors (HFEA, 2011a) from April 2012. The results of the pilot study of national 
sperm donation service programme are awaited which may provide valuable 
information to improve sperm donor recruitment and if considered successful, may be 
an effective solution for the national problem of sperm donor shortage with the most 
efficient use of the available limited resources. Locally at NFC, the donor selection and 
recruitment criteria have been addressed to improve sperm donor recruitment; strategies 
have been introduced to improve the efficiency of the donor sperm use by modifying 
the laboratory processing of semen samples to obtain more straws per ejaculate and 
introducing protocols which decrease the utilization of straws, whilst continuing to 
assist patients in their efforts for donor sperm treatment without compromise to success 
rates.
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Academic Achievements so far from this project 
 
International oral presentations 
1. How has the Disclosure of Donor Information act affected the donor programme at a 
tertiary care fertility centre in the UK?   
Presented at 27th Annual Meeting of the European Society of Human Reproduction and 
Embryology, Stockholm, Sweden; July 2011. Human Reproduction:  2011, volume 26, 
issue supplement 1, Ppi22-124 (doi:10.1093/humrep/26.s1.16).This presentation also 
attracted the media attention and was published in Daily telegraph on 7
th
 July 2011 
http://www.telegraph.co.uk/health/healthnews/8623260/Law-leads-to-18-month-wait-
for-fertility-treatment.html. 
 
 2. ‘Does a rise in vitamin D level improve semen quality?’  
Presented at 28
th
 Annual Meeting of the European Society of Human Reproduction and 
Embryology, Istanbul, Turkey; July 2012. Human Reproduction: 2012, volume 27, 
issue supplement 2, ii47-ii49.(doi: 10.1093/humrep/27.s2.32 ) 
   
National oral presentations  
1. Is there a correlation between serum levels of Vitamin D and male fertility? 
Presented at Fertility 2012, 6th-7th January 2012, Leeds, UK, British Fertility Society 
Annual meeting. Human Fertility, 2012; 15(1): 43    
 
2. Is there a seasonal variation in conceptions by donor insemination?  
Presented at Fertility 2013 (8th biennial conference of the UK Fertility Societies), 
January 2013, Liverpool, UK.  Human Fertility, 2013; 16(3): 221    
 
Local presentations 
1. How has the ‘Removal of Donor Anonymity’ affected the donor programme at 
Newcastle Fertility Centre at Life? Presented at Northern Deanery Trainee Prize 
competition in October 2010 and was awarded best prize. 
 
2. ‘Association of vitamin D and semen quality’ – presented at North East Fertility 
Forum NEFF meeting in January 2012. 
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 Poster presentations 
1. How has the ‘Removal of Anonymity’ law affected the Donor Programme at 
Newcastle Fertility Centre? Presented at Fertility 2011, 5th–7th January 2011, Dublin, 
7th biennial conference of the UK Fertility Societies.Posted online, Poster 128, Human 
Fertility, 2011; Early Online, 1–88 
http://informahealthcare.com/doi/abs/10.3109/14647273.2011.575665  
 
2.‘Seasonal variation of semen quality in a 3 year study’  Presented at Fertility 2012, 
6th-7th January 2012, Leeds, UK, British Fertility Society Annual meeting. Human 
Fertility, 2012; 15(1): 45 
 
Publication 
1."The Sperm Donor programme over 11years at Newcastle Fertility Centre” published 
in Human Fertility, December 2013, Vol 16, No: 4, Pages 258-265.  
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Appendix A: Patient information sheet 
Seasonal Variation of vitamin D levels and sperm   
parameters (Version number / Date – 02/ 221010)          
Information for potential research patients 
We would like to invite you to take part in research. Before you decide it is important 
that you understand why the research is being done and what it will involve.This 
information sheet is yours to keep. It tells you the purpose of the study and explains 
what will happen to you if you take part.Please take time to read the following 
information carefully and discuss it with others if you wish. Ask us if there is anything 
that is not clear or if you would like more information. Your standard NHS clinical care 
will not be affected whether or not you decide to help in the study. 
 
What is the purpose of the study? 
It is known that vitamin D levels in the blood vary in different seasons due to different 
amount of sunlight exposure at different times of the year. We also know that there are 
seasonal variations in number and quality of a man’s sperm. This research aims to 
consider the seasonal variation in Vitamin D levels and its possible effect on sperm 
characteristics. 
  
What am I asked to do?  
We will fill in a questionnaire about your health when you attend the clinic. We are 
asking you for a blood test for vitamin D levels and a semen sample on 2 occasions 
about 6 months apart, once in winter/spring and once in summer/autumn. Semen 
analysis will be done as a part of your standard investigations and this can be used for 
the study. The blood test (about a tablespoon of blood) can be taken when you attend 
the clinic to avoid extra visits where possible. Sometimes however you may be asked to 
attend the unit for a test specifically for research. If you are happy to participate in this 
research you will need to sign the consent form attached.   
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What are the possible benefits of taking part? 
Occasionally we may find a man with very low vitamin D levels that would lead to 
softening of bone tissue. We would let you know the results as this would need 
treatment. There are no direct benefits to you with regards to fertility. 
  
What will happen to me if I take part? 
Taking part in the research will not alter your treatment. It will not directly increase or 
decrease your chances of having a baby.   Your visits to the unit to submit tests for the 
research will be minimised and co-ordinated with your clinical management as much as 
possible. 
 
What possible problems might occur? 
Semen samples 
There are no specific problems associated with producing a semen sample although you 
will be asked to produce it in the unit. You may well have already produced samples in 
this way. If you are unable to produce a sample at the appointment time don’t worry we 
can rearrange the appointment if necessary or make other arrangements if appropriate. 
 Blood samples 
There is rarely a problem with taking a small blood sample – usually from a vein in 
your arm. You may experience some discomfort or on occasion some bruising at the site 
of blood taking but you will be instructed on how best to avoid this at the time. 
 
What will happen to my samples if I take part? 
Your samples are a gift to the Newcastle Upon Tyne Hospitals NHS Foundation Trust 
and will be used solely for the purposes of this research project. Taking part in this 
research study has no financial benefit to you. Both blood and semen samples will be 
disposed of after analysis. 
 
Will participating in research affect our treatment? 
No. You can be assured that your treatment always comes first and we would not do 
anything that would compromise your chance of achieving a successful pregnancy. 
Data and Results 
Will my taking part in research be kept confidential? 
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All information collected about you during the course of the research will be kept 
confidential by those involved in the research. The collected data will be kept by the 
researchers for 6-12 months after the completion of the study. 
 
What will happen to the results of the study? 
Whenever possible we will publish the results of our studies in scientific journals. We 
will also present data at scientific conferences. You will not be identified personally in 
any way in any publication or presentation. 
 
Will we get any results that we will need to know about? 
If the level of the vitamin D is low enough to warrant treatment we will let you know as 
soon as possible. You can be notified about the final outcome of the research if you 
wish. 
 
Management of this research 
Who is funding the research? 
Research is supported by Department of Reproductive Medicine, Newcastle Fertility 
Centre at Life. 
 
How is the research overseen? 
Research is overseen by the Newcastle upon Tyne NHS Hospitals Foundation trust.  
 
What if something goes wrong? 
It is highly unlikely anything could go wrong in this study but in the rare event that you 
are harmed during the research due to someone’s negligence, then you may have the 
grounds for a legal action for compensation against Newcastle upon Tyne hospitals 
NHS Foundation Trust but you may have to pay your legal costs. 
If you wish to complain, or have any concerns about any aspect of the way you have 
been approached or treated during the course of the study, the normal NHS complaints 
procedure are available to you. You could also discuss any issues with PALS (Patient 
Advice Liaison Service). 
Address –  
North of Tyne PALS, 
The Old Stables, 
Grey’s Yard, 
Morpeth, 
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NE61 1QD. 
Phone – 0800 032 0202 
Text – 01670 511260 
E-mail – northoftynepals@nhct.nhs.uk 
 
Contact for further information 
For further information you can contact  Dr.Madhavi Gudipati during 9am to 5pm, 
Monday to Friday on 0191 2138213 . 
Who is leading the research?                                               
Dr. Madhavi Gudipati,                                                
Clinical Research Fellow, 
Newcastle Fertility Centre at Life, 
Contact No: - 07771985883. 
 
Dr. Jane Stewart, 
Consultant in Reproductive Medicine, 
Newcastle Fertility Centre at Life, 
Contact No: 0191 2135011. 
 
Mr. Kevin McEleny, 
Consultant Andrologist, 
Newcastle Fertility Centre at Life 
Contact No: 0191 2138223. 
 
Professor Simon Pearce, 
Professor of Endocrinology, 
Institute of Human Genetics, 
International Centre for Life, 
Contact No: 0191 2418674.
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Appendix B: Questionnaire 
CODE 
Questionnaire (version number / Date: 02/ 201010) 
 
1. Hosp.No: 
  
2. Age 
 
3. Ethnic Group 
 
4. Occupation 
 
5. Primary / Secondary subfertility 
 
6. Medical problems affecting fertility-   Yes / No 
 
7. Febrile illness in the last 3 months- Yes /No 
 
8. Surgical problems affecting fertility – Yes / No 
 
9. STD- Yes / No 
 
10. Alcohol -     units/day 
 
11. Smoking-      per day 
 
12. Regular medication- Yes / No 
 
13. Recreational drugs/ Steroids – Yes /No 
 
14. Vitamin Supplements containing vitaminD – Yes / No 
 
15. Recent travel to hot countries / southern hemisphere or to tropical places in last 
3 months Yes / No 
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16. Vegetarian – Yes / No 
 
17. Margarine – daily / weekly / less than weekly 
 
18. Oily fish – weekly / less than wkly / never 
(salmon / trout / mackerel) 
 
19. Use of sun protection – Usually / sometimes / rare or never 
 
20. Time spent watching TV/ using PC - <2H / 2-3H / >3H per day 
 
21. Outdoor activity in previous month - <1H/ 1-3H / >3H per day 
 
22.  BMI >30 – Yes / No 
 
23. Results  
 
         Month      Vitamin D    Semen analysis 
   
   
 
Comments 
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Appendix C: Consent form 
 
 
Seasonal variation in Vitamin D levels and sperm parameters 
                                   CONSENT FORM      
□      I have read and understood the information sheet and the consent form    about the 
study; and have had the opportunity to discuss it. 
□      I understand that I have to submit blood and semen samples on 2 occasions to take 
part in the research study. 
□      I understand that I am under no obligation to take part in this study and that a   
decision not to participate will not alter any treatment that I would normally 
receive. 
□      I am aware that I can withdraw my consent at any time.  
□      I uunderstand that relevant sections of my medical notes and data collected during 
the study may be looked at by regulatory authorities or from the NHS Trust, where 
it is relevant to my taking part in this research. I give permission for these 
individuals to have access to my records.    
□      I consent to be reminded of the test appointment by letter / phone / text message 
/mail. 
□      I consent to the storing and processing of data collected about me. I understand the 
data will be kept for 6 – 12 months after the completion of the study. I understand 
data will be kept secure and confidential. I am aware that electronic data base will 
not have any identifying information and is coded.  
□     I understand that an abnormally low Vitamin D level may be found and am happy 
for my GP to be informed of this result to arrange replacement treatment. 
□      I understand that I will not benefit financially from this research and its outcome. 
 □    I want / do not want to be informed of the outcome of the study. 
I consent to my participation in the study. 
 
 
Patient’s name - ……………………Signature……………….Date…….. 
 
Clinician’s name-……………………Signature……………….Date…… 
Best contact- ……………… 
CODE-……………………..
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Appendix D: Invitation letter to the participants 
a) For participant’s with normal vitamin D levels 
Head of Department:  Professor Alison Murdoch 
Consultant in Reproductive Medicine:  Dr Jane Stewart 
Consultant in Reproductive Medicine:  Dr Alka Prakash 
Consultant Andrologist:  Mr Kevin McEleny 
Scientific Director:  Dr Mary Herbert 
Senior Nurse:  Eilis Moody/Jan Dutton 
 
Reference MG 
Typed: 24/8/2011 
Private & Confidential 
 
Mr. xxxxx 
Address 
Dear Mr.xxxxx, 
Many thanks for participating in the research project ‘Seasonal variation in vitamin D 
and semen parameters’. I am pleased to inform you that we have completed the first 
phase of the research. Your participation is greatly appreciated. 
This is to remind you your next appointment which includes a blood and semen sample 
from you has been arranged for   
Monday 17
TH
   October 2011 at 16.00 
I would be very grateful if you could attend. It would be helpful if you could 
acknowledge this letter to confirm your participation. 
 If you have routine appointment in this Unit, please let me know so that I can arrange 
to see you then instead. If you cannot attend please do not hesitate to contact me and I 
will be able to find a suitable alternate time for you. You may find a weekend or 
evening appointment more convenient.  
You may remember abstinence for 2-7 days prior to producing the semen sample for 
optimal analysis. You can consider producing the semen sample at home if you live 
nearby and it suits you to do so. I would be able to arrange this for you. 
Your failure to attend the appointment will unfortunately leave the research incomplete 
and we will be unable to draw any valid conclusions. So I am most grateful for your co-
operation. 
Kind regards 
Madhavi Gudipati 
Research registrar  
Newcastle fertility centre 
Phone – 0191 2138213 
E-Mail – madhavi.gudipati@nuth.nhs.uk 
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b) For participant’s with deficient vitamin D levels 
Head of Department:  Professor Alison Murdoch 
Consultant in Reproductive Medicine:  Dr Jane Stewart 
Consultant in Reproductive Medicine:  Dr Alka Prakash 
Consultant Andrologist:  Mr Kevin McEleny 
Scientific Director:  Dr Mary Herbert 
Senior Nurse:  Eilis Moody/Jan Dutton 
Reference MG 
Typed:  
Private & Confidential 
Mr.  
Address  
Dear   Mr. 
Many thanks for participating in the research project ‘Seasonal variation in vitamin D 
and semen parameters’. I am pleased to inform you that we have completed the first 
phase of the research. Your participation is greatly appreciated. 
This is to remind you your next appointment which includes a blood and semen sample 
from you has been arranged for   
Friday 14
th
 October 2011 at 14.30 
I would be very grateful if you could attend. It would be helpful if you could 
acknowledge this letter to confirm your participation. The repeat blood test will help 
confirm that your vitamin D levels have returned to normal with treatment.  
 If you have routine appointment in this Unit, please let me know so that I can arrange 
to see you then instead. If you cannot attend please do not hesitate to contact me and I 
will be able to find a suitable alternate time for you. You may find a weekend or 
evening appointment more convenient.  
You may remember abstinence for 2-7 days prior to producing the semen sample for 
optimal analysis. You can consider producing the semen sample at home if you live 
near by and it suits you to do so. I would be able to arrange this for you. 
Your failure to attend the appointment will unfortunately leave the research incomplete 
and we will be unable to draw any valid conclusions. So I am most grateful for your co-
operation. 
Kind regards 
Madhavi Gudipati 
Research registrar  
Newcastle fertility centre 
Phone – 0191 2138213 
E-Mail – madhavi.gudipati@nuth.nhs.uk
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          Appendix E: NEQAS calculations and results interpretation 
Definitions from the NEQAS participants handbook 
ALTM - All laboratory trimmed mean, this is the geometric mean of the entire set of 
trimmed results for a specimen. 
MRTM - Method related trimmed mean is a geometric mean of 'trimmed' results from 
one methodology. 
Bias - The difference between your result and the designated value expressed as a 
percentage. 
BIS - The bias divided by a chosen co-efficient of variation (CCV) multiplied by 100. 
CCVs are selected to give more leeway to lower designated values so as better to reflect 
clinical relevance. Values can either be positive or negative. 
Calculations: 
 
Bias (%)                  (Your result – NEQAS designated value) 
                                                   X    100 
                                                 NEQAS designated value 
  
 
Bias Index Score (BIS)                         Bias (%) 
                                 X     100 
 
                         CCV 
Chosen Co-efficient of Variation (CCV) 
 
Sperm Motility              Sperm Concentration 
 
NEQAS designated value CV  NEQAS designated value CCV 
<10 0.0 <15 50.0 
10<20 0.0 15<30 25.0 
20<30 25.0 >30 20.0 
>30 0.0  
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Interpretation of results 
Sperm Motility 
If BIS is ≥ +100 or ≤ -100 for at least 2 out of the 3 parameters in at least 3 out of the 4 
samples = unsatisfactory performance. 
Concentration 
If BIS is ≥ +100 or ≤ -100 for at least 3 out of the 4 samples = unsatisfactory 
performance. 
Sample Morphology 
If result is > twice the NEQAS designated value for at least 3 out of the 4 samples = 
unsatisfactory performance. 
Online Morphology 
Not yet defined 
For each assessment (motility, concentration, morphology), if this happens on three 
distributions within the last eight distributions, the laboratory will be contacted as a 
persistent unsatisfactory performer.  
 
Reference: UK NEQAS, Participants’ Handbook for Reproductive Science Schemes; 
www.cmft.nhs.uk/media/227268/ph%202012.pdf
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 Appendix F: Training check list 
 
Training Checklist: Routine Semen Analysis 
 
Name: _________________________________ 
 
Note: Continue until all assessments completed accurately on 5 consecutive samples.  
 
Date: ____/____/____ 
 
Sample Details:   GP   /   NFC      
 
Workstation set up correctly       Y / N 
 
Sample acceptance process followed      Y / N 
 
Liquefaction process assessed correctly     Y / N 
 
Sample volume measured accurately      Y / N 
 
pH test performed appropriately:      Y / N 
 
Slides loaded correctly: 
Glass slide:          Y / N 
Microcell:          Y / N 
 
Concentration assessment (Neubauer): 
 
Initial dilution determined correctly      Y / N 
Loading of C-Chip performed correctly     Y / N 
Number of squares counted determined correctly    Y / N 
Final total concentration determined correctly (<10% variation)  Y / N 
 
Trainee result: ______ M/ml Trainer result: _______M/ml  
 
Comments (eg if greater than > 10% variation)  
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
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Motility / Morphology assessment: 
 
Classification Trainee result (%) Trainer result (%) 
Progressive sperm           
Non-Progressive sperm   
Immotile sperm   
Normal sperm   
Abnormal sperm   
 
Comments ( eg main types of abnormalities / if greater than > 5% variation between 
operator results )  
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
 
Other observations: 
 
Accurate recognition of need for specialist processing     Y / N 
(Log any tests performed on Lab-RF/Staff/44 - Specialist testing of semen samples 
training checklist)  
 
Post analysis procedures followed correctly: 
Reporting procedure                    Y / N 
Disinfection procedure         Y / N 
 
Competency demonstrated throughout process     Y / N 
 
Full competency demonstrated (on 5 consecutive occasions)    Y / N 
 
(Concentration, motility and morphology results can be collated using Lab-RF/Staff/12 
for future reference) 
 
 
 
Trainer’s signature __________________________  Date ____/____/____
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Appendix G: NEQAS:  My accreditation paper work 
 
The details of my participation in the quality control process with the results are 
described below. The distribution (Semen samples) number with the month/ year of 
assessment is as follows 
Distribution-68:  Feb 2011 
Distribution-69: May 2011 
Distribution-70: Aug 2011  
The detailed assessment with BIS and BIAS scores are shown in the table format, 
however the results are described before- 
Internal QC:  
In distributions 69+70 where internal QC was done, I did not have any answers which 
lie > 2 SD away from the mean (of all NFC staff that took part), this was the critical 
level, rather than 1 SD. 
External QC: 
Distribution 68: Assessment of DVD motility and morphology were acceptable but 
Sperm concentration revealed unsatisfactory performance.  
Distribution 69: Assessment of all parameters was to acceptable standards.  
Distribution 70: Assessment of DVD motility, concentration and morphology were 
acceptable; however the online motility assessment showed unsatisfactory performance. 
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Distribution 68 Feb 2011 EQA Red fill = BIS > +100 or < -100
If BIS is out for 3+ out of 4 parameters in 3+ out of 4 samples = unsatisfactory performance
Sample Molility % MG
a 23.3
b 28.2
c 9.7 25.31 25.0
d 38.8 21.18 25.0
a -7.9 11.11 30.0
b 33.1 42.2 20.0
c -12.7
d -8.1
a -31.8
b 132.6
c -42.3
d -40.4
Sample Molility % MG
a 33.3
b 41.2
c 7.8
d 17.6
a -10.2 37.09 20.0
b 64.3 25.08 25.0
c -42.9 13.66 30.0
d -24.8 23.4 25.0
a -51.1
b 257.1
c -143.0
d -99.0
Sample Molility % MG
a 25.5
b 35.5
c 13.1
d 26.2
a 5.1
b 3.6
c -7.6 24.27 25.0
d -1.1 34.27 20.0
a 20.3 14.17 30.0
b 17.9 26.5 25.0
c -25.2
d -4.2
Sample Molility % MG
a 64.3
b 12.1
c 3.8
d 19.7
a 6.0
b 32.2
c -17.0
d -22.9
a 30.0 60.66 20.0
b 80.6 9.15 40.0
c -42.6 4.58 40.0
d -91.6 25.6 25.0
CCV
CCV
BIS
MO247
Bias
BIS
MO248
Bias
BIS
NEQAS Designated 
Values
Bias
BIS
Bias
NEQAS Designated 
Values
NEQAS Designated 
Values
CCV
MO246
MO245
NEQAS Designated 
Values
CCV
DVD sperm motility
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Distribution 68 Feb 2011 EQA Red fill = BIS > +100 or < -100
If BIS is out in 3+ out of 4 samples = unsatisfactory performance
Sample MG
S269 29 24.58 25.0
Bias 18.0
BIS 71.9
Sample MG
S270 134.5 55.84 20.0
Bias 140.9
BIS 704.3
Sample MG
S271 91.25 74.03 20.0
Bias 23.3
BIS 116.3
Sample MG
S272 35.4 22.74 25.0
Bias 55.7
BIS 222.7
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
Sample sperm concentration
NEQAS Designated 
Values
CCV
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Distribution 68 Feb 2011 EQA Red fill = result > tw ice the designated value
Sample MG
S269 4 6.85 13.7
Sample MG
S270 12 7.08 14.2
Sample MG
S271 4 6.75 13.5
Sample MG
S272 5 5.81 11.6
NEQAS Designated 
Values
Designated 
Value * 2
Sample sperm morphology
If  result is > tw ice the designated value for 3 out of 4 samples = unsatisfactory performance
Designated 
Value * 2
NEQAS Designated 
Values
Designated 
Value * 2
NEQAS Designated 
Values
Designated 
Value * 2
NEQAS Designated 
Values
  
244 
 
Distribution 69 May 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
If BIS is out for 2+ out of 3 parameters in 3+ out of 4 samples = unsatisfactory performance
Sample Molility % MG
PR 73
NP 6 Mean SD Lower Upper Lower Upper
IM 21 73.5 2.7 70.8 76.2 68.1 78.9
PR 29 7.1 2.0 5.1 9.1 3.0 11.1
NP 15 19.2 3.3 15.9 22.4 12.6 25.7
IM 56 37.8 6.7 31.2 44.5 24.5 51.1
PR 48 15.0 3.7 11.3 18.7 7.6 22.4
NP 14 47.0 7.4 39.6 54.4 32.2 61.8
IM 38 51.8 6.1 45.6 57.9 39.5 64.0
PR 60 10.8 2.9 7.9 13.8 4.9 16.7
NP 11 37.3 6.7 30.6 44.0 23.9 50.7
IM 29 59.3 5.2 54.0 64.5 48.8 69.7
Sample Motility %
MG 11.8 3.4 8.4 15.1 5.0 18.5
PR 73.0 28.9 6.6 22.3 35.5 15.7 42.1
NP 6.0
IM 21.0
PR 2.8
NP -15.0 71.01 20.0
IM 6.9 7.06 40.0
PR 14.0 19.64 30.0
NP -37.5
IM 23.1
Sample Motility %
MG
PR 29.0
NP 15.0
IM 56.0
PR -19.6
NP 15.0
IM 16.2 36.05 20.0
PR -97.8 13.04 30.0
NP 50.1 48.21 20.0
IM 80.8
Sample Motility %
MG
PR 48.0
NP 14.0
IM 38.0
PR -1.6
NP 44.8
IM -0.9
PR -8.0 48.78 20.0
NP 111.9 9.67 40.0
IM -4.3 38.33 20.0
Sample Motility %
MG
PR 60.0
NP 11.0
IM 29.0
PR 15.5
NP -2.2
IM -11.7 51.94 20.0
PR 77.6 11.25 30.0
NP -7.4 32.84 20.0
IM -58.5
CCV
BIS
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
Bias
BIS
4
± 1 SD ± 2 SD
Bias
2
Bias
BIS
3
Bias
BIS
NEQAS Designated 
Values
Online sperm motility
1
NEQAS Designated 
Values
CCV
1
2
3
4
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Distribution 69 May 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
If BIS is out for 2+ out of 3 parameters in 3+ out of 4 samples = unsatisfactory performance
Sample Molility % MG
PR 52.7
NP 5.5 Mean SD Lower Upper Lower Upper
IM 41.8 45.7 5.0 40.7 50.8 35.7 55.8
PR 94 12.5 4.6 7.9 17.1 3.3 21.7
NP 0.5 41.8 5.9 35.9 47.7 30.1 53.5
IM 5.5 90.6 2.7 87.9 93.3 85.3 95.9
PR 47.4 2.3 1.0 1.3 3.3 0.3 4.3
NP 8.3 7.1 2.0 5.2 9.1 3.2 11.1
IM 44.3 55.0 7.9 47.0 62.9 39.1 70.9
PR 33.9 10.9 4.4 6.6 15.3 2.2 19.6
NP 23.1 34.1 8.5 25.6 42.5 17.1 51.0
IM 43 36.2 7.9 28.3 44.1 20.4 52.1
PR 52.7 23.5 5.9 17.5 29.4 11.6 35.3
NP 5.5 40.3 9.9 30.4 50.2 20.6 60.0
IM 41.8
PR 22.3
NP -41.8
IM -12.1 43.08 20.0
PR 111.7 9.45 40.0
NP -104.5 47.57 20.0
IM -60.6
PR 94.0
NP 0.5
IM 5.5
PR 7.1
NP -84.0
IM -38.6 87.80 20.0
PR 35.3 3.12 40.0
NP -209.9 8.96 40.0
IM -96.5
PR 47.4
NP 8.3
IM 44.3
PR -6.7
NP -19.8 50.83 20.0
IM 14.7 10.35 30.0
PR -33.7 38.62 20.0
NP -66.0
IM 73.5
PR 33.9
NP 23.1
IM 43.0
PR -2.6 34.82 20.0
NP 13.0 20.44 25.0
IM -3.0 44.34 20.0
PR -13.2
NP 52.1
IM -15.1
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
Bias
BIS
MO250
Bias
BIS
MO251
Bias
MO252
BIS
Bias
BIS
± 1 SD ± 2 SD
MO249
NEQAS Designated 
Values
CCV
MO250
MO251
MO252
DVD sperm motility
MO249
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Distribution 69 May 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
If BIS is out for 3+ out of 4 samples = unsatisfactory performance
Sample MG Mean SD Lower Upper Lower Upper
S273 69.5 82.4 20.3 62.1 102.7 41.8 122.9
S274 6 8.5 2.8 5.7 11.4 2.9 14.2
S275 36 46.9 14.1 32.8 61.0 18.7 75.1
S276 31.5 32.2 3.2 29.0 35.3 25.8 38.5
S273 69.5 78.39 20.0
Bias -11.3
BIS -56.7
S274 6.0 9.52 50.0
Bias -37.0
BIS -73.9
S275 36.0 42.60 20.0
Bias -15.5
BIS -77.5
S276 31.5 33.59 20.0
Bias -6.2
BIS -31.1
NEQAS Designated 
Value
CCV
± 1 SD ± 2 SD
CCV
NEQAS Designated 
Value
CCV
Sample
Sample
Sample
NEQAS Designated 
Value
MG
MG
NEQAS Designated 
Value
MG
CCV
Sample
Sample sperm concentration
MG
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Distribution 69 May 2011 IQC Grey text = Outside 1 SD Blue fill = Outside 2 SD
EQA Red fill = result > tw ice the designated value
If result is > tw ice the designated value for 3 out of 4 samples = unsatisfactory performance
Sample MG Mean SD Lower Upper Lower Upper
S273 3 4.4 1.9 2.5 6.3 0.6 8.2
S274 7 5.0 2.2 2.8 7.2 0.7 9.3
S275 3 4.8 2.6 2.2 7.4 -0.4 10.0
S276 6 6.2 2.5 3.7 8.7 1.1 11.3
Sample MG
S273 3 7.07 14.14
Sample MG
S274 7 4.85 9.7
Sample MG
S275 3 6.40 12.8
Sample MG
S276 6 6.08 12.16
NEQAS Designated 
Value
Designated 
Value * 2
NEQAS Designated 
Value
Designated 
Value * 2
NEQAS Designated 
Value
Designated 
Value * 2
± 1 SD ± 2 SD
NEQAS Designated 
Value
Designated 
Value * 2
Sample sperm morphology
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Distribution 70 Aug 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
Sample Molility % MG If  BIS is out for 2+ out of 3 parameters in 3+ out of 4 samples = unsatisfactory performance
PR 33.1
NP 2.2
IM 64.6 Mean SD Lower Upper Lower Upper
PR 91.4 41.1 4.8 36.3 45.9 31.5 50.7
NP 1.4 9.0 6.0 3.0 15.0 -3.0 21.0
IM 7.1 49.9 8.9 41.0 58.7 32.1 67.6
PR 47.9 89.7 2.1 87.6 91.8 85.4 94.0
NP 2.8 2.3 1.6 0.7 4.0 -1.0 5.6
IM 49.3 8.2 1.7 6.5 10.0 4.7 11.7
PR 23.5 49.9 5.5 44.5 55.4 39.0 60.8
NP 15.2 9.2 5.3 3.8 14.5 -1.5 19.9
IM 61.4 40.9 7.8 33.1 48.7 25.4 56.5
Sample Motility %
MG 31.7 4.9 26.9 36.6 22.0 41.4
PR 33.1 21.2 5.7 15.5 26.9 9.8 32.6
NP 2.2 47.0 7.7 39.2 54.7 31.5 62.4
IM 64.6
PR -20.11
NP -74.68
IM 29.72 41.43 20.0
PR -101 8.69 40.0
NP -187 49.80 20.0
IM 149
Sample Motility %
MG
PR 91.4
NP 1.4
IM 7.1
PR 4.5
NP -47.8
IM -24.3
PR 22.4 87.48 20.0
NP -119.4 2.68 40.0
IM -60.8 9.38 40.0
Sample Motility %
MG
PR 47.9
NP 2.8
IM 49.3
PR -8.3
NP -67.7
IM 28.0 52.25 20.0
PR -41.6 8.67 40.0
NP -169.3 38.53 20.0
IM 139.8
Sample Motility % MG
PR 23.5
NP 15.2
IM 61.4
PR -35.6 36.49 20.0
NP -10.9 17.05 30.0
IM 31.8 46.59 20.0
PR -178.0
NP -36.2
IM 158.9
Online sperm motility
± 1 SD ± 2 SD1
2
3
1
4
NEQAS Designated 
Values
CCV
Bias
BIS
BIS
Bias NEQAS Designated 
Values
CCV
3
2
Bias
BIS
NEQAS Designated 
Values
CCV
NEQAS Designated 
Values
CCV
BIS
4
Bias
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Distribution 70 Aug 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
Sample Molility % MG If  BIS is out for 2+ out of 3 parameters in 3+ out of 4 samples = unsatisfactory performance
PR 17
NP 8.2
IM 74.8 Mean SD Lower Upper Lower Upper
PR 81.7 24.4 7.5 16.9 32.0 9.3 39.5
NP 1.2 9.1 3.6 5.5 12.7 1.9 16.3
IM 17.1 66.5 8.6 57.9 75.1 49.3 83.7
PR 66.7 72.2 6.4 65.8 78.6 59.4 85.0
NP 2.5 5.2 4.9 0.3 10.1 -4.6 15.0
IM 30.8 22.6 4.1 18.5 26.7 14.4 30.8
PR 50.8 61.2 7.4 53.8 68.7 46.4 76.1
NP 7 12.4 8.3 4.1 20.7 -4.2 29.0
IM 42.2 26.3 4.0 22.3 30.3 18.3 34.3
Sample Motility %
MG 40.7 11.0 29.6 51.7 18.6 62.8
PR 17 11.2 6.0 5.1 17.2 -0.9 23.2
NP 8.2 48.2 11.5 36.6 59.7 25.1 71.2
IM 74.8
PR -32.03
NP -3.98
IM 12.67 25.01 25.0
PR -128 8.54 40.0
NP -10 66.39 20.0
IM 63
PR 81.7
NP 1.2
IM 17.1
PR 13.74
NP -74.74
IM -26.67 71.83 20.0
PR 69 4.75 40.0
NP -187 23.32 25.0
IM -107
PR 66.7
NP 2.5
IM 30.8
PR 12.16
NP -77.97
IM 6.32 59.47 20.0
PR 61 11.35 30.0
NP -260 28.97 25.0
IM 25
PR 50.8
NP 7
IM 42.2
PR 24.72 40.73 20.0
NP -21.44 8.91 40.0
IM -16.12 50.31 20.0
PR 124
NP -54
IM -81
DVD sperm motility
± 1 SD ± 2 SDMO253
MO254
NEQAS Designated 
Values
CCV
MO255
MO253
MO256
Bias
BIS
BIS
Bias
NEQAS Designated 
Values
CCV
MO255
MO254
NEQAS Designated 
Values
CCV
Bias
BIS
BIS
NEQAS Designated 
Values
CCV
MO256
Bias
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Distribution 70 Aug 2011 IQC Grey text = Outside 1 SD Blue f ill = Outside 2 SD
EQA Red fill = BIS > +100 or < -100
If BIS is out for 3+ out of 4 samples = unsatisfactory performance
Sample MG Mean SD Lower Upper Lower Upper
S277 26 25.6 5.1 20.5 30.7 15.4 35.8
S278 49 60.7 13.5 47.2 74.2 33.7 87.6
S279 6 13.9 7.1 6.8 21.0 -0.3 28.1
S280 28 37.0 7.9 29.1 44.9 21.2 52.8
S277 26.0 24.98 25.0
Bias
4.1
BIS 16.3
S278 49 60.59 20.0
Bias -19.13
BIS -96
S279 6.0 8.56 50.0
Bias -29.9
BIS -59.8
S280 28.0 39.4 20.0
Bias -28.9
BIS -144.7
Sample sperm concentration
± 1 SD ± 2 SD
NEQAS Designated 
Value
CCVSample
MG
NEQAS Designated 
Value
CCV
Sample
MG
NEQAS Designated 
Value
CCV
Sample
MG
NEQAS Designated 
Value
CCVSample
MG
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Distribution 70 Aug 2011 IQC Grey text = Outside 1 SD Blue fill = Outside 2 SD
EQA Red fill = result > tw ice the designated value
If result is > tw ice the designated value for 3 out of 4 samples = unsatisfactory performance
Sample MG Mean SD Lower Upper Lower Upper
S277 7 6.6 1.6 5.0 8.2 3.4 9.8
S278 5 5.0 1.9 3.1 6.9 1.1 8.9
S279 4 3.8 2.6 1.1 6.4 -1.5 9.0
S280 4 4.8 1.2 3.6 5.9 2.4 7.1
Sample MG
S277 7 6.18 12.36
Sample MG
S278 5 6.81 13.62
Sample MG
S279 4 5.03 10.06
Sample MG
S280 4 6.87 13.74
Sample sperm morphology
± 1 SD ± 2 SD
NEQAS Designated 
Value
Designated 
Value * 2
NEQAS Designated 
Value
Designated 
Value * 2
NEQAS Designated 
Value
Designated 
Value * 2
NEQAS Designated 
Value
Designated 
Value * 2
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Appendix H: Letter to participants with vitamin D level deficiency 
 
Head of Department:  Professor Alison Murdoch 
Consultant in Reproductive Medicine:  Dr Jane Stewart 
Consultant in Reproductive Medicine:  Dr Alka Prakash 
Consultant Andrologist:  Mr Kevin McEleny 
Scientific Director:  Dr Mary Herbert 
Senior Nurse:  Eilis Moody/Jan Dutton 
MG/0890852Y 
15/03/11 
 
Joe bloggs 
Address 
Private & Confidential 
Dear Joe, 
This is regarding the blood test done recently as part of the research study “Seasonal 
variation in Vitamin D and sperm parameters”.  Your Vitamin D level is low 
(<25nmol/l).  This is nothing to worry about, but we recommend Vitamin D 
supplementation therapy.  I will write to your GP to organise treatment and perhaps you 
may wish to discuss this with your GP.  Please do not hesitate to contact me if you want 
to discuss this further.  We can also discuss it when you attend the unit next time (please 
ask for me at the reception).  As you know we will repeat your Vitamin D blood test in 
6 months time as part of the research study.  This will also help to ensure the levels have 
returned to normal with treatment. I have enclosed an information sheet on vitamin D 
treatment which also has alternatives while you are waiting for your GP prescription. 
Kind regards 
Yours sincerely, 
 
Dr Madhavi Gudipati
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Appendix I: Letter to Participant’s GP 
 
Head of Department:  Professor Alison Murdoch 
Consultant in Reproductive Medicine:  Dr Jane Stewart 
Consultant in Reproductive Medicine:  Dr Alka Prakash 
Consultant Andrologist:  Mr Kevin McEleny 
Scientific Director:  Dr Mary Herbert 
Senior Nurse:  Eilis Moody/Jan Dutton 
MG/91063611  
Typed: 24/03/11 
 
Dr.M. Henderson, 
Address 
Private & Confidential 
Dear Dr.Henderson, 
Re:  Hosp No:, DOB  
The above patient had their serum Vitamin D level (Serum 25-Hydroxy Vitamin D) 
checked as a part of a research study being done at Newcastle Fertility Centre.  The 
result shows that the Vitamin D level is low (20mol/l).  I would be grateful if you could 
organise for Vitamin D supplementation therapy.  The general recommendation is a 6-8 
week course of Cholecalciferol 20,000 IU, 3 Capsules per week.  Thereafter, patients 
can go on a Vitamin D regime of 1,000 IU per day, or a modified diet to include oily 
fish twice weekly.  As per the research protocol, we will repeat the blood test for 
Vitamin D levels 6 months after the initial test.  This will also help to ensure the levels 
have returned to normal with treatment.  Many thanks for your help. 
I am enclosing a Dekristol (Colecalciferol) information sheet which you may find 
helpful. 
Kind regards 
Yours sincerely, 
 
Dr Madhavi Gudipati 
  
254 
Appendix J: Vitamin D information leaflet   
Dekristol information sheet for primary care & community pharmacies 
1. Dekristol = Colecalciferol (Vitamin D3) 20,000 Unit capsules. 
2. Prescribed for severe Vitamin D deficiency, where standard Calcium+Vitamin D 
will be inadequate and/or the Calcium component undesired (eg. due to dyspepsia, 
constipation, etc).  
3. Although Dekristol is not listed in the BNF, its use has been suggested by the 
Society for Endocrinology and it has been incorporated into the Newcastle, North 
Tyneside & Northumbria Formulary by the Area Medicines Committee, because the 
relevant licensed products (Colecalciferol 10,000 IU and Ergocalciferol [D2] 50,000 IU) 
listed in the BNF are no longer being imported into the UK. 
4. Repeat prescriptions in primary care may need to handwritten if it does not appear 
on the electronic drop-down prescribing system. 
5. Are there any alternatives? 
a. Patient buys Vitamin D tablets (25mcg =1000 Units) over the counter (eg. from 
Holland & Barrett’s at around £7.99 for 100; 2-for-1 offers sometimes 
available).Advice to take 2 tablets per day when vitamin D level is below 25nmol/l. 
6. Is it expensive? 
a. No. The wholesale price for a bottle of 50 Dekristol capsules is only around £15 if 
ordered directly from IDIS, the sole importer. 
b. But the cost can escalate if the community Chemist tries to order smaller quantities 
and/or insists on obtaining it via his/her usual wholesaler, rather than directly from 
IDIS. 
c. As patients rarely need to take more than one capsule every 1-2 weeks, prescribing a 
3-4 month course of treatment will be more cost-effective than a monthly script. 
7. My chemist says that he/she is unable to source Dekristol from the usual 
suppliers….. 
a. Ask them to order it from: IDIS World Medicines 
IDIS house 
Churchfield Road 
Weybridge 
Surrey KT13 8DB 
Tel 01932 824000 
Dr Richard Quinton 
Consultant Endocrinologist 
Dr Glyn Trueman 
Formulary Pharmacist 
The Newcastle-upon-Tyne Hospitals NHS Foundation Trust 
August2009
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Appendix K: Embryo grading 
 
Blastomere number 
Blastomere size 4 =  regular (<10% difference) 
3 = 10-20% 
2 = 20-50% 
1 = >50% 
Fragmentation 4 =  <10% fragmentation by volume 
3 = 10-20% 
2 = 20-50% 
1 = >50% 
Other features Multinucleation 
Granular cytoplasm 
Vacuoles 
Compacting 
 
Table 46: Embryo grading Day 2 / day 3 
 
 
Grades                                            Scoring 
Top Quality Day 2: 4-6 cells 4/4 
Day 3 ≥ 7 cells 
Good quality Day 2: 4-6 cells 4/3 
3/4 Day 3 ≥ 7 cells 
Other quality Any other combination 
Slow Day 2: All 2 cells; Day 3 All ≤ 4 cells 
 
Table 47: Embryo grading  
 
Recorded as blastomere number (cells) (size / fragmentation)
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